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Elizabeth Davis Carlton 
ENERGETIC SIGNALS AND STRESSORS REGULATE REPRODUCTIVE 
IMMUNE TRADE-OFFS AND SEASONAL SICKNESS                                    
RESPONSES IN SIBERIAN HAMSTERS 
 
To ensure survival and reproductive success, animals must optimally allocate 
energy among various physiological and behavioral processes while inhabiting 
environments that change predictably across and unpredictably within seasons. In 
this dissertation, I examined the mechanisms by which a seasonally-breeding 
rodent allocates energy between the reproductive and immune systems within the 
breeding season and modulates intensity of its sickness responses to a simulated 
infection across seasons. Siberian hamsters (Phodopus sungorus) inhibit 
reproduction and display lower body masses, lower levels of the adipose hormone 
leptin, and less intense sickness responses when housed in short, winter-like days 
compared to long, summer-like days. I used several techniques to modulate the 
internal energetic state of the hamsters (i.e., food restriction, manipulation of the 
energetic hormones leptin and insulin, pharmacological induction of glucose 
deprivation) to determine its role in reproductive-immune trade-offs and seasonal 
regulation of sickness intensity. In the first chapter, I examined energetic 
mechanisms involved in regulating reproductive-immune trade-offs in 
reproductively-active female hamsters. I found that glucose deprivation resulted in 
reproductive suppression, however, suppression could be alleviated when animals 
were provided with a hormonal signal of increased fat stores (i.e., leptin). 
Alternatively, reproduction was not inhibited when animals experienced more 
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severe glucose deprivation; yet, providing animals with the signal of increased fat 
stores during this period of severe glucose deprivation resulted in decreased 
allocation to humoral immunity. In the last three chapters, I examined the 
contributions of seasonal changes in energetic fuels and signals to seasonal 
variation in sickness intensity. I found that seasonal variation in sickness-induced 
hypothermia was regulated by seasonal changes in glucose availability and leptin 
levels; however, seasonal changes in sickness-induced anorexia and body mass loss 
were regulated by seasonal differences in body mass more generally. Finally, I 
observed that changes in insulin, a pancreatic hormone secreted in response to 
positive energy balance, had both suppressive and enhancing effects on sickness 
intensity depending on energetic context. These collective findings illustrate that 
physiological trade-offs and sickness intensity are sensitive to a variety of energetic 
modulators and that the effects of these modulators are dependent on their 
interactions with each other and the environment. 
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INTRODUCTION 
Excerpts included from: Carlton, E.D., Demas, G.E., French, S.S., 2012. Leptin, a 
neuroendocrine mediator of immune responses, inflammation, and sickness 
behaviors. Hormones and Behavior 62, 272-279. 
 
Mounting an appropriate immune response to infection is fundamental to 
survival. Immunity is not only modulated in response to pathogen type and 
infection severity, but the strength of an immune response can be influenced by 
demands from other physiological systems and changes in environmental 
conditions. Animals have evolved mechanisms to maintain optimal immune 
function despite variations in their internal and external environments. As such, 
specific mechanisms facilitate energy allocation toward and away from immunity 
based upon an organism’s current energetic needs and demands.  
Energetic trade-offs 
  The majority of free-living animals have relatively finite energy stores that 
they must allocate to different biological processes, such as reproduction, growth, 
thermoregulation, and immune function (Sheldon and Verhulst, 1996). Immune 
responses are energetically costly to mount, and quantification of these costs has 
shown that inoculation with even a very mild antigen can increase oxygen 
consumption by approximately 20 percent (Demas et al., 1997a). In some cases, the 
energetic costs of mounting an immune response may be sufficiently great that 
allocation to biological processes other than immune function is compromised. For 
example, animals stimulated with an immune challenge while engaging in 
reproduction and rearing of offspring often show reduced reproductive success 
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(Bonneaud et al., 2003; Ilmonen et al., 2000; Uller et al., 2006). Similarly, animals 
that are mounting an immune response may show reduced growth and development 
(Fair et al., 1999; Romano et al., 2011).  
The severity of these trade-offs is largely dependent on the quality of the 
animal’s external environment, specifically the availability of energetic resources. 
Some of the strongest evidence that trade-offs among physiological processes are a 
result of limited energetic resources come from studies where food availability is 
manipulated within the laboratory (French et al., 2009b). For instance, female tree 
lizards that are yolking eggs (the most energetically expensive component of 
reproduction in this species) and provided with restricted access to food under 
laboratory conditions take twice as long to heal a wound as compared with non-
reproductive females provided a similarly restricted diet. When food is provided ad 
libitum, however, there is no difference in the wound healing time between the 
reproductive and non-reproductive groups (French et al., 2007). Clearly, balancing 
these trade-offs among competing physiological systems via appropriate allocation 
of energetic resources can be critical for maximizing an animal’s current health, 
survival, and reproductive success.  
Seasonality 
 Outside of laboratory settings and in the wild, organisms face energetic 
trade-offs as a result of seasonal changes in their environment. Animals that inhabit 
temperate zones face challenges that are products of temporal changes in resource 
availability and climate fluctuations (i.e., changes in temperature, precipitation, 
humidity). These changes in resource availability and environmental conditions 
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occur across the annual cycle. For example, the summer months coincide with 
warm temperatures and increased food availability, which provide organisms with 
an opportune time to engage in the energetically costly behaviors associated with 
reproduction (e.g., courtship rituals and territory defense, gestation or egg 
incubation, and offspring care) (Bronson, 1985). However, during the winter 
months, low temperatures lead to reduced food availability and increased 
thermoregulatory demands, and allocating energetic reserves toward activities that 
are non-essential for survival is often not an option. These fluctuations in 
environmental resource availability occur in a mostly predictable manner, and as 
such, animals inhabiting these temperate zones have evolved mechanisms that 
allow them to meet the challenges that accompany these seasons. 
 The most predictable signal of the changing seasons is the change in day 
length (i.e., photoperiod) across the annual cycle. As the colder, winter months 
approach, the days become shorter, and as the warmer, spring months draw near, 
the days become longer. This environmental photoperiod signal can be translated 
into a physiological signal via release of the indoleamine hormone melatonin 
(Goldman, 2001). Melatonin is secreted by the pineal gland during the dark phase 
(i.e., night) and its secretion is blocked by exposure to light. It is the daily increases 
in the duration of melatonin release that provide an organism with a physiological 
cue of the approaching winter months and the decreases in the length of secretion 
that signal the approach of the spring and summer months. Therefore, by utilizing 
this stable photoperiodic cue, animals in non-tropical zones can time the onset and 
3 
 
termination of reproductive events to occur during the months where the climate is 
mild and food is most abundant.  
  Reproduction may be the most obvious and well-studied trait under 
photoperiodic control, but photoperiodic cues also coordinate seasonal changes in 
immune function (reviewed in Nelson, 2002). To combat threats to survival via 
exposure to pathogens in the winter, some animals show enhancement of their 
immune defenses. Specifically, several species of birds and small mammals show 
enhanced immunity when housed in laboratory conditions where they are exposed 
to short, winter-like day lengths as opposed to long, summer-like day lengths 
(Nelson and Demas, 1996).This short-day enhancement of immunity that is 
observed in the laboratory might result from immune system upregulation to 
counteract the immunosuppressive effects of winter environmental stressors like 
low temperatures and reduced food abundance, so that in the wild, summer and 
winter immune function does not differ. This relationship was supported in deer 
mice (Peromyscus maniculatus) as  short-day enhancement of immune function 
disappeared when food was restricted and the lab temperature was lowered to 
simulate winter conditions (Demas and Nelson, 1998). Many of the investigations 
of seasonal variation in immune response have examined variation in immune 
parameters that require very little (i.e., constitutive immune defenses) to moderate 
(i.e., antigen-induced antibody production) energetic investment (Klasing, 2004). 
However, proper seasonal regulation of more expensive acute phase response 
(APR), and the associated sickness behaviors that accompany it, may be one of the 
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more critical immune responses to regulate to ensure survival and reproductive 
success in a temperate environment. 
Sickness responses 
A critical component of immunity, and one of the first responses of the body 
to infection, is the APR, and subsequent behavioral and physiological 
manifestations of sickness that accompanies it. During the APR, pro-inflammatory 
cytokines are released from activated neutrophils and macrophages and aid in the 
recruitment of additional immune cells to the local site of infection. These cytokines 
also act on the brain to generate sickness responses, which are characterized by 
additional release of pro-inflammatory cytokines, fever or hypothermia, anorexia, 
reductions in social, exploratory, and sexual behaviors, and hypothalamic-pituitary-
adrenal (HPA) axis stimulation (Hart, 1988; Tizard, 2008). While behavioral 
patterns associated with sickness responses may appear to be a result of infection-
induced weakness, these responses are actually part of a well-adapted mechanism 
to aid the host organism in clearance of the infectious agent (Hart, 1988). For 
instance, fever acts to inhibit the growth of some viral and bacterial pathogens, and 
the elevated temperature may increase the efficiency of immunological responses 
by enhancing bacterial killing by neutrophils and lymphocyte proliferation (Kluger, 
1986). Additionally, blocking the fever response increases the likelihood of death 
in response to infection in lizards, fish, and rabbits, suggesting that the fever 
response is critical for animals to survive illness (Covert and Reynolds, 1977; 
Kluger et al., 1975; Vaughn et al., 1980). Anorexia may also be adaptive because 
it promotes a more efficient immune response (i.e., force-feeding some organisms 
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to achieve normal dietary intake during sickness results in increased mortality) or 
it may lead to greater stringency in diet selection, which allows an animal to alter 
its internal environment rendering it less favorable for pathogen growth (Kyriazakis 
et al., 1998; Murray and Murray, 1979; Tizard, 2008). Mounting a sickness 
response is clearly beneficial to an organism’s survival, but being sick is also a 
significant energetic investment. Maintaining a fever results in an increased 
metabolic rate (Buchanan et al., 2003; Maier et al., 1994), while anorexic behavior 
limits an animal’s energetic stores and contributes to body mass loss during illness. 
Much of the work on sickness responses in this area has been performed by 
experimentally inducing sickness with lipopolysaccharide (LPS), an inert antigen 
from the cell wall of gram-negative bacteria.  LPS is recognized by Toll-like 
receptor (TLR) 4, and activation of TLR4 stimulates the production of the pro-
inflammatory cytokines, interleukin (IL)-1β, IL-6, and tumor necrosis factor 
(TNF)-α, which are released by activated neutrophils and macrophages and then 
act on the brain via the vagus nerve or humoral pathways. Ultimately, it is a 
combination of an animal’s infection-induced release of pro-inflammatory 
cytokines, sensitivity to these pro-inflammatory cytokines, and the magnitude to 
which anti-inflammatory mechanisms suppress the effects of these pro-
inflammatory cytokines that controls sickness response intensity (Konsman et al., 
2002; Quan and Banks, 2007). 
Seasonal variation in sickness responses  
Studies of sickness responses in several seasonally breeding species have 
shown that the magnitude of an animal’s response to infection varies across 
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seasons. For instance, in response to LPS, male Siberian hamsters (Phodopus 
sungorus) that are exposed to short days display shorter fever durations, less 
pronounced decreases in body mass and food intake, and reduced releases of the 
pro-inflammatory cytokines, IL-1β and IL-6 relative to long-day hamsters (Bilbo 
et al., 2002). Similarly, captive male Gambel’s white-crowned sparrows 
(Zonotrichia leucophrys gambelii) show greater weight loss and reduction in food 
intake in response to LPS injection when housed in long as compared to short days 
(Owen-Ashley et al., 2008; Owen-Ashley et al., 2006). In contrast, free-living male 
song sparrows (Melospiza melodia morphna) show more pronounced sickness 
behaviors in the winter, non-breeding season as compared to the spring, breeding 
season. For instance, in the winter, but not the spring, these males decrease 
territorial aggression and lose body mass in response to LPS injection (Owen-
Ashley and Wingfield, 2006). Although seasonal breeders, captive male Puget’s 
white-crowned sparrows (Z. l. pugetensis) show no differences in LPS-induced 
weight loss and food intake when housed in either long or short days (Owen-Ashley 
et al., 2008). Although these studies suggest that at least some seasonally breeding 
animals show variation in sickness intensity across the seasons, no clear patterns 
(i.e., summer vs. winter; breeding vs. non-breeding season) emerge at first glance. 
However, if the relationships between sickness and season are interpreted in regards 
to the seasonal changes in energetic condition of these organisms, one pattern 
becomes strikingly clear: sickness behaviors are attenuated in the season in which 
the organism has the lowest energy reserves. 
 Siberian hamsters and Gambel’s sparrows have lower body masses and body 
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fat stores when housed in short day conditions compared to long day 
conditions(Bilbo et al., 2002; Owen-Ashley et al., 2006), and the free-living song 
sparrows that showed greater sickness intensity in the winter have greater body 
masses and fat in the winter months as compared to spring months (Owen-Ashley 
and Wingfield, 2006). While the Puget’s sparrows do not show photoperiodic 
variation in sickness intensity while in captivity, they also do not show 
photoperiodic variation in body mass or fat stores in their captive environment 
(Owen-Ashley et al., 2008). Furthermore, individual variation in body mass is a 
strong predictor of individual variation in sickness response magnitude in Gambel’s 
sparrows. There is a negative correlation between initial body mass and the percent 
decrease in body mass in response to LPS injection across all birds (short- and long-
day housed), showing that initially fatter birds exhibit greater weight loss in 
response to LPS-induced sickness (Owen-Ashley et al., 2008; Owen-Ashley et al., 
2006). In general, these observations suggest that the magnitude of a sickness 
response display (i.e., specifically those characteristics of the response that are 
energetically expensive) is constrained by a minimum body mass that the animal 
can reach before it risks not being able to recover and survive (Ashley and 
Wingfield, 2012; Owen-Ashley and Wingfield, 2007). This hypothesis has not yet 
been explicitly tested, but investigations of the endocrine mechanisms that 
contribute to variation in sickness intensity may shed light on how energy reserves 
may limit the expression of sickness responses in certain seasons. 
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Energetic fuels and their neuroendocrine mechanisms of immune system 
regulation 
Over the past few decades, it has become increasingly clear that the immune 
system does not act in autonomy to clear infectious agents from an animal. Rather, 
it is the interplay among the immune, endocrine, and nervous systems that 
facilitates effective pathogen clearance. Communication among systems is 
therefore necessary to coordinate immune responses that are well suited to an 
organism’s current physiological state, and in particular, the organism’s nutritional 
condition. There is now little doubt that the development of the immune system and 
intensity of immune responses are constrained by access to and utilization of 
nutritional and energetic resources in an organism’s environment (Faggioni et al., 
2001; Kelly and Coutts, 2000; Lochmiller and Deerenberg, 2000; Long and 
Nanthakumar, 2004).  
Glucose and insulin 
 Glucose is the primary source of energy for animals, as it fuels processes 
ranging from muscle movements to immunity to cognitive functioning 
(Mergenthaler et al., 2013; Wolowczuk et al., 2008). Glucose, itself, is not an 
endocrine molecule, however, changes in its levels within an organism results in 
activation of an endocrine cycle that facilitates its regulation. For instance, if blood 
glucose concentrations fall too low, the peptide hormone glucagon is released from 
the pancreas to stimulate conversion of stored glycogen into glucose; whereas high 
blood glucose concentrations result in the release of the pancreatic peptide hormone 
insulin which causes storage of excess glucose in the form of fat. Specifically, 
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glucose acts as a fuel for inactivated and activated lymphocytes and neutrophils, 
and (Calder, 1995), and as such, glucose availability and signals of glucose 
availability have the potential to modulate immune responses.  
 Experimental manipulations of glucose availability with 2-deoxy-D-
glucose (2-DG), a non-metabolizable glucose analog that prevents cellular uptake 
of glucose and induces glucoprivation (Horton et al., 1973), have provided insight 
into the importance of glucose availability for immune responses. Reducing 
glucose availability via 2-DG decreases lymphocyte proliferation in response to 
stimulation with a mitogen, reduces leukocyte counts, and enhances pro-
inflammatory cytokine production (Chou et al., 1996; Dreau et al., 1997; Lysle et 
al., 1988; Miller et al., 1994; Miller et al., 1993). Glucose availability also regulates 
immunity in a seasonal context. For instance, glucose deprivation results in 
decreases in splenocyte proliferation in long-day housed female deer mice, 
however, has no influence on splenocyte proliferation in short-day housed animals 
(Demas et al., 1997b). Similarly, glucose deprivation causes decreases in antibody 
production in long-day housed female Siberian hamsters, but does not change 
antibody production in short-day housed females (Zysling and Demas, 2007). 
These results suggest that glucose availability may be more critical for immune 
regulation when animals are reproductively-active. As such, inducing glucose 
deprivation decreases reproductive tissue masses in Siberian hamsters (Zysling and 
Demas, 2007) and impairs estrous cycling in Syrian hamsters (Mesocricetus 
auratus) (Schneider and Wade, 1989), and there is some evidence that glucose 
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deprivation may result in the expression of energetic trade-offs between the 
reproductive and immune systems in Siberian hamsters (Martin et al., 2008a). 
 Much of the work on the effects of insulin on immune responses has been 
performed to understand the connections between inflammatory responses and 
insulin resistance and for its potential use as a therapeutic treatment during sepsis 
(Dandona et al., 2004; Shoelson et al., 2006; van den Berghe et al., 2001). Few 
studies have examined the role of insulin as an energetic signal that may modulate 
of immune and sickness responses in healthy individuals. Insulin receptors are 
expressed on immune cells in both healthy and obese individuals (Bar et al., 1976; 
Krug et al., 1972), and in healthy individuals, insulin levels correlate with adipose 
tissue mass and change rapidly, yet still in proportion to the animal’s general 
adiposity, in response to alterations in energy balance (Benoit et al., 2004). One 
study, however, has demonstrated that insulin may act as an energetic signal by 
which immunity is modulated in healthy individuals. Treating Siberian hamsters 
with exogenous insulin results in increased antibody production in short-day 
housed hamsters and a trend toward increased antibody production in long-day 
housed hamsters (Garcia et al., 2010), suggesting that insulin may act as an 
energetic modulator of immunity by facilitating enhanced immune responses. 
Adipose tissue and leptin 
Adipose tissue is composed of fat cells (i.e., adipocytes) which store fat and 
whose energy content can be liberated during negative energy balance. Adipose 
tissue is not only used for energy storage, but is an endocrine organ that secretes 
hormones and cytokines (Ahima and Flier, 2000). Reductions in adipose tissue in 
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non-obese animals can result in decreases in immune function (Demas et al., 2003; 
Demas and Sakaria, 2005), while inducing obesity can also cause immune 
impairments (Amar et al., 2007; Smith et al., 2007). Thus, adipose tissue and its 
endocrine actions appear to play critical roles in the regulation of immunity. 
Leptin is one of the hormones that is secreted by white adipose tissue 
(WAT) and functions in immune system regulation. Leptin, a peptide hormone, acts 
as a potent anorexigenic agent, and circulating concentrations of the hormone are 
directly proportional to adipose tissue mass (Ahima and Flier, 2000; Maffei et al., 
1995). High levels of leptin indicate adequate energy stores, whereas low 
circulating levels of leptin are consistent with an energy deficit and may direct the 
partitioning of energetic resources toward different systems. Leptin is categorized 
as a cytokine hormone, as its structure is similar to members of the type 1 cytokine 
superfamily, which includes interleukin (IL)-2 and IL-6 (reviewed in Otero et al., 
2006). As such, leptin may act directly to affect hematopoiesis and inflammatory 
responses (Fantuzzi, 2005; Gainsford and Alexander, 1999), and recent evidence 
suggests that some of the actions of leptin on immune function are mediated by 
actions on specific pro- and anti-inflammatory cytokines. Genetically engineered 
mice provide additional evidence for effects of leptin on immunity.  Mice with 
genetically impaired leptin signaling (e.g., ob/ob mice, db/db mice) show 
disruptions in immunity (Lord et al., 1998).  Specifically, ob/ob mice that are unable 
to produce leptin experience atrophy of lymphatic tissues (e.g., spleen, thymus), 
and decreases in circulating lymphocyte numbers (Lord et al., 1998).  Similarly, 
db/db mice, which are unresponsive to leptin due to a mutation of the leptin 
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receptor, display immunological deficits. Db/db mice have reduced splenic and 
thymic masses and have a reduced ability to reject skin grafts and to produce 
cytotoxic responses (Fernandes et al., 1978). Thus, it is clear that leptin has wide 
effects on immune function, influencing both the maintenance of immune tissues 
and activation of immune responses. 
Leptin has previously been shown to regulate seasonal changes in the 
humoral immune response (Demas and Sakaria, 2005; Drazen et al., 2001) and 
energetic trade-offs among the immune and reproductive systems (French et al., 
2009a). Yet, it is not clear if leptin may regulate seasonal changes in the APR. There 
is a growing body of work in the biomedical sciences that suggests that leptin may 
affect sickness response expression (reviewed in Fantuzzi and Faggioni, 2000; 
Steiner and Romanovsky, 2007). This work has shown that the connection between 
leptin and the pro-inflammatory cytokines that are integral to the sickness response 
is bidirectional. Leptin treatment can enhance the production of pro-inflammatory 
cytokines by macrophages and in the brain (Loffreda et al., 1998; Luheshi et al., 
1999), and LPS and pro-inflammatory cytokine administration triggers increased 
production of leptin by adipocytes (Faggioni et al., 1998; Finck et al., 1998; 
Grunfeld et al., 1996; Sarraf et al., 1997).  
While it is evident that leptin levels are both modulated by and can modulate 
pro-inflammatory cytokines, debate remains as to how leptin may influence the 
actual sickness response. Two separate studies have shown that rats that were 
administered leptin anti-serum to neutralize circulating leptin levels show a lack of 
or attenuated fever following LPS injections (Harden et al., 2006; Sachot et al., 
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2004); however, Zucker obese rats (fa/fa), which have non-functional leptin 
receptors, show no difference in their fever response to LPS treatment when 
compared with lean rats, suggesting that leptin signaling is not necessary for fever 
production (Ivanov and Romanovsky, 2002). Additionally, leptin is a likely 
candidate mediating the anorexic response to sickness as this hormone mediates 
food intake in non-sick individuals and is increased in response to infection; 
however, the evidence linking leptin to the control of sickness-induced anorexia is 
mixed. Treating rats with leptin antiserum eliminates the anorexic effects of LPS-
induced inflammation (Harden et al., 2006; Sachot et al., 2004), suggesting that 
leptin is critical for anorexic behavior in response to sickness. Alternatively, LPS 
administration produces the anorexic effect in mice and rats that lack functional 
leptin signaling due to mutations of the leptin or leptin receptor genes (Faggioni et 
al., 1997; Lugarini et al., 2005). Therefore, while it remains unclear if and how 
leptin is modulating sickness responses, if the magnitude of an animal’s sickness 
response is influenced by its available energy stores, then leptin may be 
neuroendocrine mediator of this response. 
Dissertation aims 
The overarching goals of this dissertation were to understand how animals 
respond to changes in energetic state and energetic signals to modulate their 
investment between reproduction and immunity and how these changes and signals 
may influence seasonal variation in sickness intensity. In Chapter 1, I focused my 
efforts toward understanding how variation in different types of metabolic fuels 
(and their signals) may interact to influence energetic trade-offs between the 
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reproductive and immune systems. Through this study, I sought to determine how 
different severities of glucose deprivation may cause female animals to shift energy 
allocation between the reproductive and immune systems and if increasing a signal 
fat stores (i.e., leptin) would interact with these trade-offs.  In Chapters 2, 3, and 4, 
I focused my efforts on testing the hypothesis that seasonal variation in sickness 
response intensity is a product of seasonal changes in energy stores and availability. 
I modulated energy stores and availability via food restriction and inducing glucose 
deprivation with 2-DG, respectively, and manipulated energetic signals through 
treatments with exogenous leptin and insulin. Through these multiple forms of 
experimental energy manipulation, I was able to start to piece together the role of 
energy and its signals in the mediation of energetic trade-offs and seasonal 
modulation of sickness intensity. 
Study species 
Siberian hamsters have been the focus of much a large portion of the work 
targeted at understanding the physiological mechanisms that mediate energetic 
trade-offs and seasonal variation in sickness intensity. Siberian hamsters are 
seasonally breeding rodents that are highly responsive to changes in photoperiod in 
the laboratory. When hamsters are housed in long-day (LD), summer-like 
photoperiods (light > 12 hours), they remain in reproductive condition and display 
functioning gonads. However, when housed in short-day (SD), winter-like 
photoperiods (light < 12 hours), hamsters show regression of their gonads to a non-
reproductive state, decreased food intake, and reduced fat stores and circulating 
leptin levels despite being provided with ad libitum food. With their naturally 
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occurring changes in energy balance, Siberian hamsters make an excellent study 
species for understanding the contributions of energy availability and its signals to 
the regulation of immunity in seasonal contexts.  
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CHAPTER 1: Metabolic stressors and signals differentially affect energy 
allocation between reproduction and immune function  
 
Data published in: Carlton, E.D., Cooper, C.L., and Demas, G.E. 2014. Metabolic 
stressors and signals differentially regulate trade-offs between reproduction and 
immunity. General and Comparative Endocrinology 208: 21-29. 
 
Abstract 
Most free-living animals have finite energy stores that they must allocate to 
different physiological and behavioral processes. In times of energetic stress, trade-
offs in energy allocation among these processes may occur. The manifestation of 
trade-offs may depend on the source (e.g., glucose, lipids) and severity of energy 
limitation. In this study, we investigated energetic trade-offs between the 
reproductive and immune systems by experimentally limiting energy availability to 
female Siberian hamsters (Phodopus sungorus) with 2-Deoxy-D-glucose, a 
compound that disrupts cellular utilization of glucose. We observed how 
glucoprivation at two levels of severity affected allocation to reproduction and 
immunity. Additionally, we treated a subset of these hamsters with leptin, an 
adipose hormone that provides a direct signal of available fat stores, in order to 
determine how increasing this signal of fat stores influences glucoprivation-
induced trade-offs. We observed trade-offs between the reproductive and immune 
systems and that these trade-offs depended on the severity of energy limitation and 
exogenous leptin signaling. The majority of the animals experiencing mild 
glucoprivation entered anestrus, whereas leptin treatment restored estrous cycling 
in these animals. Surprisingly, virtually all animals experiencing more severe 
glucoprivation maintained normal estrous cycling throughout the experiment; 
however, exogenous leptin resulted in lower antibody production in this group. 
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These data suggest that variation in these trade-offs may be mediated by shifts 
between glucose and fatty acid utilization. Collectively, the results of the present 
study highlight the context-dependent nature of these trade-offs, as trade-offs 
induced by the same metabolic stressor can manifest differently depending on its 
intensity. 
 
Introduction 
Animals are faced with the challenge of obtaining energetic resources. The 
energy available to an animal under most natural conditions is finite and will 
depend on the quality and abundance of these energetic resources in the 
environment. Once an animal obtains energy, it is then faced with the challenge of 
balancing energy allocation among different physiological, biochemical, and 
behavioral processes (Ricklefs and Wikelski, 2002; Sheldon and Verhulst, 1996). 
The balancing of allocation toward diverse biological processes often results in 
energetic trade-offs among physiological systems. One commonly observed 
energetic trade-off occurs between the reproductive and immune systems (Demas 
et al., 2012; Fedorka, 2014), where increased investment into one system results in 
decreased investment to the other. Maintaining reproduction and activating and 
maintaining the immune system requires a substantial allocation of energy (Demas, 
2004; Speakman, 2008). Therefore, the expression of constraints on these systems 
and trade-offs between them is often dependent on the animal’s access to energetic 
resources in its environment. This dependence on the environment may explain 
why in some cases a reproduction-immune trade-off may be observed with 
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relatively limited resources in the wild but is not observed in the laboratory where 
food is available ad lib  (French and Moore, 2008; French et al., 2009b). 
One possibility why the display of energetic trade-offs is often context-
dependent is that the display of energetic limitations and trade-offs varies with the 
type of energy that is being used to fuel the physiological and behavioral processes. 
Energetic trade-offs may be manifested in different ways depending on an animal’s 
access to both current food availability in the environment and stored energy 
availability in the form of body fat. For instance, food deprivation inhibits ovulation 
and estrous behavior in lean, but not fat, female Syrian hamsters (Mesocricetus 
auratus) (Schneider and Wade, 1989), suggesting that having large fat stores may 
be sufficient to overcome energetic deficits imposed by limited current energetic 
resources. Food restriction does not suppress antibody production in female 
Siberian hamsters (Phodopus sungorus)  (Zysling et al., 2009); however, surgically 
removing body fat stores (i.e., lipectomy) from male prairie voles and male and 
female Siberian hamsters results in decreased antibody production (Demas et al., 
2003; Demas and Sakaria, 2005). Collectively, these results provide support that 
different types of metabolic fuels (e.g., glucose from immediate food ingestion, free 
fatty acids from adipose tissue) may influence the expression of energetic trade-
offs within and between these two systems.  
One way to manipulate glucose availability is with treatment with 2-Deoxy-
D-glucose (2-DG). 2-DG is a non-metabolizable glucose analog, which causes a 
transient disruption of glycolysis by inhibiting glucose oxidation, resulting in a state 
of glucoprivation (Horton et al., 1973). Treating ad lib-fed female Syrian hamsters 
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with high doses of 2-DG (1,750 or 2,000 mg/kg) induces anestrus, whereas a lower 
dose of 2-DG (750 mg/kg) induces anestrus only in hamsters that are food restricted 
(Schneider et al., 1993). Previous work in our lab has shown that treatment with 2-
DG (750 mg/kg) results in reduced antibody production and reduced reproductive 
tissue mass in female Siberian hamsters (Zysling and Demas, 2007) and reduced 
splenocyte production in female deer mice (Peromyscus maniculatus) (Demas et 
al., 1997b). Thus, reducing glucose availability via 2-DG treatment suppresses 
energetic allocation to both reproduction and immunity. 
While it is clear from these studies that reducing glucose utilization can 
suppress reproductive and immune responses, the context-dependent nature of 
some of these results (e.g., lower doses of 2-DG suppress reproduction in only food 
restricted animals, not ad lib-fed animals) illustrates that glucose is not the only fuel 
source that animals can utilize to power reproduction and immunity. For instance, 
anestrus can be induced in ad lib-fed hamsters treated with a lower dose of 2-DG 
(750 mg/kg) if fatty acid utilization is simultaneously blocked (via methyl 
palmoxirate treatment), suggesting that changes in reproductive status may be 
driven by availability of all metabolic fuels, rather than just individual metabolic 
fuel types (Schneider and Wade, 1989). White adipose tissue (WAT), a primary 
energy source for organisms, provides storage for lipids that can be liberated to free 
fatty acids and glycerol when triggered by glucagon. WAT is not only a source of 
fuel, but it is also an endocrine organ that synthesizes and releases hormones 
(Ahima and Flier, 2000; Cinti, 2007). The peptide hormone leptin is one such 
adipose hormone, and circulating levels of leptin are directly proportional to the 
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mass of adipose tissue in mammals (Maffei et al., 1995). Thus, high levels of leptin 
indicate adequate energy stores, whereas low circulating levels of leptin are 
consistent with an energy deficit. Furthermore, leptin not only influences lipid 
metabolism but it also increases glucose metabolism, glucose uptake, glucose 
turnover, and glucose oxidation (Kamohara et al., 1997).  
While leptin was first characterized for its role in food intake and adiposity, 
there is now ample evidence that leptin plays a role in mediating both reproduction 
(Caprio et al., 2001; Schneider et al., 2012) and immunity (Carlton et al., 2012; La 
Cava and Matarese, 2004; Lord, 2002). Treatment with leptin restores estrous 
cycling in fasted female Syrian hamsters, however, when hamsters are fasted and 
treated with 2-DG, leptin does not restore estrous cycling. As 2-DG inhibits glucose 
oxidation, these results suggest that leptin influences energy allocation to 
reproduction via effects on metabolic fuel oxidation rather than through signaling 
of available adipose stores (Schneider et al., 1998). Additionally, leptin treatment 
counteracts the fasting-induced suppression of cell-mediated immunity in mice 
(Lord et al., 1998), and it attenuates the suppressive effects of surgical lipectomy 
on antibody production in male Siberian hamsters (Demas and Sakaria, 2005). Male 
Siberian hamsters treated with 2-DG show reductions in antibody production, and 
providing exogenous leptin alleviates this suppression of humoral immunity 
(Drazen, 2001) suggesting that the effects of leptin on humoral immunity are at 
least in part mediated through changes in signals of fat availability (Drazen, 2001; 
Drazen et al., 2001). Therefore, leptin may act differently in how it regulates energy 
allocation to reproduction versus immunity when glucose utilization is impaired. 
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The goal of the present study was to determine how leptin, as a 
neuroendocrine signal, affects energy allocation between the reproductive and 
immune systems in female Siberian hamsters experiencing glucoprivation. 
Specifically, we experimentally reduced glucose utilization with either a low (750 
mg/kg) or high dose (1750 mg/kg) of 2-DG, and then supplemented animals with 
exogenous leptin. We assessed reproductive (i.e., estrous cycling, reproductive 
tissue mass) and immune (i.e., serum bacterial killing, antibody production) indices 
in response to our treatments. We predicted that mild glucoprivation (low 2-DG 
dose) would reduce reproductive tissue mass and antibody production and that 
leptin treatment should restore antibody production and may restore reproductive 
tissue mass. Additionally, we predicted that at more severe glucoprivation (high 2-
DG dose), animals would be more energy limited and would show halted estrous 
cycling in addition to reduced reproductive tissue mass, antibody production, and 
bacterial killing ability. Because the high dose of 2-DG provides significant energy 
limitation, we expected that leptin supplementation would only provide a 
sufficiently large energetic signal to restore one system (e.g., the immune system 
because it is most important for survival) and this restoration might occur at a 
potential additional energetic cost to the reproductive system. Finally, in order to 
assess potential causation behind trade-offs, we assessed serum triglyceride and 
cortisol concentrations to determine the physiological mechanisms that may 
mediate energy allocation. 
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Methods 
Animals and housing 
Adult female (> 60 days of age) Siberian hamsters (n=58) were obtained 
from our breeding colony at Indiana University. The progenitors of these animals 
were generously provided by Dr. Randy Nelson (Ohio State University) and Dr. 
Timothy Bartness (Georgia State University).  In order to minimize the effects of 
inbreeding, our animals are outbred approximately every 10 generations. All 
animals were initially group housed (2-5 per cage with same sex siblings on 
weaning at 17-18 days of age) in long-day photoperiods (light:dark, 16:8). 
Temperature (20 ± 2°C) and humidity (50 ± 10%) were maintained at constant 
levels. For the experiment, animals were all housed in the same room where they 
were maintained on long days (16:8) and individually housed in polypropylene 
cages (27.8 x 17.5 x 13.0 cm). Food (Laboratory Rodent Diet 5001, LabDiet, St. 
Louis, MO, USA) and tap water were available ad lib during the entire course of 
the experiment. Animals used in this experiment came from 18 different litters 
across 8 different breeding pairs. All animal methods were reviewed and approved 
by the Institutional Animal Care and Use Committee at Indiana University 
Bloomington (protocol no. 10-038). 
 
Experimental methods 
For eight days prior to experimental treatments, vaginal cell samples were 
obtained by vaginal lavage (with 0.9% sterile saline) from each animal between 
0930h and 1130h EST to determine estrous cycle stage (Scotti et al., 2007). For five 
23 
 
days prior to experimental treatments, body mass (to the nearest 0.1g) and food 
consumption (to the nearest 0.1g) were assessed daily between 0930h and 1130h 
EST to establish pre-treatment average body mass and average food intake baseline 
values. Food consumption was assessed by weighing the food pellets remaining in 
the hopper each day. Daily vaginal sampling and body mass and food consumption 
measurements were continued throughout the entirety of the experiment. 
Animals were initially quasi-randomly selected (i.e., no more than one 
animal from each litter was placed into a single group) and assigned to one of three 
2-DG treatment groups that received 0.1 ml injections of either a 0.9% sterile saline 
control or of one of two concentrations of 2-DG (750 mg/kg dissolved in 0.9% 
sterile saline or 1750 mg/kg dissolved in 0.9% sterile saline; Sigma-Aldrich, St. 
Louis, MO, USA), administered intraperitoneally (i.p.). The 750 mg/kg dose was 
used because a previous study in Siberian hamsters showed that this dose results in 
decreased antibody production and reduced reproductive tissue mass (Zysling and 
Demas, 2007). The 1750 mg/kg dose was used because this dose is the lowest dose 
of 2-DG that induces anestrus in ad lib-fed Syrian hamsters (Schneider et al., 1993). 
Additionally, these concentrations are lower than doses that induce torpor in 
Siberian hamsters (2,500 mg/kg) (Dark et al., 1994; Zysling and Demas, 2007).  
Within each 2-DG treatment group, animals were further divided into one of two 
groups that received either control injections of 0.9% sterile saline or leptin. Control 
animals received a 0.2 ml injection of 0.9% sterile saline, while leptin-treated 
animals received a 0.2 ml injection of 45 μg recombinant murine leptin (Peprotech 
Inc., Rocky Hill, NJ, USA) dissolved in 0.9% sterile saline, administered i.p. 
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Injections of 2-DG (or saline control) were administered every other day for 12 
days, for a total of 6 injections while injections of leptin (or saline control) were 
administered every day for 12 days, for a total of 12 injections. All injections were 
provided between 1400 and 1500 h EST. Final group sample sizes were as follows: 
Veh/Veh (n=10), Veh/Lep (n=10), Low-2DG/Veh (n=10), Low-2DG/Lep (n=8), 
High-2DG/Veh (n=10), High-2DG/Lep (n=10). 
On the day following the first 2-DG or saline injection, all animals received 
a single subcutaneous injection of 100 µg of keyhole limpet hemocyanin (KLH; 
Sigma-Aldrich, St. Louis, MO, USA) suspended in 0.1 ml sterile saline in order to 
generate a humoral immune response. KLH is an innocuous respiratory protein 
derived from the giant keyhole limpet (Megathura crenulata) that generates a 
robust, non-replicating antigenic response in rodents, but does not make the animals 
sick (i.e., no inflammation or fever) (Dixon et al., 1966). 
 
Blood sampling and necropsies 
On days 5 and 10 post KLH injection, a blood sample was drawn from all 
animals via the retro-orbital sinus for immediate measurement of blood glucose and 
later measurement of bacterial killing ability (days 5 and 10), KLH-specific 
antibodies (days 5 and 10), serum triglyceride concentrations (day 5), and serum 
cortisol concentrations (day 10). These time points were chosen to capture peak 
anti-KLH immunoglobulin G production during the course of the immune response 
(Demas et al., 1997a). Triglyceride concentrations and cortisol concentrations were 
only measured at single time points during the study due to limited serum 
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availability. We chose to measure triglycerides at day 5 because animals that 
stopped estrous cycling did so no later than this date, so any effects of triglycerides 
on this measure could ideally be captured at this date. We assessed cortisol at day 
10 because a previous study in our lab showed that cortisol concentrations do not 
differ in Siberian hamsters treated with 750 mg/kg 2-DG from day 5 to day 10 
(Zysling and Demas, 2007). Briefly, animals were lightly anesthetized with 
isoflurane vapors and blood samples were drawn from the retro-orbital sinus 
between 1300 and 1400 h EST. Blood samples were allowed to clot at room 
temperature for 1 h, the clots were removed, and the samples were centrifuged at 
4°C for 30 min at 2500rpm. Serum aliquots were aspirated and stored in sealable 
polypropylene microcentrifuge tubes at -20°C until assayed. Each blood sample 
consisted of ~3.5% of the animal’s total blood volume, and all blood samples were 
collected within 3 minutes of initial handling. Animals were euthanized and 
necropsies were performed at the completion of the study (day 11 post KLH 
injection). Uterine horns, ovaries, inguinal WAT (IWAT), parametrial white 
adipose tissue (PWAT), and retroperitoneal WAT (RWAT) were removed to 
determine the effects of 2-DG and leptin on these tissues. All tissues were cleaned 
of connective tissues and weighed to the nearest 0.1 mg. A composite adipose tissue 
score was calculated by summing the individual WAT pad masses. 
 
Blood glucose measurement 
Blood glucose levels were measured from the blood samples collected at 5 
and 10 days after KLH injection. Immediately upon sampling, ~5 µl of whole blood 
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was transferred onto the test strips of a blood glucose monitoring system (ReliOn, 
Micro Blood Glucose Monitoring System, Arkray USA, Inc., Minneapolis, MN, 
USA), and the readout was recorded. The meter was previously calibrated using an 
internal standard provided by the manufacturer. 
 
Vaginal cytology 
After vaginal cell samples were obtained via vaginal lavage, samples were 
transferred to microscope slides, fixed with methanol, and stained with Giemsa. 
These samples were evaluated for estrous stage (diestrus I, diestrus II, proestrus, 
estrus) under 100x magnification. The following cellular characteristics were used 
to characterize the four stages of the estrous cycles: diestrus I (presence of many 
polymorphonuclear leucocytes and some nonnucleated keratinized cells), diestrus 
II (primarily secretory material and cellular debris, some parabasal cells), proestrus 
(clumps of lightly staining nucleated epithelial cells), estrus (many nonnucleated 
keratinized cells) (Moffatt-Blue et al., 2006; Scotti et al., 2007). In addition, 
anestrus was characterized by slides which contained a lot of cellular debris with 
cells that did not appear intact. Animals were determined to have stopped cycling 
if, after they had previously been cycling in the experiment, they entered anestrus 
and remained in anestrus until completion of the experiment. Two animals (one in 
the low dose 2-DG and vehicle group; one in the high dose 2-DG and leptin group) 
did not show normal estrous cycling during the eight days prior to the start of 
injections, so they were excluded from the cycling analysis. 
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Bacterial killing 
We used an ex vivo bacterial killing assay as a functional assessment of the 
innate immune system’s ability to clear a relevant pathogen. This assay quantifies 
the relative number of Escherichia coli colony forming units (CFU) that grow after 
incubation with serum. Briefly, lyophilized E. coli (EpowerTM, ATCC #8739, 
Microbiologics, St. Cloud, MN, USA; 1 pellet = 107 CFU) was added to 40 ml 1 M 
sterile PBS warmed to 37°C to create a bacterial stock solution. This solution was 
activated by incubation for 30 min at 37°C. The stock bacteria solution (500,000 
CFU/ml) was diluted 1:10 with sterile 1 M PBS to create a 50,000 CFU/ml working 
solution. Meanwhile, serum samples were diluted 1:20 in glutamine enriched CO2-
independent media (Invitrogen Corp., Carlsbad, CA, USA). For each sample, the 
bacterial working solution was added at a 1:10 ratio to the diluted serum sample. 
To generate a positive control (i.e., solution containing only media and bacteria), 
the bacterial working solution was diluted 1:10 with glutamine enriched CO2-
independent media. The diluted samples and the positive control were incubated 
for 30 min at 37°C to induce bacterial killing. After incubation, 50 µl of sample and 
the positive control was added to tryptic soy agar plates in duplicate. All plates were 
covered, inverted, and stored overnight at 37°C. Following incubation, colony 
numbers were counted on each plate, and duplicates were averaged. Bactericidal 
capacity was calculated as a percent of bacteria killed relative to the positive control 
plates in which no killing occurred. 
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Anti-KLH enzyme-linked immunosorbent assay (ELISA) 
 To assess humoral immunity to KLH injection, serum anti-KLH 
immunoglobulin G (IgG) concentrations were assayed using an enzyme-linked 
immunosorbent assay (ELISA) (Demas et al., 2003).  Microtiter plates were coated 
with KLH by incubating overnight at 4°C with 0.5 mg/ml KLH in sodium 
bicarbonate buffer (pH 9.6). Plates were washed with phosphate buffered saline 
(PBS) containing 0.05% Tween 20 (PBS-T; pH 7.4), then blocked with 5% non-fat 
dry milk in PBS (to reduce non-specific binding), and then washed again with PBS-
T. Thawed serum samples were diluted 1:20 with PBS-T, and 300 µL of each serum 
dilution was added to the plate wells in duplicate. Positive control samples (i.e., 
pooled sera from hamsters previously shown to have high anti-KLH antibody 
responses) and negative control samples (i.e., pooled sera from KLH-naïve 
hamsters) were also diluted 1:20 with PBS-T and added to the plate wells in 
duplicate. Plates were incubated at 37°C for 3 h and then washed with PBS-T. 150 
µL of secondary antibody (alkaline phosphatase-conjugated-anti Syrian hamster 
IgG diluted 1:500 with PBS-T; Rockland, Gilbertsville, PA, USA) was added to 
the wells and the plates were incubated for 1 h at 37°C. Plates were then washed 
again with PBS-T and 150 µL of the enzyme substrate p-nitro-phenyl phosphate 
(Sigma-Aldrich, St. Louis, MO, USA; 0.1 mg/ml in diethanolamine substrate 
buffer) was added to each well. The absorbance of each well was measured (Bio-
Rad iMark Microplate Reader, Hercules, CA, USA) at 405 nm. The mean for each 
sample was calculated and expressed as a percentage of the positive control mean 
(% plate positive). 
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Triglyceride assay 
Total serum triglyceride concentrations were assessed with a commercially 
prepared colorimetric assay kit (Triglyceride Colorimetric Assay Kit, Cayman 
Chemical Co., Ann Arbor, MI, USA). Prior to testing samples, we validated the 
appropriate dilution (1:4) so that triglyceride concentrations lay within the 
detectable range of the assay. Some samples expressed triglyceride levels at the 1:4 
dilution that ran off the curve, so these samples were rerun at a 1:10 dilution. Intra-
assay variabilities were 3.2% and 3.9%; inter-assay variability was 0.7%. 
 
Cortisol enzyme immunoassay (EIA) 
Cortisol is the predominant glucocorticoid in Siberian hamsters, with 
concentrations ~100x that of corticosterone (Reburn and Wynne-Edwards, 2000). 
Serum cortisol concentrations were determined in multiple enzyme immunoassays 
(EIAs) from a commercially prepared kit (Cortisol EIA Kit; Enzo Life Sciences, 
Inc., Farmingdale, NY, USA). This assay was previously validated for use in 
Siberian hamsters (Demas et al., 2004) and is highly specific for cortisol; cross-
reactivity with corticosterone is 27.7% and <4.0% for other steroid hormones. The 
sensitivity of the assay is 56.72 pg/ml. Samples were diluted to 1:40 with assay 
buffer and run in duplicate. Intra-assay variabilities were 3.0% and 3.5%; inter-
assay variability was 14.0%. 
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Statistical analyses 
All statistical tests were performed using JMP 10 (SAS Institute Inc., Cary, 
NC, USA), and a value of P < 0.05 was considered to be statistically significant. 
Data were checked for normality and homogeneity of variance and those data that 
were non-normally distributed were transformed. Glucose, cortisol, and 
triglyceride concentrations were not normally distributed and were log transformed 
to best meet the assumptions of parametric tests. Bacterial killing ability was not 
normally distributed and was reverse square root transformed to meet the 
assumptions of parametric tests. All differences in measurements collected at only 
one time point (i.e., fat tissue masses, reproductive tissue masses, triglyceride 
concentrations, cortisol concentrations) were assessed via a two-way (2-DG 
treatment (3) x leptin treatment (2)) analysis of variance (ANOVA). Body mass at 
the time of sampling was included as a covariate in the models for the fat tissue 
masses, reproductive tissue masses, and triglyceride concentrations to control for 
the effect of body mass on these dependent variables. Differences in repeated 
measures (i.e., body mass, food intake, antibody levels, bacterial killing ability, 
glucose concentrations) were assessed via repeated-measures ANOVAs with time 
as a within-subjects variable. Initial body mass was included as a covariate in the 
model for food intake levels to control for the effect of body mass on this measure. 
The within-subject comparisons for body mass and food intake violated 
assumptions of sphericity and were Greenhouse-Geisser (GG)-corrected. 
Treatment effects on the frequencies of animals remaining in estrus throughout the 
experiment were assessed with Fisher’s Exact Test because expected values in 
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some cells were less than 5. Post-hoc comparisons between pair-wise means were 
conducted using Fisher’s LSD tests when the overall ANOVAs were statistically 
significant. 
 
Results 
Body mass, food intake, and body fat 
There were no effects of 2-DG (F2,52 = 0.63, P = 0.535; Table 1) or leptin 
(F1,52 = 0.62, P = 0.434) on final body mass. While treatment did not affect final 
body mass, body mass decreased over the course of the experiment (within subjects, 
F1.9,103.9 = 8.89, P < 0.001, GG-corrected). Food intake over the course of the 
experiment was related to the initial body mass of the animals (F1,51 = 13.89, P < 
0.001) After controlling for the effect of body mass, there were no effects of 2-DG 
(F2,52 = 1.02, P = 0.369; Table 1) or leptin (F1,52 = 0.06, P = 0.812) on daily food 
intake. Additionally, food intake did not change over the course of the experiment 
(within subjects, F7.7,393.1 = 1.27, P = 0.258, G-G-corrected). IWAT, PWAT, 
RWAT, and composite adipose tissue mass were all related to the body mass of the 
animal at the time of tissue collection (P < 0.001 in all cases). After controlling for 
the effect of body mass, there were no treatment effects on any of these fat tissue 
measures (P > 0.05 in all cases; Table 1). 
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 Blood glucose 
Blood glucose levels did not differ across sampling times within individuals 
(F1,51 = 2.38, P = 0.129; Table 1), nor did levels differ among groups (2-DG, F2,51 
= 0.12, P = 0.886; leptin, F1,51 = 0.16, P = 0.693; 2-DG x leptin, F2,51 = 0.58, P = 
0.564).  
 
 
Table 1. Effects of 2-DG dose and leptin treatment on mean (±SEM) final body 
mass, food intake on the last day of the experiment, composite body fat mass, blood 
glucose levels, and paired ovary mass. No statistically significant differences 
between group means (P <0.05) were found for any of these measures. 
____________________________________________________________________________________________________________________________________ 
 
 Vehicle               Leptin 
____________________________________________________________________________________________________________________________________ 
 
Final body mass (g)    
  Vehicle    38.7 ± 1.9  36.1 ± 2.3 
  Low 40.1 ± 2.4  37.9 ± 2.4 
  High     38.9 ± 1.6                   41.0 ± 3.0 
 
Food Intake (g/day) 
  Vehicle 4.8 ± 0.2  4.7 ± 0.5 
  Low     5.0 ± 0.5  4.9 ± 0.4 
  High     4.7 ± 0.2  4.7 ± 0.3 
 
Composite Body Fat (g) 
  Vehicle    1.59 ± 0.21  1.43 ± 0.31 
  Low     1.97 ± 0.25  1.55 ± 0.30 
  High 1.55 ± 0.19 1.83 ± 0.35 
 
Day 10 Blood Glucose (mg/dl) 
  Vehicle    115.3 ± 6.5  113.2 ± 9.2                  
  Low     110.4 ± 4.3  120.5 ± 7.2 
  High 113.3 ± 6.3  106.9 ± 5.4 
 
Paired Ovary Mass (mg) 
  Vehicle    18.40 ± 2.69  18.36 ± 0.58                  
  Low     21.95 ± 2.69  14.80 ± 1.22 
  High     18.37 ± 1.61  23.23 ± 2.97 
____________________________________________________________________________________________________________________________________ 
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Estrous cycling 
Estrous cycling was impaired in animals treated with the low 2-DG dose 
(Figure 1A). Fifty-six percent of the animals that received the low 2-DG dose 
became anestrus by the end of the experiment, whereas in all other groups, 20% or 
fewer of the animals were anestrus at the end of the experiment. This difference in 
anestrus between the low 2-DG dose group and the other five groups was significant 
(P = 0.003). 
 
Reproductive tissue masses 
Uterine horn and ovary mass were affected by the body mass of the animal 
at the time of tissue collection (uterine horns: F1,51 = 7.36, P = 0.009; ovaries: F1,51 
= 8.68, P = 0.005). After controlling for body mass, there were effects of both 2-
DG (F2,51 = 3.36, P = 0.024) and leptin (F1,51 = 6.60, P = 0.013) but no effect of the 
2-DG x leptin interaction (F2,51 = 2.25, P = 0.116) on uterine horn mass (Figure 
1B). Specifically, uterine horn masses in all treatment groups were significantly 
lower than those of the vehicle-treated controls (for all comparisons, T ≥ 2.36, P ≤ 
0.022). Conversely, there were no treatment effects on ovary mass (2-DG, F2,51 = 
0.59, P = 0.558; leptin, F1,51 = 0.06, P = 0.811; 2-DG x leptin, F2,51 = 2.92, P = 
0.063; Table 1). 
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Figure 1. Effects of 2-DG dose and leptin treatment on (A) the percentage of 
hamsters showing normal estrous cycles and (B) mean (±SEM) uterine horn mass. 
In figure A, groups that differ significantly (P < 0.05) from the vehicle/vehicle-
treated control are indicated by an asterix (*). In figure B, groups with different 
letters indicate statistically significant differences between group means (P <0.05); 
groups sharing the same letter are statistically equivalent. 
 
Antibody production 
In all groups, anti-KLH IgG levels increased from Day 5 to Day 10 (within 
subjects, F1,52 = 64.34, P < 0.001; Figure 2A). There was a main effect of 2-DG 
dose (between subjects, F2,52 = 3.37, P = 0.042), such that animals treated with the 
high dose of 2-DG had lower IgG levels than animals treated with just the vehicle 
(P = 0.012). There were no main effects of leptin (F1,52 = 2.01, P = 0.162) or the 2-
DG x leptin interaction (F2,52 = 2.79, P = 0.071) on IgG levels. Specifically, this 
high 2-DG suppression of IgG levels was driven by animals treated with the high 
2-DG dose and leptin showing lower IgG levels than animals treated only with 
leptin (and no 2-DG) (day 5, T = 2.99, P = 0.004; day 10, T = 2.79, P = 0.007). 
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Bacterial killing 
Bacterial killing ability did not change across blood sampling time points 
(within subjects, F1,52 = 0.16, P = 0.688; Figure 2B). However, there was a main 
effect of leptin (F1,52 = 11.37, P = 0.001), but no effects of  2-DG (F2,52 = 1.36, P = 
0.266) or the 2-DG x leptin interaction (F2,52 = 0.16, P = 0.0755) on bacterial killing 
ability. Specifically, at both sampling points, bacterial killing was elevated in 
animals treated with leptin but no 2-DG as compared to the vehicle-treated controls 
(day 5, T = 2.54, P = 0.014; day 10, T = 2.29, P = 0.026).  
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Figure 2. Effects of 2-DG dose and leptin treatment on mean (±SEM) (A) serum 
anti-KLH immunoglobulin G (IgG) at day 5 (left) and day 10 (right) after KLH 
inoculation and (B) serum bacterial killing ability at day 10 after KLH inoculation 
(as there was no effect of time on this measure, only data from day 10 are shown). 
Groups with different letters indicate statistically significant differences between 
group means (P <0.05); groups sharing the same letter are statistically equivalent. 
 
 
Serum triglycerides 
Serum triglyceride levels were positively related to the body mass of the 
animal at the time of sampling (F1,57 = 11.53, P = 0.001). After controlling for the 
effect of body mass, there was an effect of 2-DG (F2,57 = 5.18, P = 0.009; Figure 
37 
 
3A), but no effects of leptin (F1,57=3.51, P=0.067) or the 2-DG x leptin interaction 
(F2,57 = 0.88, P = 0.421) on triglyceride levels. Specifically, animals treated with 
the high 2-DG dose and either vehicle (T = 3.07, P = 0.004) or leptin (T  = 3.36, P 
= 0.002) showed decreased triglyceride levels as compared to vehicle-treated 
controls. 
 
Serum cortisol 
Cortisol did not differ among groups (Figure 3B). There were no significant 
effects of 2-DG (F2,50 = 1.67, P = 0.199), leptin (F1,50 = 0.06, P = 0.805), or the 2-
DG x leptin interaction (F2,50 = 0.16, P = 0.854) on serum cortisol levels. 
 
 
 
 
Figure 3. Effects of 2-DG dose and leptin treatment on mean (±SEM) (A) serum 
triglyceride concentrations at day 5 after KLH inoculation and (B) serum cortisol 
concentrations at day 10 after KLH inoculation. Groups with different letters 
indicate statistically significant differences between group means (P <0.05); groups 
sharing the same letter are statistically equivalent. 
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Discussion 
Our findings demonstrate key trade-offs between the reproductive and 
immune systems in female Siberian hamsters and that these trade-offs depend on 
the severity of energy limitation and exogenous leptin signaling. We found that the 
majority of the animals experiencing mild glucoprivation (low dose 2-DG) entered 
anestrus, whereas leptin treatment restored estrous cycling in these animals. 
Surprisingly, virtually all animals experiencing more severe glucoprivation (high 
dose 2-DG) maintained normal estrous cycling throughout the experiment and did 
not show anestrus. In addition, we found that animals experiencing any level of 
glucoprivation displayed reduced uterine horn mass and exogenous leptin not only 
did not restore this mass, but it may have contributed to its decrease. In contrast to 
previous work in this species (Zysling and Demas, 2007), mild glucoprivation did 
not suppress antibody production in the current study. Alternatively, we found that 
animals experiencing more severe glucoprivation while receiving leptin 
supplementation showed reduced antibody production at both days 5 and 10 after 
KLH inoculation. The measure of innate immunity, serum bacterial killing ability, 
was not affected by our glucoprivation treatment, although leptin treatment may 
have enhanced this measure. Taken together, our results suggest that at mild 
glucoprivation, female Siberian hamsters show reduced energy allocation to the 
reproductive system (via inhibition of estrous cycling) but that this reduction in 
energy allocation can be alleviated with an increased signal of fat stores. At a more 
severe level of glucoprivation, female Siberian hamsters do not reduce energy 
allocation to estrous cycling; however, providing these animals with a simultaneous 
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signal of increased fat stores results in decreased antibody production, suggesting 
that these competing signals of energy availability may be resulting in energy being 
allocated to other physiological processes or systems not assessed in this study (e.g., 
thermoregulation, motor activity, self-maintenance).  
In order to understand the potential mechanisms mediating energy 
allocation to the reproductive and immune systems during glucoprivation and leptin 
supplementation, we assessed circulating cortisol and triglyceride concentrations 
during the experiment. We measured circulating cortisol levels because 2-DG is 
often used in experimental procedures to induce metabolic stress, as its glucoprivic 
effects are often accompanied by increases in circulating glucocorticoid levels 
(Demas et al., 1997b; Weidenfeld et al., 1994). Stress can have both enhancing 
(e.g., acute stress) and suppressive (e.g., chronic stress) effects on immunity, while 
it acts mainly to suppress reproduction (Dhabhar, 2002; Sapolsky et al., 2000; Weil 
and Nelson, 2012). We found no differences in cortisol levels among the groups in 
our study. Similarly, previous studies in female Siberian hamsters found no 
differences in cortisol levels between animals treated with a 750 mg/kg dose of 2-
DG as compared to controls (Zysling and Demas, 2007) and between hamsters food 
restricted to 70% of ad lib intake in comparison to controls (Zysling et al., 2009). 
Chronic stress from our daily injections could have contributed to the lack of 
differences in cortisol (and blood glucose) among groups, as all animals may have 
shown elevated baseline cortisol levels as a product of injection-related stress. The 
cortisol values measured in this study are ~50 ng/ml higher than those of female 
Siberian hamsters who have not been given daily injections or daily handling 
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(Zysling et al., 2009). However, this large difference in cortisol levels between the 
hamsters in our study and the hamsters in the earlier study (Zysling et al., 2009) is 
more likely due to changes in the sensitivity of the cortisol antibody, as a previous 
study applying similar injection and handling methods to ours found cortisol levels 
similar to baseline levels of non-injected animals (Zysling and Demas, 2007). 
Additionally, it is possible that we did not see differences in cortisol levels among 
the groups because we took blood samples prior to the day’s injection of 2-DG (i.e., 
23 hours from the last injection of 2-DG), and cortisol levels were not chronically 
elevated by our 2-DG treatment. Alternatively, the differential effects of our 
treatments on reproduction and immunity may not be caused by glucocorticoids but 
rather may be mediated by the utilization of different energy forms or energy 
reallocation.  
We measured serum triglyceride levels to assess whether animals were 
potentially tapping into lipid energy stores while their glucose stores were less 
accessible during glucoprivation. We were motivated to probe this mechanism 
when we discovered that estrous cycling was only suppressed in the group receiving 
the low 2-DG dose and not in the group that received the high 2-DG dose. This 
result is in contrast to work in Syrian hamsters that showed that in animals that are 
provided ad lib access to food, estrus is only suppressed when animals receive a 
dose of at least 1,750 mg/kg 2-DG and not suppressed in animals receiving a dose 
of 750 mg/kg (Schneider et al., 1993). One hypothesis for why we observed no 
suppression of estrous cycling in hamsters treated with the high 2-DG dose could 
be that this high dose inhibited glucoprivation so greatly that it required animals to 
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shift their main source of fuel to free fatty acids (FFA). It is well established that 
when oxidation of one fuel type is inhibited, oxidation of the other fuel type is 
enhanced (Friedman, 1998), and FFAs can be used to fuel reproduction and 
immunity (Pond, 1996; Schneider, 2004). Furthermore, administration of 2-DG 
results in increases in circulating FFA in rats and Siberian hamsters (Brito et al., 
2008; Yamamoto et al., 1984). Consistent with this hypothesis, animals that were 
treated with the high 2-DG dose had the lowest levels of circulating triglycerides, 
possibly indicating that these animals were showing greater breakdown of 
triglycerides into FFA and glycerol (i.e., undergoing lipolysis). If hamsters 
experiencing more severe glucoprivation increase lipolysis to a greater extent than 
hamsters experiencing less severe glucoprivation, this increase in FFA availability 
may be great enough in the high 2-DG group to fuel estrous cycling despite the 
reduction in useable glucose. Furthermore, in ad lib fed Syrian hamsters, estrous 
cycling is only halted in animals experiencing both glucoprivation and 
lipoprivation, not in animals that are only experiencing one of the two (Schneider 
and Wade, 1989). Thus, it is possible that an increase in lipolysis could have 
counteracted the estrus-suppressing effects of glucoprivation. 
While estrous cycling was suppressed in hamsters treated with the low 2-
DG dose, concurrent treatment with leptin restored cycling. This result is in contrast 
to work in Syrian hamsters that shows that leptin does not restore normal estrous 
cycling in animals that are fasted while receiving treatment with 2-DG (Schneider 
et al., 1998). However, our study differs from this study because our animals were 
fed ad lib, and leptin treatment restores normal estrous cycling in Syrian hamsters 
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that are fasted but do not receive 2-DG (Schneider et al., 1998). Since leptin 
supplementation cannot override the suppressive effects of glucoprivation on 
estrous cycling in fasted animals, Schneider and colleagues suggest that leptin 
influences reproductive function by indirectly affecting fuel oxidation (i.e., the 
“metabolic hypothesis”), not by acting as a signal of available fat stores (Schneider 
et al., 1998; Schneider et al., 2012; Schneider and Zhou, 1999). In non-food 
restricted animals, however, it seems plausible that leptin supplementation may be 
able to overcome some of the energy limitations of glucoprivation since leptin 
increases intracellular oxidation of fatty acids (Shimabukuro et al., 1997). Thus, in 
our study, because animals were not fasted while being treated with 2-DG, leptin 
treatment may have been able to increase intracellular oxidation of fatty acids 
enough so as to compensate for the estrus-suppressing effects of reduced 
intracellular glucose oxidation at the low dose of 2-DG (although if entirely the 
case, we may have seen lower triglyceride levels in the group that received low 2-
DG and leptin).  
It is not surprising that our measure of innate immunity, serum bacteria 
killing, was not affected by any of our treatments, as maintaining the innate immune 
system comes at a fairly low energetic cost (Klasing, 2004). We did expect that 2-
DG treatment (at both doses) would result in decreased antibody production due to 
the energetic costs of antibody generation, but instead, we found that 2-DG treated 
animals only showed a reduction in anti-KLH IgG production at the high dose. It is 
possible that, although we did not see reduced IgG production at the low dose, we 
may have seen reduced production of a different antibody type that we did not 
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measure (e.g., IgM). It is also possible that because energy was allocated away from 
investment in reproduction (i.e., all groups experiencing glucoprivation showed 
decreased uterine horn mass), then energy allocation toward humoral immunity 
could be maintained. For instance, other work in Siberian hamsters has shown that 
males that are treated with 2-DG show decreased testes mass but no reduction in 
delayed-type hypersensitivity (DTH) immune response, while females show no 
reduction in uterine mass but do show decreased DTH response (Martin et al., 
2008a). In our study, the group that received the high dose of 2-DG and leptin 
showed a reduction in IgG levels as compared to the group that only received leptin. 
This result was contrary to our predictions but may be the result of leptin treatment 
causing energy to be allocated to other energetically-costly physiological processes 
that we did not quantify in this study (e.g., thermoregulation, motor activity, self-
maintenance). For example, treating pregnant Siberian hamsters with leptin results 
in increased allocation to reproduction but a subsequent decrease in innate immune 
function (French et al., 2009a). In our study, it is quite possible that leptin treatment 
increased energy allocation to another physiological process. This shunting of 
energy toward another process, coupled with already limited energy due to 
glucoprivation, may have resulted in less energy available for immune function. 
These results highlight the importance of expanding our investigation from 
dichotomous trade-offs to trade-offs among several systems in future studies of this 
sort. 
It is important to note that much of the work on energetic regulation of 
estrous cycling has been performed in Syrian hamsters. Syrian and Siberian 
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hamsters are both seasonally breeding rodents that reproduce in long-day lengths 
and shut down reproduction in short photoperiods; however, Syrian hamsters lose 
weight while transferring from short to long photoperiods, while Siberian hamsters 
gain weight during this transition (Bartness and Wade, 1985). In addition, these 
species show differences in how 2-DG treatment affects other metabolically-
sensitive processes like food consumption and torpor (Bartness et al., 1995; Dark 
et al., 1994; Ritter and Balch, 1978; Schneider et al., 1993). Thus, it is not surprising 
that these animals may show differences in their reproductive responses to 
glucoprivation. In our study and a previous study from our lab (Zysling and Demas, 
2007), we induced glucoprivation by injecting animals with 2-DG every other day. 
Alternatively, many of the studies that we have cited in this paper have induced 
glucoprivation by injecting animals with 2-DG more frequently (e.g., every six 
hours over the course of two days (Schneider et al., 1993); every 24 hours for three 
consecutive days (Demas et al., 1997b)). These differences in the frequency of 
injections may be reflected in the differences in the effects of glucoprivation across 
these studies. Although we provided 2-DG less frequently than in some of these 
other studies, we are still confident that we were inducing glucoprivic effects 
because this same injection protocol has been previously shown to cause 
glucoprivation and affect immune responses in rats at a lower dose than the doses 
we chose (Chou et al., 1996). 
In conclusion, our data support the presence of trade-offs between the 
reproductive and immune systems, which are regulated distinctly based upon the 
severity of glucoprivation and leptin signaling that the animal experiences. Because 
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varying components of the reproductive and immune systems were suppressed 
under different levels of glucoprivation, these results highlight how trade-offs 
induced by the same energetic stressor can manifest in opposite ways depending on 
the intensity of the stressor. In addition, the context-dependent nature of these trade-
offs support the idea that animals should preferentially allocate energy to processes 
that support survival or reproduction based upon their internal energetic 
environment. Collectively, these data showcase the complexities underlying the 
metabolic mechanisms facilitating energetic trade-offs and highlight that future 
studies should examine trade-offs among several physiological systems to elucidate 
how metabolic fuels are being allocated during energetic stress. 
 
 
 
  
46 
 
CHAPTER 2: Leptin mediates seasonal variation in some but not all 
symptoms of sickness in Siberian hamsters 
 
Data published in: Carlton, E.D. and Demas, G.E. 2014. Leptin mediates seasonal 
variation in some but not all symptoms of sickness in Siberian hamsters. Hormones 
and Behavior 66: 802-811. 
 
Abstract 
Many seasonally breeding species, including Siberian hamsters (Phodopus 
sungorus), exhibit seasonal variation in sickness responses. One hypothesis 
regarding the mechanism of this variation is that sickness intensity tracks an 
animal’s energetic state, such that sickness is attenuated in the season that an animal 
has the lowest fat stores. Energetic state may be signaled via leptin, an adipose 
hormone that provides a signal of fat stores. Siberian hamsters respond to extended 
housing in short, winter-like days by reducing fat stores and leptin levels, relative 
to those housed in long, summer-like days. Sickness responses are also attenuated 
in short-day hamsters as compared to long-day hamsters. We hypothesized that 
leptin provides a physiological signal by which seasonally breeding animals 
modulate sickness responses, such that animals with higher leptin levels show 
increased sickness intensity. To test this, we provided short-day hamsters with a 
long-day-like leptin signal and assessed their responses to lipopolysaccharide 
(LPS), a sickness-inducing antigen. We compared these responses to short-day 
vehicle-, long-day vehicle-, and long-day leptin-treated hamsters. Unexpectedly, 
LPS induced a hypothermic response (rather than fever) in all groups. Short-day 
vehicle-treated hamsters exhibited the greatest LPS-induced hypothermia, and 
leptin treatment attenuated this response, making hypothermia more long-day-like. 
Contrary to our hypothesis, short-day leptin-treated hamsters showed the least 
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pronounced LPS-induced anorexia among all groups. These results suggest that 
leptin may mediate some but not all aspects of seasonal sickness variation in this 
species. Future studies should be targeted at determining roles of other energetic 
hormones in regulating seasonal sickness response variation. 
 
Introduction 
 Seasonally breeding animals must respond to temporal changes in 
environmental factors like climate fluctuations, social interactions, and resource 
availability. While their abiotic and biotic environments are changing, seasonal 
breeders respond with appropriate morphological, physiological, and behavioral 
adaptations in order to maximize their chances of survival and reproductive success 
(Bronson, 1985). Such seasonal adaptations include changes in reproductive 
function and behavior, frequency and magnitude of agonistic behaviors, 
metabolism, and immune function (Demas et al., 2010). All of these processes 
require substantial energy, and as energetic resources may be less plentiful during 
certain times of the year (e.g., winter), changes in the expression of these traits 
occur when energy is shifted away from certain processes and toward those that 
will prioritize immediate survival (Nelson and Demas, 2004). In particular, 
immunity is quite sensitive to the energetic state of organism, as seasonal alterations 
in immune function can be best predicted by changes in an animal’s energetic state 
rather than reproductive state or photoperiodic cues (Demas, 2004).  Seasonal 
changes in immune responses have been documented in all three branches of the 
immune system (i.e., innate, cell-mediated, humoral) in several different species of 
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mammals and birds (Martin et al., 2008c). Seasonal changes in immunity are 
commonly observed in inducible immune defenses because the energetic costs of 
mounting an immune response can be very high (e.g., can raise resting metabolic 
rate by as much as 50%) (Lochmiller and Deerenberg, 2000). 
 One of the initial and more energetically expensive immune responses is the 
acute phase response (APR), and the behavioral and physiological manifestations 
of sickness that accompany it. During the APR, pro-inflammatory cytokines are 
released from immune cells and act on the brain to generate the symptoms of a 
sickness response. Sickness responses are characterized by hyperthermia (i.e., 
fever) or hypothermia, anorexia, body mass loss, reductions in social, hedonic, and 
sexual behaviors, and hypothalamic-pituitary-adrenal (HPA) axis stimulation 
(Hart, 1988; Tizard, 2008). While these symptoms may appear to be a result of 
infection-induced weakness or malaise, these responses are actually a well-adapted 
mechanism to aid the host organism in clearance of the infectious agent (Hart, 
1988). Blocking fever and anorexia during sickness can actually result in increased 
mortality via failure to eliminate the infection (Covert and Reynolds, 1977; Kluger 
et al., 1975; Kyriazakis et al., 1998; Vaughn et al., 1980), while blocking 
glucocorticoid production can cause mortality via sepsis (Bertini et al., 1988). 
Mounting an appropriate sickness response is clearly beneficial to an organism’s 
survival, but being sick also carries significant energetic costs that can be 
detrimental to survival if too severe (Buchanan et al., 2003; Maier et al., 1994; 
Plata-Salaman, 1996). While variations in sickness response intensity at the 
extremes of the spectrum clearly negatively affect survival, the ability to modulate 
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sickness intensity between these “mortality endpoints” may be critical for ensuring 
survival in environments with variable energetic resource availability. 
 Seasonally breeding animals live in environments where energetic 
resources vary across the annual cycle (i.e., resources more plentiful in summer 
than winter), and studies of sickness responses in several seasonally breeding 
species have revealed that sickness response intensity can also vary with the 
seasons (reviewed in Ashley et al., 2012; Ashley and Wingfield, 2012). 
Collectively, the patterns of sickness response variation in these species reveal that 
there is not one critical season in which animals display a weak or strong sickness 
response, suggesting that seasonal photoperiodic cues or reproductive status may 
not drive variation in sickness intensity. Rather, the common predictor of sickness 
response intensity across these studies is the current energetic state of the animal—
sickness responses are attenuated in the season in which the organism has the lowest 
energy reserves (i.e., lowest body mass and fat stores) (Bilbo et al., 2002; Owen-
Ashley et al., 2008; Owen-Ashley et al., 2006; Prendergast et al., 2008). In further 
support of the hypothesis that energetic state is a predictor of sickness response 
intensity in seasonally breeding animals, pre-sickness body mass and body fat 
levels are correlated with infection-induced anorexia and body mass loss, such that 
animals with higher initial body masses and fat stores show greater percent 
decreases in food intake and body mass after LPS injection (Owen-Ashley et al., 
2008; Owen-Ashley et al., 2006). These observations suggest that the magnitudes 
of the energetically expensive components of a sickness response are constrained 
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by a minimum body mass that an animal can reach before it risks its survival 
(Ashley and Wingfield, 2012; Owen-Ashley and Wingfield, 2007).  
 If energetic state is the critical predictor of seasonal variation in sickness 
response intensity, then the adipose hormone leptin is a promising candidate for a 
neuroendocrine mediator of this variation. Leptin is not only tightly coupled with 
the energetic state of an organism, but it also interacts with the immune system 
(Carlton et al., 2012; La Cava and Matarese, 2004). Leptin levels are directly 
proportional to the mass of adipose tissue in several mammalian species (Johnson 
et al., 2004; Maffei et al., 1995), and as such, high levels of leptin indicate adequate 
energy stores, whereas low levels are consistent with energy deficit. Leptin levels 
change across seasons in seasonally breeding animals, and these seasonal changes 
track seasonal changes in body mass and body fat (Concannon et al., 2001; Gaspar-
Lopez et al., 2009; Horton et al., 2000). Immune function can be restored via leptin 
treatment in animals that have been food deprived or have had body fat 
experimentally reduced (Demas and Sakaria, 2005; Lord et al., 1998), and there is 
also evidence that leptin may modulate seasonal changes in immunity (Drazen et 
al., 2001). Although there is no yet established role of leptin in mediating seasonal 
variation in sickness responses, there is considerable evidence that leptin does 
influence sickness responses (Harden et al., 2006; Sachot et al., 2004), although the 
direct mechanisms and their effects are not entirely understood (Carlton et al., 
2012).  
 The goal of the present study was to test the hypothesis that leptin serves as 
a neuroendocrine signal mediating seasonal variation in sickness responses. To 
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accomplish this, we housed male Siberian hamsters (Phodopus sungorus) in long 
and short days to induce two photoperiodic morphs, experimentally elevated leptin 
levels in a subset of hamsters in each morph, and then measured sickness response 
variables (e.g., body temperature, anorexia, body mass loss, anhedonia, nest 
building behavior, HPA axis activation) in response to inoculation with 
lipopolysaccharide (LPS), a sickness-inducing bacterial mimetic. When housed in 
short days, Siberian hamsters regress their gonads to a non-reproductive state and 
decrease food intake, body mass, and fat stores. In addition, Siberian hamsters have 
lower leptin levels in short days as compared to long days (Horton et al., 2000) and 
display less intense sickness responses (i.e., lower fever amplitude, shorter 
durations of and lesser decreases in food intake and body mass loss, lesser decreases 
in hedonic and nest shredding behaviors, higher cortisol secretion) (Bilbo et al., 
2002; Bilbo et al., 2003; Wen et al., 2007). We predicted that if leptin mediates 
seasonal variation in sickness responses, then short-day leptin-treated hamsters 
would display sickness responses similar to long-day vehicle-treated hamsters and 
would display more intense sickness responses than short-day vehicle-treated 
hamsters. Leptin treatment, however, should have no effect on the sickness 
responses of long-day housed hamsters because previous studies in this species 
have shown that leptin does not enhance other measures of immunity in long-day 
animals even though it enhances them in short-day animals (Demas, 2002; Drazen 
et al., 2001). 
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Methods 
 
Animals and housing conditions 
Adult male (> 60 days of age) Siberian hamsters (n = 117) were obtained 
from our breeding colony at Indiana University. The progenitors of these animals 
were generously provided by Dr. Randy Nelson (Ohio State University) and Dr. 
Timothy Bartness (Georgia State University).  In order to minimize the effects of 
inbreeding, our animals are outbred approximately every 10 generations. All 
animals were initially group housed (2-5 with same sex siblings on weaning at 17-
18 days of age) in long-day photoperiods (light:dark (L:D) 16:8), and then 
individually housed in polypropylene cages (27.8 x 17.5 x 13.0 cm) for one week 
prior to the start of the experiment. Food (Laboratory Rodent Diet 5001, LabDiet, 
St. Louis, MO, USA) and tap water were available ad libitum during the entire 
course of the experiment. Temperature (20 ± 2°C) and humidity (50 ± 10%) were 
maintained at constant levels. Animals were then randomly assigned to either long 
(L:D 16:8) (n = 40) or short days (L:D 8:16) (n = 74) for the remainder of the study. 
A greater number of hamsters were housed in short days to account for reproductive 
non-responders (described below). All animal methods were reviewed and 
approved by the Institutional Animal Care and Use Committee at Indiana 
University Bloomington (protocol no. 10-038). 
A subset of hamsters within the short-day group often fails to show 
reproductive responsiveness to photoperiod (i.e., do not display gonadal regression, 
reductions in body mass and fat stores, or changes in pelage coloration and 
thickness) despite prolonged exposure to short days. These individuals are referred 
53 
 
to as photoperiodic non-responders (Puchalski and Lynch, 1986). After ten weeks 
of exposure to short-day photoperiods, 36 animals were determined to be non-
responders (defined by a reduction in body mass less than or equal to 10% of their 
mass at the beginning of the experiment) and were removed from the experiment. 
At the conclusion of the experiment, paired testes mass was collected to confirm 
short-day responsiveness (defined as a paired testes mass < 0.15 g) (Greives et al., 
2008). At the end of the study, we were left with 40 hamsters exhibiting the long-
day phenotype (referred to as LD from here forward) and 38 hamsters exhibiting 
the short-day responder phenotype (referred to as SD from here forward). 
 
Experimental methods 
During the first 10 weeks of photoperiodic treatment, hamsters were 
weighed weekly to the nearest 0.1 g to track photoperiodic responsiveness. After 
these ten weeks and when the photoperiodic non-responders were removed from 
the study, body mass (to the nearest 0.1 g) and food consumption (to the nearest 0.1 
g) were assessed daily to establish pre-leptin treatment body mass and food intake 
baseline values. Food consumption was assessed by weighing the food pellets 
remaining in the hopper each day. 
After five days, animals were surgically implanted with an osmotic mini-
pump subcutaneously in the intra-scapular region under isoflurane anesthesia 
(Alzet 1002; 100 µl volume; 0.25 µl/h delivery rate; 14 days; Durect Corp., 
Cupertino, CA, USA). Half of the animals from each photoperiodic group were 
randomly assigned to receive mini-pumps containing recombinant murine leptin (n 
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= 39; 2.67 µg/µl leptin; Peprotech Inc., Rocky Hill, NJ, USA) dissolved in 0.5 M 
Tris buffer. The remaining animals received mini-pumps containing vehicle (n = 
39; 0.5 M Tris buffer) (Drazen et al., 2001). Murine leptin has been used in several 
studies in Siberian hamsters and has elicited responses consistent to those reported 
for mice, suggesting that murine leptin can bind the Siberian hamster leptin receptor 
(Demas and Sakaria, 2005; Drazen et al., 2001; French et al., 2009a; Klingenspor 
et al., 2000).  For the eight days after mini-pump implantation, body mass and food 
consumption were collected daily to assess surgery recovery and leptin effects on 
these measures. 
On the eighth day after mini-pump implantation and ~15 min before the 
onset of darkness (long days: ~1945 h; short days: ~1545 h), a portion of the 
animals in each group (LD-Vehicle, n = 10; LD-Leptin, n = 10; SD-Vehicle, n = 
11; SD-Leptin, n = 11) were injected intraperitoneally (i.p.) with 25 µg LPS (LPS 
from Salmonella enterica serotype typhimurium, Sigma-Aldrich, St. Louis, MO, 
USA; Durazzo et al., 2008; French et al., 2013) suspended in 0.1 ml sterile 0.9% 
saline. The remaining animals were injected i.p. with 0.1 ml sterile 0.9% saline 
(LD-Vehicle, n = 10; LD-Leptin, n = 10; SD-Vehicle, n = 8; SD-Leptin, n = 8). 
Sickness responses and behaviors (i.e., fever, anorexia, body mass loss, anhedonia, 
nest building) were assessed throughout the four days following injections. 
 
Blood sampling and necropsies 
Blood samples were drawn from each animal 4 h after the onset of darkness 
(long days: 2400 h; short days: 2000 h) 3 days before injection and on the day of 
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injection in order to assess circulating leptin and cortisol concentrations. We chose 
this time point (~4 hours after LPS injection) because it has previously been shown 
to be the point where there is the greatest difference in LPS-induced cortisol 
secretion between LD- and SD-housed Siberian hamsters (Bilbo et al., 2003). 
Briefly, animals were lightly anesthetized with isoflurane vapors, and blood 
samples were drawn from the retro-orbital sinus. Blood samples were allowed to 
clot at room temperature for 1 h, the clots were removed, and samples were 
centrifuged at 4 °C for 30 min at 2500 rpm. Serum aliquots were aspirated and 
stored in sealable polypropylene microcentrifuge tubes at -20 °C until assayed. All 
blood samples were collected within 3 min of initial handling. Animals were 
euthanized 5 days after LPS injection and necropsies were performed. Testes were 
removed, cleaned of connective tissues, and weighed to the nearest 0.1 mg in order 
to assess reproductive responsiveness. 
 
Sickness response measurements 
     Fever, anorexia, and body mass 
On the day of injection, colonic temperatures (Tc; to the nearest 0.1 °C) were 
collected immediately before injection and 2, 4, 6, 8, 10, 12, 16, 20, and 24 h after 
injection using a MicroTherma 2T thermometer (ThermoWorks, Alpine, UT, USA) 
and a lubricated RET-3-ISO thermocouple probe (Physitemp Instruments, Inc., 
Clifton, NJ, USA) inserted ~12 mm into the rectum. To assess anorexia and body 
mass loss, daily body mass and food consumption measurements continued until 
the end of the study.  
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     Anhedonic behavior  
To assess the effects of our treatments on hedonic behavior, we provided 
hamsters with a highly palatable sodium saccharin solution (Baillie and 
Prendergast, 2008). Beginning 5 days before LPS and saline injections, for the first 
6 h of the dark phase (long days: 2000 h to 200 h; short days: 1600 h to 2200 h) 
hamsters were provided with a fluid bottle containing a solution of 0.1% sodium 
saccharin (saccharin sodium salt hydrate, Sigma-Aldrich, St. Louis, MO, USA) 
dissolved in tap water (Baillie and Prendergast, 2008). The saccharin solution 
bottles were weighed (to the nearest 0.1 g) before they were given and after they 
were collected from the hamsters each day. Presentation of saccharin solution 
continued daily through day 3 post-injection.  
      
     Nest building behavior  
To assess the effects of our treatments on thermoregulatory behavior, 
beginning 5 days before LPS or saline injection, each hamster was provided with a 
compressed cotton nestlet weighing ~2.5 g (Ancare, Bellmore, NY, USA) for the 
first 6 h of the dark phase (Baillie and Prendergast, 2008). The whole nestlet was 
weighed (to the nearest 0.1 g) before presentation, and the unshredded portion of 
the nestlet was weighed after presentation. When provided a nestlet, hamsters 
quickly start shredding the cotton to build a nest. Nest-building is an adaptive 
behavior to enhance energy conservation in low temperatures, however, hamsters 
readily build nests in room temperature (20-23 °C) (Puchalski et al., 1988). 
Presentation of nestlets continued daily through day 3 post-injection. 
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Leptin enzyme-linked immunosorbent assay (ELISA) 
Circulating leptin levels were assayed via commercially prepared mouse 
leptin ELISA kits (Crystal Chem, Downers Grove, IL, USA). This kit has 
previously been used in another non-murine rodent (Johnson et al., 2004), and prior 
to testing samples, we validated the assay and determined the appropriate dilutions 
so that leptin concentrations lay within the detectable range of the ELISA. Samples 
were diluted 1:4 (non-leptin treated) or 1:8 (leptin treated) with sample diluent and 
run in duplicate. Intra-assay variabilities were 3.9% and 5.8% for the two plates. 
 
Cortisol enzyme immunoassay (EIA) 
We assessed circulating cortisol levels to determine if our photoperiod and 
leptin treatments affected the magnitude of LPS-induced HPA axis activation. 
Cortisol is the predominant glucocorticoid in Siberian hamsters, with 
concentrations ~100x that of corticosterone (Reburn and Wynne-Edwards, 2000). 
Serum cortisol concentrations were determined in multiple enzyme immunoassays 
(EIAs) from a commercially prepared kit (Cortisol EIA Kit; Enzo Life Sciences, 
Inc., Farmingdale, NY, USA). This assay was previously validated for use in 
Siberian hamsters (Demas et al., 2004) and is highly specific for cortisol; cross-
reactivity with corticosterone is 27.7% and < 4.0% for other steroid hormones. The 
sensitivity of the assay is 56.72 pg/ml. Samples were diluted to 1:80 with assay 
buffer and run in duplicate. Intra-assay variabilities were 6.7% and 7.4%. 
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Statistical analyses 
All statistical tests were performed using JMP 10 (SAS Institute Inc., Cary, 
NC, USA), and a value of P < 0.05 was considered to be statistically significant. 
Residuals were checked for normality and homogeneity of variance, and those data 
that were non-normally distributed were transformed. Two LPS-treated animals 
were excluded from analyses (1 from SD-Leptin group; 1 from SD-Vehicle group) 
because they failed to exhibit any sickness symptoms. One LPS-treated animal 
(from SD-Leptin group) was excluded from analyses because it displayed 
exaggerated LPS-induced sickness symptoms and was not showing any signs of 
recovery by the end of the experiment (as is typical for all LPS-treated SD animals). 
The final sample sizes were as follows: LD-Vehicle-Saline (n=10), LD-Vehicle-
LPS (n=10), LD-Leptin-Saline (n=10), LD-Leptin-LPS (n=10), SD-Vehicle-Saline 
(n=8), SD-Vehicle-LPS (n=10), SD-Leptin-Saline (n=8), and SD-Leptin-LPS 
(n=9). 
 Non-normally distributed variables differed in their directions and degrees 
of skewness, and as such, each variable was transformed with the function that best 
fits the data to normality. Leptin concentrations and pre-injection saccharin solution 
intake were log transformed, pre-injection food intake was inverse transformed, 
post-injection percent change in saccharin solution intake was square root 
transformed, and post-injection percent change in nesting material shredded was 
square transformed. Finally, pre-injection percent nesting material shredded was 
not normally distributed and could not be transformed to meet the assumptions of 
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normality, so a Kruskal-Wallis test was performed to determine if there were 
differences among groups for this measure. 
 Pre-injection baseline values were calculated for body mass, food intake, 
saccharin solution intake, and percent nesting material shredded by averaging the 
three daily measurements immediately prior to injections. To determine if there 
were effects of photoperiod or leptin treatment on pre-injection leptin levels, 
baseline body mass, baseline food intake, and baseline saccharin solution intake, 
two-way (photoperiod (2) x leptin treatment (2)) analyses of variance (ANOVA) 
were performed. Pre-injection body mass was included as a covariate in the model 
for leptin levels to control for the effect of body mass on this dependent variable. 
Pre-injection body mass was initially included as a covariate in the model for pre-
injection food intake but was removed from the model after it was determined to 
not be significant predictor (P > 0.05).  
Changes in colonic temperature across groups and time were assessed via 
Linear Mixed Models (LMM) with leptin treatment, injection, time, and their 
interactions as fixed effects and animal ID as a random effect. Due to natural 
circadian variation in temperature between LD and SD hamsters, individual LMMs 
were run for each photoperiod. We used a LMM for this measure, as opposed to a 
repeated-measures ANOVA, because the thermometer failed during the 
temperature collection for six animals at the 4 h time-point, and the LMM allowed 
us to keep these animals in our analyses. Pairwise comparisons were conducted 
using t-tests between each LPS-injected group and their respective saline control at 
each time point. 
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Because photoperiod affected pre-injection body mass, food intake, and 
saccharin solution intake (see Results), post-injection changes in these 
measurements were expressed as percentages of each animal’s baseline values for 
these variables. Although nest shredding was not affected by photoperiod, for 
continuity in presentation of results, this measurement was also expressed as a 
percentage of baseline. Differences in these repeated measures (i.e., percent change 
in food intake, percent change in body mass, percent change in saccharin solution 
intake, and percent change in nesting material shredded) were assessed via 
repeated-measures ANOVAs with photoperiod, leptin treatment, injection, and 
their interactions as between subjects variables and time and its interactions as the 
within-subjects variables. The within-subject comparisons for percent change in 
body mass, percent change in saccharin solution intake, and percent change in 
nesting material shredded violated the assumptions of sphericity and were 
Greenhouse-Geisser (GG)-corrected. Differences in serum cortisol concentrations 
among the groups were assessed with a three-way (photoperiod (2) x leptin 
treatment (2) x injection (2)) ANOVA. Post-hoc comparisons between pairwise 
means were conducted using Tukey’s honestly significant difference (HSD) tests 
when the overall ANOVA was significant. Effect size estimates for ANOVAs and 
pair-wise comparisons were calculated by eta squared (η2) and Cohen’s d, 
respectively. 
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Results 
 
Pre-injection/Post-leptin baseline measures 
 
Leptin levels in both vehicle- and leptin-treated animals were related to the 
animal’s pre-injection body mass (F1,70 = 22.26, P < 0.001, η2 = 0.116). In addition, 
leptin levels were affected by photoperiod (F1,70 = 5.67, P = 0.02, η2 = 0.029), leptin 
treatment (F1,70 = 82.77, P < 0.001, η2 = 0.430) and the photoperiod x leptin 
interaction (F1,70 = 12.01, P < 0.001, η2 = 0.062) (Table 1). Specifically, SD-Leptin 
hamsters showed leptin levels that were higher than the levels of SD-Vehicle 
hamsters (P < 0.01, d = 2.567) but statistically equivalent to LD-Vehicle levels (P 
> 0.90, d = 0.181). 
Prior to injection, photoperiod affected baseline body mass (F1,71 = 92.49, 
P < 0.001, η2 = 0.548), such that SD hamsters had significantly lower body masses 
than LD hamsters; however, neither leptin treatment (F1,71 = 1.53, P = 0.220, η2 = 
0.009) or the photoperiod x leptin interaction (F1,71 = 3.85, P = 0.0538, η2 = 0.023) 
had effects on pre-injection body mass (Table 1). Additionally, pre-injection 
baseline food intake was affected by both photoperiod (F1,71 = 39.09, P < 0.001, η2 
= 0.320) and leptin treatment (F1,71 = 8.21, P = 0.006, η2 = 0.067) and a trend toward 
the photoperiod x leptin interaction (F1,71 = , 3.94, P = 0.051, η2 = 0.0322) (Table 
1). Specifically, SD hamsters consumed less food per day than LD hamsters (T = 
6.25, P < 0.001, d = -1.3471), and leptin-treated hamsters consumed less food per 
day than vehicle-treated hamsters (T = 2.86, P = 0.003, d = -0.490); however, the 
effect of leptin on food intake was largely driven by SD-Leptin hamsters exhibiting 
lower daily food consumption than SD-Vehicle hamsters.  
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Pre-injection baseline saccharin solution intake was affected by photoperiod 
(F1,70 = 9.17, P = 0.003, η2 = 0.116) and the photoperiod x leptin interaction (F1,70 
= 5.38, P = 0.023, η2 = 0.069) but not leptin treatment alone (F1,70 = 0.004, P = 
0.953, η2 = 0.0004) (Table 1). Specifically, SD-Leptin hamsters consumed less 
saccharin solution than LD-Leptin hamsters. Pre-injection baseline nest shredding 
was not affected by our treatments, and percent nesting material shredded did not 
differ among groups (H = 3.97, P = 0.265) (Table 1). 
 
 
Table 1.  Mean (± SEM) circulating leptin concentration, body mass, food intake, 
saccharin solution intake, and percent nesting material shredded prior to LPS and 
saline injections in long-day (LD) and short-day (SD) housed male Siberian 
hamsters implanted with vehicle- or leptin-filled osmotic mini-pumps. Baseline 
measurements were calculated by averaging the values collected for the 
measurements during the 3 days prior to LPS or saline injection. Groups with 
different letters indicate statistically significant differences between group means 
(P < 0.05); groups sharing the same letter are statistically equivalent. 
____________________________________________________________________________________________________________________________________ 
       
    Vehicle                  Leptin 
____________________________________________________________________________________________________________________________________ 
 
Leptin Concentration (ng / ml)    
    LD      12.03 ± 1.08a  24.65 ± 2.54c 
    SD  4.06 ± 0.53b  12.90 ± 1.30a 
 
Baseline Body Mass (g) 
    LD  41.4 ± 1.2a  44..9 ± 1.0a 
    SD      33.2 ± 1.1b  32.4 ± 1.1b 
 
Baseline Food Intake (g / day) 
    LD  5.3 ± 0.2a  5.1 ± 0.1a,b 
    SD      4.5 ± 0.2b  3.9 ± 0.2c 
 
Baseline Saccharin Solution Intake (g / 6 h) 
    LD      2.1 ± 0.2a,b  2.5 ± 0.2a                  
    SD      1.9 ± 0.2a,b  1.5 ± 0.2b 
 
Baseline Percent Nesting Material Shredded 
    LD      87.4 ± 4.5  97.2 ± 1.2                
    SD      92.0 ± 4.7  97.5 ± 1.8 
____________________________________________________________________________________________________________________________________ 
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Febrile/Hypothermic responses 
Within each photoperiod, colonic temperature was significantly affected by 
injection (LD: F1, 36 = 9.76, P = 0.004; SD: F1, 31.11 = 7.667, P = 0.009), time (LD: 
F9, 324 = 68.42, P < 0.001; SD: F9, 273.2 = 63.02, P < 0.001), and the interaction 
between injection and time (LD: F9, 324 = 14.06, P < 0.001; SD: F9, 273.2 = 22.21, P 
< 0.001) (Figure 1). In addition, the pattern of colonic temperature was influenced 
by the leptin x time interaction in LD animals only (F9, 324 = 3.06, P = 0.002). 
Colonic temperature was not predicted by leptin treatment or any of the additional 
interaction terms in either photoperiods (P > 0.05 in all cases). LPS-injected LD-
Vehicle, SD-Vehicle, and SD-Leptin hamsters had significantly higher Tc at 2 hours 
after injections as compared to their respective saline-injected controls (T > 3.06, P 
< 0.05 in all cases, dLD-Veh = 1.374, dSD-Veh = 2.408, dSD-Lep = 1.837). In the LPS-
injected SD-Vehicle and SD-Leptin hamsters, the higher temperature in animals 
appears to be due to a transient hypothermic response in the saline-injected controls, 
rather than an increase in temperature in LPS-treated animals. After these higher 
temperatures at 2 hours post-LPS, all LPS-treated hamsters showed varying degrees 
of hypothermia. Specifically, LD-Vehicle, LD-Leptin, and SD-Leptin hamsters 
each showed hypothermia at two or three time points post-LPS treatment (LD-
Vehicle: 6h, 24h; Figure 1A; LD-Leptin: 6h, 12h, 24h, Figure 1B; SD-Leptin: 12h, 
16h; Figure 1B) as compared to their respective saline-injected controls (T > 2.60, 
P < 0.05 in all cases, LD-Veh: d6h = -2.634, d24h = -1.644; LD-Lep: d6h = -2.2637, 
d12h = -1.814, d24h = -1.170; SD-Lep: d12h = -1.493, d16h = -1.34). In contrast, SD-
Vehicle hamsters showed hypothermia at all measured time points from 6 h to 24 
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h post-LPS treatment as compared to their respective saline-injected controls (T > 
2.31, P < 0.05 in all cases, d < -1.048; Figure 1A). 
  
 
 
Figure 1. Mean (± SEM) colonic temperature following LPS and saline treatments 
delivered at the 0 h time point in long-day (LD; top panels) and short-day (SD; 
bottom panels) housed male Siberian hamsters implanted with (A) vehicle-filled 
and (B) leptin-filled osmotic mini-pumps. Black and white bars at the bottom of the 
graphs indicate the active, dark (black) and inactive, light (white) phases of the 
light-dark cycle for each photoperiodic morph. Within each panel: *P < 0.05 versus 
saline-treated group exposed to the same photoperiod and osmotic mini-pump 
treatment. 
 
Anorexia 
 Changes in food intake after injections were affected by photoperiod (F1,67 
= 20.15, P < 0.001, η2 = 0.083), injection (F1,67 = 132.55, P < 0.001, η2 = 0.548), 
and the photoperiod x injection interaction (F1,67 = 16.06, P < 0.001, η2 = 0.066), 
such that SD hamsters from both the vehicle- and leptin-treated groups showed 
decreased magnitudes of LPS-induced anorexia as compared to LD hamsters 
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(Figure 2).  In addition, food intake changed across the course of the four days post 
injection (within subjects, F3,65 = 122.78, P < 0.001, η2 = 0.531). Additional within 
subjects analyses revealed time x injection (F3,65 = 50.51, P < 0.001, η2 = 0.206), 
time x photoperiod x injection (F3,65 = 3.24, P = 0.028, η2 = 0.011), and time x 
photoperiod x leptin interactions (F3,65 = 4.53, P = 0.006, η2 = 0.017). Specifically, 
LPS-treated LD-Vehicle hamsters showed decreased food intake on days 1, 2, 3, 
and 4 post-LPS treatment as compared to their respective saline treated controls (P 
< 0.03 for all comparisons, dday1 = -4.931, dday2 = -3.587, dday3 = -1.989, dday4 = -
1.799), while LPS-treated SD-Vehicle hamsters showed decreased food intake on 
days 1 and 2 post-LPS as compared to controls (P < 0.01 for day 1 and 2 
comparisons, dday1 = -2.727, dday2 = -1.632; P > 0.90 for day 3 and 4 comparisons, 
dday3 = -0.356, dday4 = 0.498; Figure 2A). Alternatively, leptin-treated hamsters from 
both photoperiods showed attenuated LPS-induced anorexic responses as compared 
to vehicle-treated hamsters. Specifically, LPS-treated LD-Leptin hamsters only 
showed decreased food intake on days 1, 2, and 3 post-injection as compared to 
their respective saline-treated controls (P < 0.01 for day 1, 2, and 3 comparisons,  
dday1 = -9.349, dday2 = -4.324, dday3 = -2.07; P > 0.08 for day 4 comparison, dday4 = -
1.3149), while LPS-treated SD-Leptin hamsters showed decreased food intake only 
on day 1 post-injection as compared to controls (P < 0.05 for day 1 comparison, 
dday1 = -2.701; P > 0.80 for day 2, 3, and 4 comparisons, dday2 = -0.541, dday3 = -
0.216, dday4 = 0.425; Figure 2B). 
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Figure 2. Mean (± SEM) percent change in daily food intake from baseline 
following LPS and saline treatment delivered on day 0 in long-day (LD) and short-
day (SD) housed male Siberian hamsters implanted with (A) vehicle-filled and (B) 
leptin-filled osmotic mini-pumps. Day +1 represents the time period from 0-24 h 
after LPS or saline injection, Day +2 represents the time period from 24-48 h after 
LPS or saline injection, and so forth. *P < 0.05 versus saline-treated group exposed 
to the same photoperiod and osmotic mini-pump treatment. #P < 0.05 versus SD 
LPS-treated group exposed to the same osmotic mini-pump treatment. 
 
Body mass loss 
 Changes in body mass after injections were affected by injection (F1,67 = 
130.30, P < 0.001, η2 = 0.631) and the leptin x injection interaction  (F1,67 = 5.04, 
P = 0.0281, η2 = 0.024) (Figure 3). Percent body mass loss changed across the 
course of the four days post injection (within subjects, F2.03,136.31 = 30.75, P < 0.001, 
G-G corrected, η2 = 0.190). In addition, within subjects analyses revealed time x 
photoperiod (F2.03,136.31 = 26.20, P < 0.001, G-G corrected, η2 = 0.162), time x 
injection (F2.03,136.31 = 10.05, P < 0.001, G-G corrected, η2 = 0.062), and time x 
photoperiod x injection interactions (F2.03,136.31 = 25.14, G-G corrected, P < 0.001, 
η2 = 0.156). Specifically, LPS-treated LD-Vehicle and SD-Vehicle hamsters 
showed body mass decreases that were greater than their respective saline-treated 
controls at all 4 days post-injection (P < 0.03 for all comparisons, LD: dday1 = -
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2.686, dday2 = -4.087, dday3 = -3.596, dday4 = -3.409; SD: dday1 = -2.823, dday2 = -
3.554, dday3 = -2.871, dday4 = -1.755; Figure 3A), although body mass appeared to 
be recovering toward baseline in SD-Vehicle hamsters by day 4. LPS-treated LD-
Leptin hamsters only showed post-injection body mass decreases that were greater 
than their respective saline-treated controls at days 2, 3, and 4 post-injection (P < 
0.001 for day 2, 3 and 4 comparisons, dday2 = -1.421, dday3 = -1.721, dday4 = -1.702; 
P > 0.17 for day 1 comparison, dday1 =  -1.176; Figure 3B). Alternatively, LPS-
treated SD-Leptin hamsters showed post-injection body mass decreases that were 
greater than their respective saline-treated controls only at days 1, 2, and 3 post-
injection (P < 0.001 for day 1, 2 and 3 comparisons, dday1 = -2.898, dday2 = -2.917, 
dday3 = -2.907), while the LPS-induced body mass loss did not persist to day 4 post-
injection (P > 0.57, dday4 = -1.108; Figure 3B). 
 
 
Figure 3. Mean (± SEM) percent change in body mass from baseline following 
LPS and saline treatment delivered on day 0 in long-day (LD) and short-day (SD) 
housed male Siberian hamsters implanted with (A) vehicle-filled and (B) leptin-
filled osmotic mini-pumps. Day +1 represents the time period from 0-24 h after 
LPS or saline injection, Day +2 represents the time period from 24-48 h after LPS 
or saline injection, and so forth. *P < 0.05 versus saline-treated group exposed to 
the same photoperiod and osmotic mini-pump treatment. #P < 0.05 versus SD LPS-
treated group exposed to the same osmotic mini-pump treatment. 
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Saccharin solution intake 
 Changes in saccharin solution intake after injections were affected by 
photoperiod (F1,66 = 18.62, P < 0.001, η2 = 0.184), injection (F1,66 = 5.41, P = 0.023, 
η2 = 0.054), and the photoperiod x injection interaction (F1,67 = 4.47, P = 0.038, η2 
= 0.044) (Figure 4). Additionally, percent saccharin intake changed across time 
(within subjects, F2.47,163.01 = 3.39, P = 0.027, G-G corrected, η2 = 0.043) and was 
affected by the time x photoperiod x leptin interaction (within subjects, F2.47,163.01 = 
5.17, P = 0.004, G-G corrected, η2 = 0.065). As there was a lot of variance in this 
measure, post hoc analyses only revealed that, at the 48-54 h time point, LPS-
treated LD-Vehicle hamsters showed a greater percent decrease in saccharin 
solution intake as compared to LPS-treated SD-Vehicle hamsters (P < 0.01, d = 
1.562;  Figure 4A). However, LPS-treated hamsters (independent of photoperiod 
and leptin treatments) showed greater percent decreases in saccharin solution at the 
0-6 h time point as compared to saline-treated hamsters (T = 2.18, P < 0.04, d = -
0.532).  
 
Figure 4. Mean (± SEM) percent change in saccharin solution intake from baseline 
following LPS and saline treatment delivered at the 0 h time point in long-day (LD) 
and short-day (SD) housed male Siberian hamsters implanted with (A) vehicle-
filled and (B) leptin-filled osmotic mini-pumps. #P < 0.05 versus SD LPS-treated 
group exposed to the same osmotic mini-pump treatment. 
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Nest building behavior 
 Percent changes in nesting material shredded were affected by injection 
(F1,67 = 118.51, P < 0.001, η2 = 0.626), but not by photoperiod, leptin, or any of the 
interaction terms (P > 0.05 for all effects) (Figure 5). In addition, percent nesting 
material shredded changed over time (F2.7,183.4 = 46.63, P < 0.001, G-G corrected, 
η2 = 0.270) and changed according to the time x injection interaction (F0.9,52.3 = 
52.32, P < 0.001, G-G corrected, η2 = 0.303). LPS-treated LD-Vehicle, SD-
Vehicle, and SD-Leptin hamsters showed greater decreases in nesting material 
shredded as compared to saline-injected controls at the 0-6 h and 24-30 h time 
points (P < 0.02 for all comparisons, LD-Veh: d0-6h = -1.383, d24-30h = -4.933; SD-
Veh: d0-6h = -1.684, d24-30h =  -4.306; SD-Lep: d0-6h = -2.830, d24-30h = -4.416; 
Figures 5A and 5B). Nest building behavior in these groups had recovered to levels 
equivalent to saline-injected controls by the 48-54 h time point. LPS-treated LD-
Leptin hamsters showed greater percent decreases in nesting material shredded as 
compared to saline-injected controls at the 24-30 h and the 48-54 h time points (P 
< 0.02, d24-30h = -23.403, d48-54h = -1.721; Figure 5B), and nest building behavior 
had recovered in this group by the 72-78 hour time point. 
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 Figure 5. Mean (± SEM) percent change in nesting material shredded from baseline 
following LPS and saline treatment delivered at the 0 h time point in long-day (LD) 
and short-day (SD) housed male Siberian hamsters implanted with (A) vehicle-
filled and (B) leptin-filled osmotic mini-pumps. *P < 0.05 versus saline-treated 
group exposed to the same photoperiod and osmotic mini-pump treatment. 
 
 
Serum cortisol 
 Post-injection circulating cortisol levels were affected by photoperiod (F1,67 
= 19.55, P < 0.001, η2 = 0.148) and injection (F1,67 = 41.73, P < 0.001, η2 = 0.317) 
(Figure 6). Specifically, SD hamsters had higher levels of circulating cortisol than 
LD hamsters (T = 4.42, P < 0.01, d = 0.880), and LPS-treated hamsters had higher 
cortisol levels than saline-treated hamsters (T = 6.46, P < 0.01, d = 1.377). 
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Figure 6. Mean (± SEM) circulating serum cortisol taken 4 h following LPS and 
saline treatments in long-day (LD) and short-day (SD) housed male Siberian 
hamsters implanted with vehicle-filled or leptin-filled osmotic mini-pumps. Groups 
with different letters indicate statistically significant differences between group 
means (P < 0.05); groups sharing the same letter are statistically equivalent. 
 
 
Discussion 
 Our findings demonstrate that leptin acts as a neuroendocrine regulator of 
sickness.  Specifically, leptin mediated some but not all symptoms of seasonal 
sickness response variation in Siberian hamsters.  In this experiment, we 
experimentally elevated the circulating leptin levels of short-day hamsters so that 
they were comparable to the leptin levels of long-day hamsters and then assessed 
various components of their sickness responses to LPS. Although animals showed 
mainly hypothermic responses to LPS, short-day leptin-treated hamsters showed 
patterns of LPS-induced hypothermia that were greatly attenuated as compared to 
short-day vehicle-treated hamsters. The attenuated pattern of LPS-induced 
hypothermia in short-day leptin-treated hamsters was more similar to the 
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hypothermic responses exhibited by long-day vehicle- and long-day leptin-treated 
hamsters. Conversely, while we predicted that short-day leptin-treated hamsters 
would show longer durations and greater magnitudes of LPS-induced anorexia and 
body mass loss as compared to short-day vehicle-treated hamsters, we actually 
found that short-day leptin-treated hamsters had the shortest durations and lowest 
magnitudes of LPS-induced anorexia and body mass loss of all four groups. Finally, 
our measures of anhedonic behavior (i.e., saccharin solution intake), 
thermoregulatory behavior (i.e., nesting material shredding), and circulating 
cortisol were affected by LPS injection. LPS injection resulted in decreased 
saccharin solution intake and nest material shredding and increased circulating 
cortisol levels, however, none of the LPS-induced decreases and increases in these 
measures were modulated by leptin treatment.  
Collectively, these results suggest that leptin acts as a mediator of 
seasonally appropriate fever/hypothermic responses. Although we did not initially 
predict that animals would show hypothermic responses to LPS, hypothermic 
responses to LPS are not uncommon and have been observed in several species of 
birds and mammals in experimental settings where a hypothermic response was not 
predicted (Burness et al., 2010; Martin et al., 2008b; Owen-Ashley et al., 2008).   
Hypothermic responses may be beneficial as they can help improve survival 
chances during severe systemic inflammation and sepsis (Romanovsky and 
Szekely, 1998). Additionally, hypothermia may be an adaptive strategy used for 
fighting infection when energy levels are low, as fever can only be beneficial if its 
heightened energy demands can be supported (Romanovsky and Szekely, 1998). In 
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support of this hypothesis, green iguanas (Iguana iguana) can show both febrile 
and hypothermic responses to LPS, and the type of response that a lizard displays 
is dependent on its body mass (Deen and Hutchison, 2001). Heavier lizards choose 
to behaviorally thermoregulate to higher body temperatures (i.e., fever), while 
smaller lizards choose to behaviorally thermoregulate to lower body temperatures 
(i.e., hypothermia) after LPS-injection (Deen and Hutchison, 2001). Further 
support for this hypothesis comes from studies showing that negative energy 
balance, induced via fasting, results in attenuated fever responses to LPS in rats and 
hamsters (Bilbo and Nelson, 2002; Inoue and Luheshi, 2010; Inoue et al., 2008). 
There is also evidence that circulating leptin levels play a role in fever and 
hypothermic responses to LPS (Steiner and Romanovsky, 2007), as neutralizing 
leptin via a leptin anti-serum depresses or abolishes fever in rats treated with LPS 
(Harden et al., 2006; Sachot et al., 2004). Leptin receptor-deficient rats (Koletsky 
f/f) show increased durations of LPS-induced hypothermia as compared to rats with 
functional receptors (Koletsky F/?) (Steiner et al., 2004); however, these fever- and 
hypothermia-modulating effects of leptin are not always seen in all experimental 
systems or at all LPS doses (Inoue and Luheshi, 2010; Ivanov and Romanovsky, 
2002). Therefore, it is possible that the short-day vehicle-treated hamsters showed 
the greatest magnitude of LPS-induced hypothermia because they had the lowest 
energy stores and leptin levels and were engaging in energy conservation. 
Additionally, increased circulating leptin levels in short-day leptin-treated hamsters 
may have acted as a signal of increased energy stores in these animals and mediated 
the attenuated hypothermic response. 
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We did not expect that long-day hamsters would show  LPS-induced 
hypothermia, as they were not energetically challenged and because other studies 
in this species have shown that both long-day and short-day hamsters exhibit febrile 
responses to LPS (Bilbo et al., 2002; Wen et al., 2007). Although we used the same 
dose of LPS in our study as was used in the previous studies, this difference in our 
results from those of the other studies may be due to differences in the species and 
serotypes of the LPS used in these studies. In the current study, we used LPS from 
Salmonella enterica, whereas LPS from Escherichia coli was used in other studies. 
Different serotypes of E. coli can produce different patterns of LPS-induced fever 
and hypothermia (Akarsu and Mamuk, 2007); therefore, it seems likely that LPS 
from different species could also elicit different fever and hypothermia patterns. 
We have previously used LPS from S. enterica in our lab and found that it induced 
hypothermia, rather than fever in the hamsters (French et al., 2013a). These species 
differences in LPS may also explain why we did not see photoperiodic differences 
in LPS-induced decreases in nest building behavior as previous studies have 
reported (Prendergast et al., 2008; Wen et al., 2007). For instance, huddling in a 
nest would likely prevent radiative heat loss and reduce hypothermia, so animals 
exhibiting sickness-induced hypothermia may want to avoid nesting during illness. 
As such, if sickness-induced hypothermia is adaptive in this experimental context, 
then we would not expect to see short-day attenuation of LPS-induced decreases in 
nest building behavior. However, as we still saw seasonal variation in sickness 
responses between the long-day and short-day groups in several of our measures 
(i.e., temperature, anorexia, body mass loss, cortisol levels), these LPS species 
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differences should not influence our ability to make meaningful comparisons to 
previous studies.  
One of our initial predictions was that if leptin mediated seasonal changes 
in sickness responses, then we expected that providing short-day hamsters with 
supplemental leptin would increase the magnitude and duration of LPS-induced 
anorexia and body mass loss. Rather, we found that leptin treatment attenuated 
these measures in short-day hamsters. Leptin was first characterized for its role in 
regulating food intake and body mass, with experimentally increased leptin levels 
resulting in decreases in food intake and body mass (Friedman and Halaas, 1998). 
Furthermore, circulating leptin levels are increased in response to LPS injection 
(Sarraf et al., 1997). Because LPS increases circulating leptin levels, and increased 
leptin levels decrease food intake and body mass, it seems that leptin could be a 
likely candidate for regulating infection-induced anorexia and body mass loss; 
however, the evidence supporting this relationship is mixed (Carlton et al., 2012). 
Our results suggest that leptin modulates LPS-induced anorexia and body mass loss 
because these measures are attenuated in both the long-day and short-day leptin 
treated groups; however, as it does not regulate these responses in our predicted 
manner, it is likely not regulating these responses in this seasonal context. 
Another possible explanation for the unexpected attenuation of LPS-
induced anorexia and body mass loss in the short-day leptin-treated group is that 
anorexia and body mass loss were attenuated in this group to counteract the effects 
of the weakened hypothermic response. If reducing hypothermia resulted in greater 
energy expenditure, then these animals might have had to preserve energy by 
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reducing anorexia in order to avoid reaching a level of survival-risking negative 
energy balance (Ashley and Wingfield, 2012; Owen-Ashley and Wingfield, 2007). 
If reductions in LPS-induced anorexia in short-day leptin-treated animals are the 
result of an energy conservation mechanism, then it is possible that seasonal 
changes in infection-induced fever/hypothermia are regulated by circulating leptin 
levels while changes in infection-induced anorexia are regulated by some other 
energetic mechanism. There are several other orexigenic and anorexigenic 
hormones (e.g., ghrelin, neuropeptide Y, alpha-melanocyte-stimulating hormone, 
cholecystokinin, corticotropin-releasing hormone) that have been experimentally 
linked to infection-induced anorexia (Carlton et al., 2012). Therefore, it is likely 
that leptin may be just one among many hormones that act to coordinate seasonally 
appropriate sickness.  
Further support of this idea that different symptoms of seasonal sickness 
responses are regulated by different hormonal and physiological mechanisms 
comes from previous studies that have examined the roles of other seasonally 
variable traits in sickness response modulation (Adelman and Martin, 2009). For 
example, removing the endogenous melatonin signal that organizes the seasonal 
response in Siberian hamsters (i.e., the short-day morph is induced when animals 
secrete melatonin for long durations; the long-day morph is induced when animals 
secrete melatonin for short durations) via pinealectomy causes hamsters housed in 
short days to display long-day-like patterns of LPS-induced anorexia, body mass 
loss, and reductions in nesting material use (Wen et al., 2007). Providing short-day 
pinealectomized hamsters with peripheral melatonin implants restores short-day-
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typical responses for these three LPS-induced measures (Freeman et al., 2007). 
Surprisingly, short-day pinealectomized animals still show short-day-typical fever 
responses (Wen et al., 2007), suggesting that this response is mediated by some 
factor other than melatonin. Long-day hamsters that are castrated show shortened 
durations of LPS-induced anorexia and decreased magnitudes of LPS-induced body 
mass loss as compared to uncastrated long-day controls; however, castration results 
in no attenuations in LPS-induced decreases in nesting material use (Prendergast et 
al., 2008).  
While these studies show that manipulating different seasonally variable 
traits (e.g., photoperiodic rhythms, melatonin, testosterone) affects some of the 
same and some different components of sickness responses, manipulating these 
traits also have effects on the animal’s body mass. Pinealectomy results in short-
day hamsters displaying long-day-like body masses, while providing peripheral 
melatonin to these pinealectomized animals once again renders their body masses 
short-day-like (Freeman et al., 2007; Wen et al., 2007). Additionally, castrating 
long-day hamsters results in body mass decreases (Prendergast et al., 2008). Even 
though our study suggests that leptin does not influence all components of seasonal 
sickness response variation, we cannot eliminate the hypothesis that energetic state 
is a primary driver of the seasonal differences in any of these symptoms of sickness.  
Because we did not manipulate actual body mass in this study (and leptin is 
only one among many signals of energy) and prior studies have not controlled for 
changes in body mass while manipulating other seasonally-changing variables, 
there could be other energetic hormones modulating these responses. Additional 
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support for the need to continue to test the hypothesis that energetic state drives 
seasonal variation in sickness responses comes from observations that these 
correlations between sickness responses and body mass extended beyond seasonal 
breeders. For instance, in rats, ranging from lean to obese, there are positive 
correlations between body mass and the length of time it takes for an animal to 
recover from LPS-induced sickness (i.e., heavier animals take longer to recover) 
and the number of sickness symptoms that an animal displays (i.e., heavier animals 
display more sickness symptoms) (Pohl et al., 2014). Exploring the connections 
between other energetic hormones and seasonal variation in sickness responses will 
hopefully allow us to narrow in on the mechanisms promoting these correlations 
between body mass and sickness response intensity in seasonally breeding animals, 
as well as non-seasonal model organisms. We may also gain a better understanding 
of the mechanisms driving these relationships between energy stores and sickness 
responses by investigating the role of cytokines as intermediate factors between 
energy and sickness. Leptin (and other seasonal and energetic factors) is likely 
driving seasonal differences in sickness response intensity through effects on 
cytokine release and sensitivity (Dantzer, 2004; Zimmerman et al., 2014).  Previous 
studies have shown photoperiodic differences in cytokine release (Bilbo et al., 
2002), gene expression (Pyter et al., 2005), and sensitivity (Wen and Prendergast, 
2007), so the effects of seasonal leptin variation on these factors should be a target 
of future investigations. 
 In conclusion, our data show that leptin does play a role in regulating 
seasonal variation in sickness response symptoms. Although leptin may not 
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influence all the components of sickness responses in Siberian hamsters, leptin 
supplementation clearly attenuated the hypothermic response to LPS in short-day 
hamsters. This leptin-induced suppression of hypothermia in short-day hamsters 
may have required animals to conserve energy by reducing their displays of LPS-
induced anorexia. Our results (and the results of previous studies) do not exclude 
the hypothesis that seasonal variation in sickness responses is a product of seasonal 
changes in energetic stores. Instead, our results suggest that individual symptoms 
in the sickness responses of these seasonally breeding animals may be modulated 
by various energetic and non-energetic hormones, providing opportunities for 
future investigations. 
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CHAPTER 3: Body mass affects seasonal variation in sickness intensity in a 
seasonally-breeding rodent 
 
Data published in: Carlton, E.D. and Demas, G.E. 2015. Body mass affects seasonal 
variation in sickness intensity in a seasonally-breeding rodent. Journal of 
Experimental Biology, in press. 
 
Abstract 
Species that display seasonal variation in sickness intensity show the most 
intense response in the season during which they have the highest body mass, 
suggesting that sickness intensity may be limited by an animal’s energy stores. 
Siberian hamsters (Phodopus sungorus) display lower body masses and less intense 
sickness when housed in short, winter-like days as opposed to long, summer-like 
days. To determine if reduced sickness intensity displayed by short-day hamsters is 
a product of seasonal changes in body mass, we food-restricted long-day hamsters 
so that they exhibited body mass loss that mimicked the natural photoperiod-
induced loss of body mass in short-day hamsters. We then experimentally induced 
sickness with lipopolysaccharide (LPS) and compared sickness responses among 
long-day food restricted and long- and short-day ad libitum fed groups, predicting 
that long-day restricted hamsters would show sickness responses comparable to 
short-day ad libitum hamsters and attenuated in comparison to long-day ad libitum 
hamsters. We found that long-day restricted hamsters showed attenuated LPS-
induced anorexia, loss of body mass, and hypothermia compared to long-day ad 
libitum animals; however, anorexia was still more pronounced than in short-day ad 
libitum animals. Additionally, LPS-induced anhedonia and decreases in nest 
building were not influenced by body mass. Results of hormone assays suggest that 
cortisol levels could play a role in the attenuation of sickness in long-day restricted 
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hamsters, indicating that future research should target the roles of glucocorticoids 
and natural variation in energy stores in seasonal sickness variation.  
 
Introduction 
Mounting an appropriate immune response to infection is a necessity for 
survival in a pathogen-rich environment. An organism’s immune response is 
sensitive to both its external and internal environments and can be influenced by 
variables such as environmental temperature, photoperiod, stress, reproductive 
effort, and energy stores (Demas and Nelson, 1998; Lochmiller and Deerenberg, 
2000; Martin et al., 2008c; Sheldon and Verhulst, 1996). While each of these 
variables can fluctuate individually across short time spans, for seasonally breeding 
animals, these variables often change simultaneously with transitions between 
seasons. Therefore, one challenge for determining the specific physiological and 
environmental variables underlying seasonal changes in immunity is disentangling 
the effects of each of these variables from one another. 
The acute phase response (APR) is one component of the immune system 
that can vary seasonally (Adelman and Martin, 2009; Ashley and Wingfield, 2012). 
When the APR is activated at an infection site, neutrophils and macrophages release 
pro-inflammatory cytokines which not only facilitate the recruitment of other 
immune cells to this local site of infection, but also act on the brain to generate 
sickness responses. Sickness responses are characterized by fever or hypothermia, 
anorexia, body mass loss, reductions in social and hedonic behaviors, and 
hypothalamic-pituitary-adrenal (HPA) endocrine axis activation (Hart, 1988; 
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Tizard, 2008). These sickness symptoms are generated as adaptive mechanisms for 
fighting off infection (Hart, 1988), and in several seasonally breeding animals, 
sickness intensity varies across the seasons (Bilbo et al., 2002; Owen-Ashley et al., 
2008; Owen-Ashley et al., 2006; Owen-Ashley and Wingfield, 2006). Because 
generating a sickness response is critical for eliminating pathogens, variation in the 
magnitude of this response can profoundly affect an animal’s ability to survive an 
infection (Kluger et al., 1975; Murray and Murray, 1979; Vaughn et al., 1980). 
Thus, questions remain: why and how are seasonally breeding animals modulating 
sickness intensity? 
When looking across species in which seasonally variable sickness 
responses have been documented, the common variable that predicts which season 
an animal will show reduced or enhanced sickness is the animal’s body mass, not 
reproductive state or day length (Ashley and Wingfield, 2012; Carlton et al., 2012). 
Specifically, seasonally breeding animals show attenuated sickness responses to the 
bacterial mimetic lipopolysaccharide (LPS) in the season that they have the lowest 
body masses (Bilbo et al., 2002; Owen-Ashley et al., 2008; Owen-Ashley et al., 
2006; Owen-Ashley and Wingfield, 2006). Siberian hamsters (Phodopus sungorus) 
are one species that displays seasonal variation in sickness intensity. Hamsters 
display more intense sickness responses (i.e., greater fever amplitude, longer 
durations of and greater decreases in food intake and body mass loss, greater 
decreases in hedonic and nest building behaviors) to LPS when housed in long, 
summer-like photoperiods as compared to short, winter-like photoperiods (Bilbo et 
al., 2002; Wen et al., 2007; Wen and Prendergast, 2007). Hamsters housed in long 
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photoperiods remain reproductively active and show higher body masses than 
hamsters housed in reproductively inhibiting short-day photoperiods. Previous 
studies have manipulated reproductive state and patterns of endogenous melatonin 
(i.e., an indolemine hormone whose release acts as a physiological signal of 
photoperiod) to determine their contributions to seasonal variation in sickness 
intensity in Siberian hamsters (Freeman et al., 2007; Prendergast et al., 2008; Wen 
et al., 2007). While these manipulations modulated some sickness symptoms, they 
also resulted in body mass changes (Bilbo and Nelson, 2002; Prendergast et al., 
2008; Wen et al., 2007). Therefore, while there were clearly effects of reproductive 
state and melatonin on seasonal variation in sickness, it is unclear if intensity was 
mediated directly by the manipulations or indirectly through changes in energetic 
state. 
In a previous study, we manipulated a hormonal correlate of energetic state 
(i.e., leptin) in order to disentangle the effects of seasonal energetic changes from 
other seasonally modulated variables on sickness intensity variation (Carlton and 
Demas, 2014). Leptin levels are directly proportional with adipose tissue mass in 
mammals (Johnson et al., 2004; Maffei et al., 1995), and leptin changes seasonally, 
in parallel with seasonal changes in body mass, in Siberian hamsters and other 
seasonally breeding animals (Concannon et al., 2001; Gaspar-Lopez et al., 2009; 
Horton et al., 2000). We experimentally elevated circulating leptin levels in short-
day Siberian hamsters so that they were comparable to long-day levels. We found 
that leptin treatment resulted in short-day hamsters showing hypothermic responses 
to LPS that were more long-day-like. Short-day hamsters treated with leptin, 
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however, showed LPS-induced anorexia that was not enhanced to the levels of 
long-day animals, but instead, was attenuated even below that of typical short-day 
levels. These results suggest that leptin modulates some but not all aspects of 
seasonal sickness variation. As leptin is only one of many energetic hormones, our 
findings did not eliminate the hypothesis that seasonal variation in sickness 
intensity is mediated by changes in energy stores. The goals of the present study 
were to manipulate seasonal energy stores, by using food restriction in long-day 
hamsters to mimic the pattern of seasonal body mass loss in short-day hamsters, to 
determine its effects on sickness intensity and to elucidate a potential hormonal 
mechanism mediating any changes in intensity. If seasonal variation in sickness 
intensity is driven by seasonal changes in energy stores, then we expected long-day 
hamsters displaying body mass loss patterns like short-day hamsters to show 
similar sickness intensity to short-day hamsters and less intensity than long-day 
hamsters fed ad libitum. 
 
Methods 
Animals and housing conditions 
Adult male (> 60 days of age; average age = 156 days) Siberian hamsters 
(n = 90) were obtained from our breeding colony at Indiana University. All animals 
were initially group housed (2-5 per cage with same sex siblings on weaning at 17-
18 days of age) in long-day photoperiods (light:dark (L:D) 16:8), and then 
individually housed in polypropylene cages (27.8 x 17.5 x 13.0 cm) for one week 
prior to experimental housing. Food (Laboratory Rodent Diet 5001, LabDiet, St. 
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Louis, MO, USA) and water were available ad libitum prior to the start of the 
experiment. Temperature (20 ± 2°C) and humidity (50 ± 10%) were maintained at 
constant levels. All animal methods were reviewed and approved by the 
Institutional Animal Care and Use Committee at Indiana University. 
 
Experimental methods 
Animals were assigned to one of three groups matched for initial body mass. 
The first group was housed in short days (L:D 8:16) and was fed ad libitum 
throughout the entire experiment (SD-AdLib; n = 46). Measures of body mass (to 
the nearest 0.1 g) and food consumption (to the nearest 0.1 g) were collected every 
other day for 10 weeks to track short-day induced changes in body mass and food 
intake and photoperiodic responsiveness to short days (described below). Food 
intake was assessed by weighing the food pellets remaining in the hopper each day.  
The second and third groups were housed in long days (L:D 16:8) for the 
length of the experiment. The second group was fed ad libitum throughout the entire 
experiment (LD-AdLib; n = 20). Body mass and food intake were measured every 
other day for 10 weeks. The third group was provided ad libitum access to food for 
the first 10 days and then food restricted for the following 60 days (LD-FR; n = 
24). During the first 10 days, body mass and food intake was measured every other 
day to establish pre-restriction mean values for these measures. During the next 60 
days, these animals were allocated a pre-measured amount of food each day at the 
start of their active dark phase (1600 h) that ranged in quantities from 65-100% of 
the animal’s pre-restriction mean food intake (Mauer and Bartness, 1997). Body 
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mass was recorded every other day for this group, and food access was adjusted in 
to keep the LD-FR group mean body mass tracking the SD-AdLib group mean. We 
modulated food availability to the LD-FR group to target the pattern of body mass 
loss in the SD-AdLib group, rather than providing food quantities that were pair 
matched to SD-AdLib food intake, because body mass loss in short days is both 
food intake dependent and independent (Wade and Bartness, 1984). 
The SD-AdLib group was housed in experimental conditions six weeks 
prior to the LD-AdLib and LD-FR groups because a subset of hamsters housed in 
short days fails to show reproductive responsiveness to prolonged exposure to this 
photoperiod (i.e., do not display gonadal regression or reductions in body mass and 
fat stores). These individuals are referred to as photoperiodic non-responders 
(Puchalski and Lynch, 1986). Because we wanted to directly match body mass loss 
of the SD-AdLib and LD-FR groups, we needed to exclude the photoperiodic non-
responders from our calculations of the SD-AdLib body mass loss trajectory 
(Mauer and Bartness, 1997). By observing body mass loss patterns in the short-day 
hamsters during the six weeks prior to housing the LD-FR group, we could remove 
animals who were not losing weight (and were likely photoperiodic non-
responders) from the SD-AdLib body mass group means. Paired testes mass was 
collected at the end of the experiment in order to confirm short-day responsiveness 
(defined as a paired testes mass < 0.15 g) (Greives et al., 2008). Twelve animals 
were determined to be photoperiodic non-responders and removed from the 
experiment. 
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Starting on experimental day 70 for each group, body mass and food intake 
measurements were collected daily for the next 5 days to establish pre-injection 
baseline values for these measures. During these 5 days, at the start of the dark 
phase, LD-FR animals were provided daily food allocations equal to 100% of their 
pre-restriction means in order to relieve the effects of food restriction but not result 
in excessive food hoarding. After periods of food restriction, Siberian hamsters do 
not increase their food intake above normal levels when provided ad libitum access 
to food but do increase food hoarding (Bartness and Clein, 1994). In order to avoid 
complications with increased hoarding, we only provided hamsters access to their 
normal food intake rather than access to excess food that would be hoarded rather 
than consumed. 
On the fifth day of baseline measurement collection, half of the animals in 
each group were injected intraperitoneally (i.p.) ~15 minutes before the onset of 
darkness with 25 µg LPS (LPS from Salmonella enterica serotype typhimurium, 
Sigma-Aldrich, St. Louis, MO, USA; Carlton and Demas, 2014)  suspended in 0.1 
ml sterile 0.9% saline. The remaining animals were injected i.p. with 0.1 ml sterile 
0.9% saline. Sickness responses were assessed throughout the four days following 
injections. 
 
Sickness response measurements 
     Fever, body mass loss, anorexia 
Colonic temperatures (to the nearest 0.1°C) were collected immediately 
before injection and 2, 4, 6, 8, 10, 12, 16, 20, and 24 h after injection using a 
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MicroTherma 2T thermometer (ThermoWorks, Alpine, UT, USA) and a lubricated 
RET-3-ISO thermocouple probe (Physitemp Instruments, Inc., Clifton, NJ, USA) 
inserted ~12 mm into the rectum. To assess body mass loss and anorexia, daily 
body mass and food intake measurements continued until the end of the study. 
Hamsters in the SD-AdLib and LD-AdLib groups received ad libitum access to 
food until the end of the experiment, while hamsters in the LD-FR group continued 
to receive daily food allocations equal to 100% of their pre-restriction mean values. 
 
     Hedonic behavior  
To assess the effects of our treatments on hedonic behavior, we provided 
hamsters with a highly palatable sodium saccharin solution (Baillie and 
Prendergast, 2008). Saccharin is a non-caloric artificial sweetener. As such, 
differences in ingestion between the groups would not interfere with our abilities 
to control energy intake. Beginning 5 days before injection, for the first 6 h of the 
dark phase (1600 h to 2200 h) hamsters were provided with a fluid bottle containing 
a solution of 0.1% sodium saccharin (saccharin sodium salt hydrate, Sigma-
Aldrich, St. Louis, MO, USA) dissolved in tap water (Baillie and Prendergast, 
2008). The saccharin solution bottles were weighed (to the nearest 0.1 g) before 
they were given and after they were collected from the hamsters each day. 
Presentation of saccharin solution continued daily through day 3 post-injection.  
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     Nest building behavior  
To assess the effects of our treatments on thermoregulatory behavior, 
beginning five days before injection, each hamster was provided with a compressed 
cotton nestlet weighing ~2.5 g (Ancare, Bellmore, NY, USA) for the first 6 h of the 
dark phase (Baillie and Prendergast, 2008). The nestlet was weighed (to the nearest 
0.1 g) before presentation, and the unshredded portion was weighed after 
presentation. When provided a nestlet, hamsters quickly start shredding the cotton 
to build a nest. Nest building is an adaptive behavior to enhance energy 
conservation in low temperatures, however, hamsters readily build nests in room 
temperature (20-23°C) (Puchalski et al., 1988). Presentation of nestlets continued 
daily through day 3 post-injection. 
 
Blood sampling and necropsies 
Blood samples (~250 µl) were drawn from each animal 4 h after the onset 
of darkness at two time points (three days before injection and on the day of 
injection) to assess circulating blood glucose, leptin, and cortisol concentrations. 
Briefly, animals were lightly anesthetized with isoflurane vapors, and blood 
samples were drawn from the retro-orbital sinus. Blood samples were allowed to 
clot at room temperature for 1 h, clots were removed, and samples were centrifuged 
at 4°C for 30 min at 2500 rpm. Serum aliquots were aspirated and stored in sealable 
polypropylene microcentrifuge tubes at -20°C until assayed. All blood samples 
were collected within 3 min of initial handling. Animals were euthanized five days 
after LPS injection and necropsies were performed. Testes, inguinal white adipose 
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tissue (IWAT), epidydimal WAT (EWAT), and retroperitoneal WAT (RWAT) 
were removed, cleaned of connective tissues, and weighed to the nearest 0.1 mg. A 
composite adipose tissue score was calculated by summing the individual WAT 
pad masses. 
 
Blood glucose measurement 
Blood glucose was measured from the samples collected 4 hours after 
injection. Immediately upon collection, ~5 µl of whole blood was transferred onto 
test strips of a blood glucose monitoring system (ReliOn, Micro Blood Glucose 
Monitoring System, Arkray USA, Inc., Minneapolis, MN, USA), and the readout 
was recorded. The meter was previously calibrated using an internal standard 
provided by the manufacturer. 
Leptin enzyme-linked immunosorbent assay (ELISA) 
We assessed circulating leptin levels in the samples collected three days 
prior to injection to determine if the groups showed differing serum concentrations 
of this hormone. Leptin levels were assayed via commercially prepared mouse 
leptin ELISA kits (Crystal Chem, Downers Grove, IL, USA). This kit has 
previously been validated in Siberian hamsters (Carlton and Demas, 2014). 
Samples were diluted 1:4 and run in duplicate. Intra-assay variabilities were 6.8%, 
12.5%, and 1.8%. 
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Cortisol enzyme immunoassay (EIA) 
We assessed circulating cortisol levels to determine if the groups differed 
in the magnitude of baseline and LPS-induced activation of the HPA axis. Cortisol 
is the predominant glucocorticoid in Siberian hamsters (Reburn and Wynne-
Edwards, 2000). Serum cortisol concentrations were determined in multiple EIAs 
from a commercially prepared kit (Enzo Life Sciences, Inc., Farmingdale, NY, 
USA). This assay was previously validated for use in Siberian hamsters (Demas et 
al., 2004). Samples were diluted to 1:80 with assay buffer and run in duplicate. 
Intra-assay variabilities were 3.1%, 0%, and 0.6%. 
 
Statistical analyses 
All statistics were performed using JMP 10 (SAS Institute Inc., Cary, NC, 
USA). Residuals were checked for normality and homogeneity of variance, and 
those data that were non-normally distributed were transformed with the function 
that best fit the data. Three animals were excluded from the final analyses: one from 
the saline-treated SD-AdLib group because it exhibited sickness symptoms despite 
receiving no LPS, one from the LPS-treated LD-AdLib group because it showed 
abnormal body mass loss despite no food restriction, and one from the saline-treated 
LD-AdLib group because it displayed abnormal food hoarding. The final sample 
sizes were as follows: SD-AdLib-Saline (n = 16), SD-AdLib-LPS (n=17), LD-
AdLib-Saline (n=9), LD-AdLib-LPS (n=9), LD-FR-Saline (n=12), LD-FR-LPS 
(n=12). 
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 Pre-injection baseline values were calculated for body mass, food intake, 
saccharin solution intake, and percent nesting material shredded by averaging the 
three daily measurements immediately prior to injections (days 72-74). We did not 
include days 70-71 in this mean because measures on these days were more variable 
as animals were adjusting to changes in food allocations and the presence of 
saccharin solution and nestlets. To determine if there were group effects on pre-
injection baseline body mass, baseline food intake, leptin levels, and baseline 
saccharin solution intake, one-way analyses of variance (ANOVA) were 
performed. Pre-injection baseline saccharin solution intake was log transformed 
and leptin concentration was square root transformed. Pre-injection baseline 
percent nesting material shredded could not be transformed to meet the assumptions 
of normality, so a Kruskal-Wallis test was performed.  
 Because group affected pre-injection food intake, body mass, saccharin 
solution intake, and percent nesting material shredded (see Results), post-injection 
changes in these measurements were expressed as percentages of each animal’s 
baseline values. Repeated measures ANOVAs were performed on post-injection 
percent changes in food intake, body mass, and saccharin solution intake and 
colonic temperature. The within-subject comparisons for percent change in body 
mass, colonic temperature, and percent change in saccharin solution intake violated 
the assumptions of sphericity and were Greenhouse-Geisser corrected. Post-
injection percent change in saccharin solution intake was square root transformed. 
Post-injection changes in percent nesting material shredded could not be 
transformed to meet the assumptions of normality, so a Kruskal-Wallis test was 
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performed. Differences in glucose, cortisol, and tissue masses among the groups 
were assessed with two-way ANOVAs. Glucose was square root transformed, 
while cortisol and the tissue masses were log transformed. Correlations between 
pre-injection baseline body mass and percent changes in body mass were assessed 
for LPS-treated animals using analyses of covariance (ANCOVA). Post-hoc 
comparisons were conducted using Fisher’s Least Significant Difference tests when 
ANOVAs were statistically significant.  
 
Results 
An experimental timeline is presented in Figure 1 in order to clarify at which 
timepoints measures were collected. 
 
 
Figure 1. Experimental timeline indicating when treatments were performed and 
when measures were collected. Day 0 refers to the timepoint when each group was 
housed in their experimental photoperiods, after one week of acclimation to 
individual housing. 
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Experimental induction of body mass loss 
Body mass did not differ among the groups prior to experimental housing 
(F2,72 = 0.281, P = 0.756). After 70 days in experimental photoperiods and food 
restriction for the long-day food-restricted group (LD-FR), body mass differed 
among the groups (F2,72 = 25.372, P < 0.001) (Fig. 2). Long-day ad libitum (LD-
AdLib) hamsters showed no change in body mass from days 0 to 70 (Paired T = 
0.230, P = 0.821), while short-day ad libitum (SD-AdLib) and LD-FR hamsters 
showed 22.3% and 22.0% decreases in body mass, respectively. There were no 
differences in body mass at day 70 between the LD-FR and SD-AdLib groups (T17 
= 0.117, P = 0.907). 
 
Figure 2. Mean (± SEM) body mass of male Siberian hamsters over the course of 
the first 70 days of experimental housing. Hamsters were either allowed ad libitum 
access to food during the experiment and housed in short- (SD-AdLib) or long-day 
(LD-AdLib) photoperiods or provided restricted access to food and housed in long-
day photoperiod (LD-FR). 
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Pre-injection baseline measures 
At the end of those 70 days and until the end of the experiment, LD-FR 
animals were allocated food at their pre-restriction mean values. Pre-injection 
baseline food consumption differed among the groups (F2,72 = 12.143, P < 0.001) 
(Table 1). Specifically, SD-AdLib hamsters consumed less food than LD-AdLib 
and LD-FR hamsters (T > 3.560, P < 0.001 for both comparisons), while there was 
no difference in consumption between the LD-AdLib and LD-FR hamsters (T = 
1.181, P = 0.241). LD-FR body mass did increase slightly upon access to pre-
restriction mean food levels (Paired T = 5.105, P < 0.001); however, pre-injection 
baseline body masses still did not differ between the LD-FR and SD-AdLib groups 
(T = 1.495, P = 0.139) (Table 1). While body mass did not differ between the LD-
FR and SD-AdLib groups, serum leptin levels differed among all three groups (F2,72 
= 25.412, P < 0.001) (Table 1). Specifically, LD-AdLib hamsters showed the 
highest leptin concentrations, while LD-FR and SD-AdLib hamsters had leptin 
concentrations 33.5% and 67.1%, respectively, lower than this group. 
Pre-injection baseline saccharin solution intake varied among the groups 
(F2,72 = 16.917, P < 0.001) (Table 1). Specifically, LD-FR animals consumed 
greater volumes of saccharin solution as compared to LD-AdLib (T = 3.428, P = 
0.001) and SD-AdLib (T = 5.782, P < 0.001) animals. There was no difference in 
pre-injection baseline saccharin solution intake between the LD-AdLib and SD-
AdLib groups (T = 1.646, P = 0.104). Pre-injection baseline percent nesting 
material shredded also differed by group prior to injection (H = 15.105, P < 0.001) 
(Table 1). Specifically, LD-FR animals shredded a lower percentage of their cotton 
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nestlet as compared to LD-AdLib (Z = 1.987, P = 0.047) and SD-AdLib (Z = 3.813, 
P < 0.001) animals. There was no difference in percent nesting material shredded 
between the LD-FR and SD-AdLib groups (Z = 1.136, P = 0.256). 
 
 
 
Table 1.  Mean (± SEM) pre-injection baseline food intake, baseline body mass, 
circulating serum leptin concentrations, baseline saccharin solution intake, and 
baseline percent nesting material shredded in short-day ad libitum fed (SD-
AdLib), long-day ad libitum fed (LD-AdLib), and long-day (previously) food 
restricted (LD-FR) male Siberian hamsters. Pre-injection baseline measurements 
were calculated by averaging the values collected for the measurements during 
the three days prior to LPS or saline injection. During the five days prior to 
injection, animals in the LD-FR group were allocated food at 100% of their pre-
restriction mean values. Groups with different letters indicate statistically 
significant differences between group means (P < 0.05); groups sharing the same 
letter are statistically equivalent. 
____________________________________________________________________________________________________________________________________ 
 
  
SD-AdLib  LD-AdLib  LD-FR 
____________________________________________________________________________________________________________________________________ 
 
Baseline Food  
Intake (g/day)  4.1 ± 0.1a  5.0 ± 0.2b  4.8 ± 0.1b 
 
Baseline Body  
Mass (g)  35.5 ± 0.8a  45.3 ± 1.4b  37.3 ± 0.7a 
 
Leptin conc.  
(pg/ml)  7.07 ± 0.96a  18.88 ± 1.41c  12.90 ± 1.15b 
 
Baseline Saccharin  
Solution Intake  
(g / 6 h)  1.5 ± 0.1a  1.8 ± 0.2a  3.0 ± 0.3b  
     
Baseline Percent  
Nesting Material  
Shredded    99.0 ± 0.5a  93.8 ± 3.2a  85.9 ± 4.1b  
___________________________________________________________________________________________________ 
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Post-injection sickness measures 
     Anorexia 
Percent changes in food intake were affected by group (F2,69 = 5.325, P = 
0.007) and by injection (F1,69 = 158.030, P < 0.001) but not by the group x injection 
interaction (F2,69 = 0.314, P = 0.731) (Fig. 3). Percent changes in food intake varied 
across the four days after injection (within subjects, F3,67 = 157.130, P < 0.001) and 
with the time x group (F6,134 = 3.521, P = 0.003) and the time x injection (F3,67 = 
157.130, P < 0.001) interactions. All LPS-treated animals showed greater decreases 
in food intake compared to their respective saline-treated controls at days 1, 2, and 
3 post-injection (P < 0.003 for all comparisons). By day 4, the LPS-treated LD-FR 
and SD-AdLib groups no longer showed reduced food intake compared to controls 
(P > 0.06 for both comparisons); however, the LPS-treated LD-AdLib group still 
showed reduced food intake on this day as compared to controls (P = 0.006). 
Additionally, at day 4 post-injection, the LPS-treated LD-AdLib group showed 
greater percent decreases in food intake than the LPS-treated SD-AdLib group (P 
= 0.016) but not the LD-FR group (P = 0.149).  
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 Figure 3. Mean (± SEM) percent change in daily food intake from baseline 
following LPS (black icons) or saline (white icons) treatment delivered on day 0 in 
short-day ad libitum fed (SD-AdLib,  ), long-day ad libitum fed (LD-AdLib, 
), and long-day (previously) food restricted (LD-FR, ) male Siberian hamsters.  
Day +1 represents the time period from 0-24 h after LPS or saline injection, Day 
+2 represents the time period from 24-48 h after LPS or saline injection, and so 
forth. *P < 0.05 versus saline-treated group exposed to the same photoperiod and 
food treatments. #P < 0.05 versus SD-AdLib LPS-treated group. 
 
     Body mass loss 
 Percent changes in body mass were affected by group (F2,69 = 11.896, P < 
0.001) and by injection (F1,69 = 174.759, P < 0.001) but not by the group x injection 
interaction (F2,69 = 1.034, P = 0.361) (Fig. 4). Percent decreases in body mass 
changed across the four days post injection (within subjects, F2.2,149.4 = 7.545, P < 
0.001) and with the time x group (F4.3,149.4 = 2.809, P = 0.024), time x injection 
(F2.2,149.4 = 12.564, P < 0.001), and time x group x injection (F4.3,149.4 = 4.096, P = 
0.003) interactions. At all 4 days after injection, LPS-treated animals showed 
greater percent decreases in body mass as compared to their respective saline-
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treated controls (P < 0.001 for all comparisons); however, the LPS-treated LD-FR 
and SD-AdLib groups showed attenuated percent decreases in body mass relative 
to the LPS-treated LD-AdLib group. Specifically, the LD-FR group showed lesser 
percent body mass decreases as compared to the LD-AdLib group on days 2, 3, and 
4 post-LPS injection (P < 0.02 for all comparisons), while the SD-AdLib group 
showed lesser decreases in percent body mass loss on days 3 and 4 post-LPS 
injection (P < 0.002 for both comparisons).  
In LPS-treated animals, percent change in body mass was negatively 
correlated with pre-injection baseline body mass, such that animals with greater 
initial body masses showed greater percent decreases in body mass on days 3 (body 
mass: F1, 34 = 9.011, P = 0.005; group: F2, 34 = 2.644, P = 0.086) and 4 (body mass: 
F1, 34 = 6.037, P = 0.019; group: F2, 34 = 3.771, P = 0.033) but not days 1 or 2 (P > 
0.05 for body mass on both days). In addition, the maximum percent change in 
body mass that each LPS-treated animal displayed after injection was not correlated 
with pre-injection baseline body mass (body mass: F1, 34 = 1.890, P = 0.178; group: 
F2, 34 = 2.852, P = 0.0716). 
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Figure 4. Mean (± SEM) percent change in body mass from baseline following 
LPS (black icons) or saline (white icons) treatment delivered on day 0 in short-day 
ad libitum fed (SD-AdLib, ), long-day ad libitum fed (LD-AdLib, ), and 
long-day (previously) food restricted (LD-FR, ) male Siberian hamsters.  Day 
+1 represents the time period from 0-24 h after LPS or saline injection, Day +2 
represents the time period from 24-48 h after LPS or saline injection, and so forth. 
*P < 0.05 versus saline-treated group exposed to the same photoperiod and food 
treatments. #P < 0.05 versus LD-AdLib LPS-treated group. %P < 0.05 versus SD-
AdLib LPS-treated group.  
 
 
Body temperature 
 Colonic temperature differed by group (F2,69 = 7.368, P = 0.001) and 
injection (F1,69 = 44.515, P < 0.001) but not by the group x injection interaction 
(F2,69 = 1.302, P = 0.279) (Fig. 5). Colonic temperature changed across time (within 
subjects, F6.0,415.4 = 180.880, P < 0.001) and with the time x injection (F6.0,415.4 = 
34.795, P < 0.001) and time x group x injection (F2.3,12,0 = 2.329, P = 0.007)  
interactions. Among saline-injected animals, the SD-AdLib group showed higher 
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temperatures than the LD-AdLib and LD-FR groups at 8, 10, and 16 h post-
injection (P < 0.05). LPS injection resulted in a hypothermic response across all 
groups at most time points after injection. However, at 2 h post-injection, LPS-
treated SD-AdLib and LD-FR hamsters showed greater temperatures as compared 
to their respective saline controls (P < 0.003); the temperature of LPS-treated LD-
AdLib hamsters did not differ from that of the saline-treated controls at this time 
point (P = 0.369). LPS-treated animals in all groups exhibited hypothermic 
responses as compared to their respective saline controls starting at either 4 h post-
injection (LD-AdLib) or 6 h post-injection (SD-AdLib and LD-FR) throughout the 
end of the 24 h measurement period (P < 0.05 for all comparisons except SD-AdLib 
at 20 h post-injection). The temperature of the LPS-treated LD-AdLib group was 
lower than the temperature of the LPS-treated SD-AdLib group at 4, 8, 10, and 16 
h post-injection (P < 0.05 for these comparisons), while the temperature of the LD-
FR group was only lower than that of the SD-AdLib group at 8 h post-injection (P 
= 0.016).  
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 Figure 5. Mean (± SEM) colonic temperature following LPS and saline treatments 
delivered at the 0 h time point in short-day ad libitum fed (SD-AdLib, top panel ), 
long-day ad libitum fed (LD-AdLib, middle panel), and long-day (previously) food 
restricted (LD-FR, bottom panel) male Siberian hamsters. Black and white bars at 
the top of the graphs indicate the active, dark (black) and inactive, light (white) 
phases of the light-dark cycle for each photoperiodic morph. Within each panel: *P 
< 0.05 versus saline-treated group exposed to the same photoperiod and food 
treatments. Across panels: #P < 0.05 versus LPS-treated SD-AdLib group. ^P < 
0.05 from saline-treated LD-AdLib and LD-FR groups. 
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  Saccharin solution intake 
 Percent change in saccharin solution intake was affected by injection 
treatment only (F1,69 = 7.600, P = 0.008) and not by group (F2,69 = 1.089, P = 0.342) 
or the group x injection interaction (F2,69 = 0.885, P = 0.418) (Fig. 6A). Percent 
change in saccharin solution intake varied across time (within subjects, F2.5,173.8 = 
3.674, P = 0.019) and with the time x group (F5.0,173.8 = 4.966, P < 0.001) and time 
x injection (F2.5,173.8 = 9.081, P < 0.001) interactions. While there was considerable 
variance in this measure, post hoc analyses revealed that saccharin solution intake 
was reduced in the LPS-treated LD-AdLib and LD-FR groups during the 0-6 h 
timepoint as compared to their respective saline-treated controls (P < 0.009 for both 
comparisons). 
 
     Nest building behavior 
 Percent change in nesting material shredded differed among the groups 
from the 0-6 h (H = 43.543, P < 0.001), 24-30 h (H = 59.684, P < 0.001), and 48-
54 h (H = 50.964, P < 0.001) timepoints but not at the 72-78 h timepoint (H = 4.356, 
P = 0.499) (Fig. 6B). Specifically, at the 0-6 h, 24-30 h, and 48-54 h timepoints, all 
three LPS-treated groups showed decreases in nesting material shredded as 
compared to their respective saline-treated controls (Z > 3.003, P < 0.002 for all 
comparisons); however, LPS-treated LD-FR animals showed lesser percent 
decreases in nesting material shredded than the LPS-treated SD-AdLib group at the 
24-30 h (Z = 2.483, P = 0.013) and 48-54 h  (Z = 2.037, P = 0.042) timepoints and 
the LPS-treated LD-AdLib group at the 24-30 h timepoint (Z = 2.111, P = 0.035).  
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Figure 6. Mean (± SEM) percent changes in (A) saccharin solution intake and (B) 
nesting material shredded from baseline following LPS (black icons) and saline 
treatment (white icons) delivered at the 0 h time point in short-day ad libitum fed 
(SD-AdLib,  ), long-day ad libitum fed (LD-AdLib, ), and long-day 
(previously) food restricted (LD-FR, ) male Siberian hamsters. *P < 0.05 versus 
saline-treated group exposed to the same photoperiod and food treatments. #P < 
0.05 versus LD-FR LPS-treated group. 
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Blood glucose 
Blood glucose levels were affected by group (F2,69 = 3.77, P = 0.028) and 
injection (F1,69 = 114.23, P < 0.001) but not the group x injection interaction (F2,69 
= 0.24, P = 0.784) (Fig. 7A). All LPS-treated hamsters showed lower blood glucose 
levels than their respective saline-treated controls (T > 5.75, P < 0.001 for all 
comparisons). Additionally, saline-treated LD-FR hamsters had lower blood 
glucose concentrations than saline-treated LD-AdLib hamsters (T = 2.42, P = 
0.018). 
 
Cortisol 
 Cortisol was affected by group (F2,69 = 18.082, P < 0.001) and injection 
(F1,69 = 65.005, P < 0.001) but not the group x injection interaction (F2,69 = 0.402, 
P = 0.671) (Fig. 7B). LPS-treated animals from all groups showed elevated cortisol 
levels compared to their respective saline-treated controls (P < 0.001 for all 
comparisons). LPS-treated LD-FR and SD-AdLib animals had higher cortisol 
levels than LPS-treated LD-AdLib animals (P < 0.02 for both comparisons), while 
saline-treated LD-FR and SD-AdLib animals had higher cortisol levels than saline-
treated LD-AdLib animals (P < 0.006 for both comparisons). Cortisol levels of the 
LPS-treated LD-AdLib animals were similar to those of saline-treated LD-FR and 
SD-AdLib animals (P > 0.05 for both comparisons). 
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 Figure 7. Mean (± SEM) (A) blood glucose and (B) circulating serum cortisol 
concentrations taken 4 h following LPS and saline treatments in short-day ad 
libitum fed (SD-AdLib), long-day ad libitum fed (LD-AdLib), and long-day 
(previously) food restricted (LD-FR) male Siberian hamsters. Within each panel, 
groups with different letters indicate statistically significant differences between 
group means (P < 0.05); groups sharing the same letter are statistically equivalent. 
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Tissue masses 
Paired testes mass was affected by group (F2,69 = 1425.837, P < 0.001) but 
not by injection (F1,69 = 2.454, P = 0.122) or the group x injection interaction (F2,69 
= 0.373, P = 0.690) (Table 2). Specifically, SD-AdLib hamsters had paired testes 
masses that were regressed in comparison to LD-AdLib and LD-FR hamsters 
regardless of injection treatment (P < 0.001 for all comparisons). IWAT, EWAT, 
RWAT, and composite fat masses were affected by group (F2,69 > 15.69, P < 0.001 
for all models), but not injection (F1,69 < 0.07, P > 0.806 for all models) or the group 
x injection interaction (F2,69 < 0.23, P > 0.799 for all models) (Table 2). All groups 
showed significantly different composite fat masses from each other, with the LD-
AdLib groups having the greatest composite fat mass, followed by the LD-FR 
groups, and then the SD-AdLib groups (P < 0.02 for all comparisons between 
groups). 
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Table 2.  Mean (± SEM) paired testes, inguinal white adipose tissue (IWAT), 
epidydimal WAT  (EWAT), retroperitoneal WAT (RWAT), and composite adipose 
tissue masses from short-day ad libitum fed (SD-AdLib), long-day ad libitum fed 
(LD-AdLib), and long-day (previously) food restricted (LD-FR) male Siberian 
hamsters. Tissue masses were collected via necropsy at the conclusion of the 
experiment (five days after LPS or saline injection). Groups with different letters 
indicate statistically significant differences between group means (P < 0.05); 
groups sharing the same letter are statistically equivalent. 
____________________________________________________________________________________________________________________________________ 
 
  
SD-AdLib  LD-AdLib  LD-FR 
____________________________________________________________________________________________________________________________________ 
 
Paired testes mass (g)     
Saline  0.049 ± 0.004a  0.778 ± 0.042c  0.623 ± 0.025b 
 LPS  0.046 ± 0.003a  0.671 ± 0.033b,c 0.606 ± 0.028b  
 
IWAT mass (g)  
 Saline  0.488 ± 0.084a  1.062 ± 0.141b  0.627 ± 0.085a 
 LPS  0.465 ± 0.077a  1.083 ± 0.107b  0.513 ± 0.054a 
 
EWAT mass (g) 
 Saline  0.357 ± 0.044a  0.935 ± 0.109b,c 0.624 ± 0.067b  
 LPS  0.340 ± 0.049a  0.999 ± 0.119c  0.610 ± 0.055b 
 
RWAT mass (g) 
 Saline  0.057 ± 0.009a  0.164 ± 0.024e  0.106 ± 0.019c,d 
 LPS  0.064 ± 0.011a,b 0.155 ± 0.018d,e 0.087 ± 0.012b,c 
 
Composite adipose tissue mass (g) 
 Saline  0.902 ± 0.133a  2.160 ± 0.264c  1.357 ± 0.166b 
 LPS  0.869 ± 0.134a  2.237 ± 0.237c  1.210 ± 0.112b 
____________________________________________________________________________________________________________________________________ 
 
 
Discussion 
 The results of this study demonstrate that seasonal differences in body mass 
alone do not regulate all variation in sickness symptoms in Siberian hamsters; 
however, inducing body mass loss in long-day housed hamsters does result in 
animals displaying some symptoms that appear more short-day-like. Specifically, 
long-day hamsters that were food restricted showed body mass loss in response to 
109 
 
LPS that was attenuated in comparison to long-day ad libitum hamsters but 
comparable to short-day ad libitum hamsters. The attenuation of body mass loss in 
long-day food restricted hamsters was likely due in part to attenuation of LPS-
induced anorexia, as the long-day restricted hamsters showed patterns of anorexia 
intermediate between the short-day and long-day ad libitum groups but showed the 
lowest percentage of body mass loss of the three groups. We expected to see 
differences in the magnitude of LPS-induced decreases in nest building between 
the short- and long-day ad libitum groups; however, no differences were observed. 
Rather, we found that the long-day restricted group showed less of a decrease in 
nest building after LPS, suggesting that in this experimental context, the act of prior 
food restriction may have had greater impacts than photoperiod on this measure. In 
contrast to our predictions, the intensity of LPS-induced anhedonic behavior was 
not affected by food restriction, as both long-day ad libitum and restricted animals 
showed LPS-induced decreases in saccharin solution intake at 0-6 h post-injection 
while short-day ad libitum animals did not.  
All three LPS-treated groups showed hypothermia, rather than fever, from 
4 or 6 hours post-injection until the end of the measuring period 24 hours after 
injection. Hypothermic responses to sickness are not uncommon (Burness et al., 
2010; Carlton and Demas, 2014; French et al., 2013b; Martin et al., 2008b; Owen-
Ashley et al., 2008) and can actually be beneficial to survival during severe 
inflammation or low energy availability (Romanovsky and Szekely, 1998). For 
instance, rats that receive high concentrations of endotoxin display hypothermic 
responses and also show decreased glucose levels compared to control-injected 
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animals; however, rats that receive lower doses of endotoxin show fever and no 
hypoglycemia (Lang et al., 1985). As all three LPS-treated groups showed reduced 
glucose in comparison to saline-treated animals after injection, their glucose levels 
coupled with their hypothermic responses may suggest the animals were 
experiencing severe inflammation. In concordance with the photoperiodic 
influence on temperature, hamsters in the LPS-treated long-day ad libitum group 
had colonic temperatures that were lower than the short-day group at several 
timepoints, indicating that photoperiodic influences on temperature were 
maintained during the hypothermic response. Alternatively, the LPS-treated long-
day restricted group only had temperature recordings that were lower than the LPS-
treated short-day group at 8 hours post-injection, suggesting that hypothermia was 
attenuated in this group as compared to the LPS-treated long-day ad libitum group.  
 We assessed correlations between pre-LPS baseline body mass and the 
maximum percent body mass loss that was displayed after injection. We did not 
find a significant correlation between these measures, suggesting that intensity of 
energetically costly sickness symptoms may not be entirely limited by a minimum 
body mass threshold that the animal cannot surpass in order to survive (Ashley and 
Wingfield, 2012). However, there were significant correlations between pre-LPS 
body mass and percent body mass loss at days 3 and 4 post-LPS. Whereas 
maximum percent body mass loss may not be correlated with pre-LPS body mass, 
correlations at days 3 and 4 post-LPS suggest that the length of time an animal can 
maintain body mass loss throughout sickness may be constrained by their pre-
sickness body mass. In white-crowned sparrows (Zonatrichia leucophrys), baseline 
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body mass is correlated with post-LPS percent decreases in body mass, with 
initially heavier individuals showing the greatest decreases in body mass 24 hours 
after LPS injection (Owen-Ashley et al., 2008; Owen-Ashley et al., 2006).  The 
differences in timepoints at which these correlations are observed between hamsters 
and sparrows may reflect species differences in the amount of extra energy reserves 
each animal stores. For instance, if hamsters maintain greater surplus energy stores 
than sparrows, then the need to regulate sickness symptoms to avoid hitting a body 
mass where survival is risked may not occur until later into the sickness response. 
In the future, doing comparative studies across species with varying degrees of 
surplus energy stores may elucidate relationships between body mass and sickness 
intensity. 
 Because we found that long-day restricted hamsters showed attenuation of 
some sickness symptoms, we sought to determine what energetic hormones could 
be acting as intermediaries between body mass and sickness. We previously 
showed that seasonal variation in leptin mediates seasonal variation in LPS-induced 
hypothermia but not other sickness symptoms (Carlton and Demas, 2014). In the 
present study, we found that even though the long-day restricted group showed 
comparable body masses to the short-day ad libitum group, long-day restricted 
animals had higher leptin levels than short-day ad libitum animals. Therefore, if 
leptin is the primary intermediary between body mass and sickness, then we would 
have expected to see that sickness symptoms exhibited by the long-day restricted 
group were in-between the short- and long-day ad libitum groups. The results of 
this present study are largely consistent with previous findings (Carlton and Demas, 
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2014), as the long-day restricted group showed an intermediate hypothermic 
response, exhibiting temperatures that fell inbetween those of the short-day and 
long-day ad libitum groups at several timepoints. The long-day restricted group also 
showed an intermediate anorexic response.  While the intensity of this measure is 
consistent with differences in leptin levels across groups, our previous work 
directly manipulating leptin levels does not support the hypothesis that leptin 
mediates sickness-induced anorexia in Siberian hamsters (Carlton and Demas, 
2014). Although some research has linked leptin with sickness-induced anorexia 
(Harden et al., 2006; Sachot et al., 2004), other studies have suggested that these 
variables have little relationship with each other (Faggioni et al., 1997; Lugarini et 
al., 2005). Thus, the role of leptin in modulating sickness-induced anorexia in 
Siberian hamsters and other species remains unresolved. 
Suppression of the inflammatory response via circulating cortisol may be a 
promising mechanism to explain the attenuated sickness in the long-day restricted 
group. Glucocorticoids are released during sickness responses and are critical for 
regulating their intensity (Sapolsky et al., 2000). Rats that have their adrenal glands 
removed to prevent glucocorticoid production show greater body mass loss in 
response to LPS as compared to sham-operated controls (Johnson et al., 1996), 
while administration of synthetic glucocorticoids concurrently with LPS attenuates 
sickness-induced decreases in food intake (Uehara et al., 1989). Both the saline- 
and LPS-treated long-day restricted groups in our study exhibited elevated cortisol 
levels relative to their respective long-day ad libitum counterparts. Thus, it is 
possible that increased circulating cortisol levels in the long-day restricted animals 
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may have acted to suppress immunological modulators of sickness-induced 
anorexia and body mass loss. 
Although the long-day restricted group exhibited elevated cortisol levels 
relative to the long-day ad libitum group, both the saline-treated and LPS-treated 
long-day restricted groups had similar cortisol levels to their respective short-day 
ad libitum counterparts. Siberian hamsters show increased circulating cortisol 
levels in short days as compared to long days (Ashley et al., 2013; Bilbo and 
Nelson, 2003; Carlton and Demas, 2014). Therefore, it is possible that increased 
cortisol levels may be facilitating the attenuation of sickness symptoms in short-
day animals. Previous studies have investigated the effects of melatonin, 
testosterone, and leptin on seasonal variation in sickness intensity, but none have 
identified a seasonally modulated hormone that explains the majority of sickness 
response variation in this species (Bilbo and Nelson, 2002; Carlton and Demas, 
2014; Prendergast et al., 2008; Wen et al., 2007). In addition, there may also be 
seasonal changes in glucocorticoid receptors or binding proteins in this species that 
may affect regulation of sickness responses. Although no studies have explored 
seasonal variation in glucocorticoid receptors and proteins in Siberian hamsters, 
there is evidence that they vary seasonally in other species and that seasonal 
variation in receptors can occur within immune tissues (Lattin et al., 2013; Romero 
et al., 2006) Thus, examining the roles that seasonal variation in glucocorticoid 
mechanism play in this phenomenon may be a promising next step. 
While short-day hamsters displayed increased cortisol levels with ad 
libitum food access, we had to food restrict long-day hamsters to achieve the same 
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levels. Sustained moderate food restriction has been shown to increase cortisol 
levels in Siberian hamsters (Bilbo and Nelson, 2004; Zysling et al., 2009). 
Corticosterone is elevated to higher levels after LPS injection in food restricted 
mice and rats than in non-food restricted animals, and its elevation corresponds 
with lower levels of proinflammatory cytokines (MacDonald et al., 2014; 
Matsuzaki et al., 2001). Thus, it is possible that increased cortisol levels generated 
by food restriction may be suppressing proinflammatory cytokines in long-day 
restricted hamsters in this study. 
It cannot be ignored that although we induced body mass loss in the long-
day restricted group so that it mimicked natural short-day body mass loss, this 
pattern of body mass loss in long-day animals would likely be interpreted by the 
brain and periphery as “seasonally inappropriate” (Mercer et al., 2001). Differences 
in neural interpretation of energetic state between the long-day restricted and short-
day ad libitum groups may explain why the long-day restricted group showed 
attenuated body mass loss in response to LPS as compared to the short-day group, 
despite exhibiting a longer duration of LPS-induced anorexia. It is possible that 
food restriction resulted in a slowing of metabolic rate in long-day restricted 
animals. Syrian hamsters (Mesocricetus auratus) recover from short-term food 
restriction by slowing down their resting metabolic rates, rather than increasing 
food consumption over normal pre-restriction levels (Borer et al., 1985). As 
Siberian hamsters also do not recover from energy deficit by increasing food 
consumption (Bartness and Clein, 1994), long-day restricted animals in this current 
study may have had reduced metabolic rates as well. Even though the long-day 
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restricted group may have shown greater intensity of LPS-induced anorexia than 
the short-day ad libitum group, if their metabolic rates were slower, they could have 
exhibited reduced body mass loss. The food restriction treatment may also explain 
why the long-day food restricted group displayed lesser decreases in nest building. 
Having access to a nest decreases food intake in Siberian hamsters housed in low 
temperatures by 18%, suggesting that nesting is an energy conservation strategy 
(Kauffman et al., 2003). Athough the long-day food restricted group was provided 
with access to 100% of their pre-restriction mean food intake, they may have still 
been in energy conservation mode, explaining why they did not decrease nest 
building as much as the two other groups. 
In conclusion, our data show that food restricting long-day Siberian 
hamsters to mimic short-day body mass loss results in the attenuation of some 
sickness symptoms, rendering them more short-day like. However, our results do 
not provide conclusive evidence that all seasonal variation in sickness intensity can 
be attributed to seasonal changes in energy stores, as the intensity of some 
symptoms remained unchanged or intermediate between those of the short- and 
long-day ad libitum groups. One promising mediator of seasonal variation in 
sickness intensity may be glucocorticoids, as glucocorticoids act to suppress 
sickness and can vary both seasonally and with food restriction. Future work should 
target understanding the role of glucocorticoids in modulating seasonal sickness 
responses and work toward understanding how natural variation in energy stores 
within and across species and seasons contribute to sickness intensity.  
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CHAPTER 4: Glucose and insulin modulate sickness responses in male 
Siberian hamsters 
 
Data in review at General and Comparative Endocrinology: Carlton, E.D. and 
Demas, G.E. Glucose and insulin modulate sickness responses in male Siberian 
hamsters. 
 
Abstract 
Mounting a sickness response is an energetically expensive task and 
requires precise balancing of energy allocation to ensure pathogen clearance while 
avoiding compromising energy reserves. Sickness intensity has previously been 
shown to be modulated by food restriction, body mass, and hormonal signals of 
energy reserves. In the current study, we tested the hypothesis that sickness 
intensity is modulated by glucose availability and an endocrine signal of glucose 
availability, insulin. We utilized male Siberian hamsters (Phodopus sungorus) and 
predicted that pharmacological induction of glucoprivation with 2-deoxy-D-
glucose (2-DG), a non-metabolizable glucose analog that disrupts glycolysis, 
would attenuate energetically expensive sickness symptoms. Alternatively, we 
predicted that treatment of animals with insulin would enhance energetically 
expensive sickness symptoms, as insulin would act as a signal of increased glucose 
availability. Upon experimental treatment with lipopolysaccharide (LPS), we found 
that glucose deprivation resulted in increased sickness-induced hypothermia as 
compared to control- and insulin-treated animals; however, it did not have any 
effects on sickness-induced anorexia or body mass loss. Insulin treatment resulted 
in an unexpectedly exaggerated sickness response in animals of lesser body masses; 
however, in animals of greater body masses, insulin actually attenuated sickness-
induced body mass loss and had no effects on hypothermia or anorexia. The effects 
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of insulin on sickness severity may be modulated by sensitivity to sickness-induced 
hypoglycemia. Collectively, these results demonstrate that both glucose availability 
and signals of glucose availability can modulate the intensity of energetically 
expensive sickness symptoms, but their effects differ among different sickness 
symptoms and are sensitive to energetic context.   
 
Introduction 
 Animals must obtain and utilize energy to fuel virtually every physiological 
and behavioral process required for their survival and reproductive success. In 
times of energy limitation, constraints may require energy to be shunted away from 
processes of a lesser priority for an organism’s current needs and toward those 
processes most fundamental for survival (Sheldon and Verhulst, 1996) . Mounting 
a sickness response is a process that requires precise balancing of energy allocation. 
Sickness responses are characterized by energetically expensive symptoms such as 
fever, anorexia, and body mass loss. These symptoms have adaptive benefits and 
reductions in their magnitude can negatively affect an animal’s ability to clear its 
infection; however, if these symptoms are displayed too strongly, an animal may 
also succumb to death due to energy depletion (Adelman and Martin, 2009; Ashley 
and Wingfield, 2012; Hart, 1988; Moret and Schmid-Hempel, 2000). 
Sickness responses are not static; animals are able to modulate sickness in 
response to their energy reserves. Previous work has shown that food restriction 
results in suppression of sickness symptoms (Bilbo and Nelson, 2002; MacDonald 
et al., 2014; MacDonald et al., 2011). Additionally, the intensity of the energetically 
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costly symptoms of sickness are correlated with body mass in several species, such 
that animals with higher body masses show more intense sickness responses  
(Carlton and Demas, in review; Owen-Ashley et al., 2008; Owen-Ashley et al., 
2006; Pohl et al., 2014). Siberian hamsters (Phodopus sungorus) are a species that 
shows variation in sickness intensity that correlates with energetic state. For 
instance, hamsters show seasonal variation in both body mass and sickness intensity 
and exhibit the most intense sickness responses in the season in which they have 
the greatest body mass (Bilbo et al., 2002). We have previously manipulated body 
mass and an endocrine signal of fat stores (i.e., leptin) to determine their effects on 
sickness intensity variation in this species (Carlton and Demas, 2014; Carlton and 
Demas, in review). These studies showed that hamsters modulate sickness 
symptoms in response to decreases in energy stores (i.e., attenuation of sickness-
induced anorexia and body mass loss in hamsters that were food restricted to lose 
body mass; Carlton and Demas, in review) and increases in circulating leptin levels 
(i.e., attenuation of sickness-induced hypothermia in hamsters provided exogenous 
leptin to simulate increased fat stores; Carlton and Demas, 2014).  
In addition to signals of long-term energy stores, animals may also rely on 
signals of short-term energy availability (i.e., blood glucose levels) to modulate 
sickness. While an animal must avoid risking future survival by over-expending its 
excess energy stores, it may also be necessary for it to assess current environmental 
energy availability in order to avoid insufficient food resources during recovery. 
Glucose is the primary source of energy that is used by an animal, so blood glucose 
levels may provide the most immediate indicator of food availability. Furthermore, 
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glucose is critical for fueling immune responses (Wolowczuk et al., 2008). Previous 
work has shown that reductions in glucose availability via treatment with 2-deoxy-
D-glucose (2-DG), a non-metabolizable glucose analog that disrupts glycolysis and 
induces a state of glucoprivation (Horton et al., 1973), impairs antibody production, 
delayed-type hypersensitivity responses, splenocyte production, and leukocyte 
counts in Siberian hamsters, deer mice (Peromyscus maniculatus), and Lewis rats 
(Chou et al., 1996; Demas et al., 1997b; Martin et al., 2008a; Zysling and Demas, 
2007). Although there is considerable evidence that reducing glucose availability 
modulates many aspects of the immune response, it remains unclear how glucose 
availability may affect sickness responses.  
While we can manipulate actual glucose availability with 2-DG, we can 
manipulate signals of glucose availability via the pancreatic peptide hormone 
insulin. Insulin is secreted upon food consumption, and its release facilitates the 
storage of energy. In the short-term, increased insulin levels signal positive energy 
balance, and levels rapidly change in response to an organism’s current energetic 
state (Benoit et al., 2004). Insulin receptors are expressed on activated lymphocytes, 
and administration of insulin to these activated lymphocytes increases cellular 
metabolism (Delmastro-Greenwood and Piganelli, 2013; Helderman, 1981). 
Insulin has been shown to modulate immune responses in Siberian hamsters, 
specifically enhancing antibody production in the smaller short-day housed 
hamsters so that their antibody levels are comparable to those produced by the 
larger long-day housed hamsters (Garcia et al., 2010). These results suggest that 
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insulin may act as a signal of current energy availability to allow coordination of 
energetically-appropriate immune responses. 
The goals of the present study were to manipulate current glucose 
availability and a signal of glucose to determine their effects on sickness response 
intensity in male Siberian hamsters. If glucose availability is a limiting factor in the 
display of energetically expensive sickness symptoms, then we expected that 
animals experiencing 2-DG-induced glucoprivation would show weakened fever or 
enhanced hypothermia and attenuated anorexia and body mass loss in response to 
the bacterial mimetic lipopolysaccharide (LPS) as compared to LPS-treated control 
animals. Similarly, we expected animals receiving insulin as a signal of increased 
glucose availability would show enhanced LPS-induced fever or weakened 
hypothermia and enhanced anorexia and body mass loss as compared to LPS-
treated control animals. We also measured behaviors that are modulated during 
sickness in this species, thermoregulatory nest building behavior and hedonic 
behavior. We predicted that animals in the glucose-deprived group would show 
lesser sickness-induced declines in nesting behavior in response to LPS than the 
other two groups, as nesting can provide energy saving benefits; however, we 
predicted that we would see no differences in the decreases in hedonic behavior 
among the groups, as this behavior is not largely energetically demanding in this 
context.  
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Methods 
Animals and housing conditions 
Adult ( > 60 days of age) male Siberian hamsters (n = 63) were obtained 
from our breeding colony at Indiana University. All animals were initially group 
housed (2-5 per cage with same sex siblings on weaning at 17-18 days of age) in 
long-day photoperiods (light:dark (L:D) 16:8) and then individually housed in 
polypropylene cages (27.8 x 17.5 x 13.0 cm) for one week prior to the start of the 
experiment. Animals were housed in long-day photoperiods for the entirety of the 
study. Food (Laboratory Rodent Diet 5001, LabDiet, St. Louis, MO, USA) and 
water were available ad libitum prior to and throughout the experiment. 
Temperature (20 ± 2°C) and humidity (50 ± 10%) were maintained at constant 
levels. All animal methods were reviewed and approved by the Institutional Animal 
Care and Use Committee (IACUC) at Indiana University. 
 
 Experimental methods 
 After one week of acclimation to individual housing, hamsters were quasi-
randomly sorted (controlling for body mass, age, and genetic relatedness) into three 
groups: Control, 2-DG, or Insulin. Prior to receiving any experimental injections, 
daily measurements of body mass (to the nearest 0.1 g) and food consumption (to 
the nearest 0.1 g) were taken for five days. Food consumption was assessed by 
weighing the food pellets remaining in the hopper each day. Daily body mass and 
food consumption measurements continued through the entirety of the experiment.  
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 After the five days of initial body mass and food intake measurements, 
hamsters started receiving daily injections. Animals in the Control group received 
one 0.2 ml intraperitoneal (i.p.) injection of 0.9% sterile saline every other day and 
one 0.1 ml subcutaneous (s.c.) injection of 0.9% sterile saline every day until the 
end of the experiment. Animals in the 2-DG group received one 0.2 ml i.p. injection 
of 1250 mg/kg 2-DG (Sigma-Aldrich, St. Louis, MO, USA) dissolved in 0.9% 
sterile saline every other day and one 0.1 ml s.c. injection of 0.9% sterile saline 
every day until the end of the experiment. This dose was chosen because it is greater 
than the 2-DG dose that affects least one immune measure (i.e., antibody 
production) in this species but well below the dose that induces torpor (Dark et al., 
1994; Zysling and Demas, 2007). The Insulin group received one 0.2 ml i.p. 
injection of 0.9% sterile saline every other day and one 0.1 ml s.c. injection of the 
long-lasting form of insulin, protamine zinc insulin (PZI) (ProZinc, Boehringer 
Ingelheim Vetmedica, Inc., St. Joseph, MO, USA), dissolved in 0.9% sterile saline 
every day until the end of the experiment. The insulin dose was gradually increased 
over the course of 11 days to 20 U/kg, in order to avoid death-inducing severe 
hypoglycemia (Garcia et al., 2010). A dose of 20 U/kg was chosen because we 
wanted to modulate the signal of glucose availability without necessarily 
modulating actual blood glucose levels (Garcia et al., 2010). The PZI injections 
were administered according to the following dosing schedule: day 1: 0.625 U/kg; 
days 2-3: 1.25 U/kg; days 4-6: 5 U/kg; days 7-10: 10 U/kg; days 11-23: 20 U/kg. 
The 2-DG injections were provided on the odd-numbered experimental days. 
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 On the 19th day of injections, a portion of the animals in each group were 
injected i.p. ~ 15 minutes before the onset of darkness (~1545 h) with 25 µg LPS 
(LPS from Salmonella enterica serotype typhimurium, Sigma-Aldrich, St. Louis, 
MO, USA; Carlton and Demas, 2014) suspended in 0.1 ml sterile 0.9% saline. 
Sickness responses were assessed throughout the four days following injections.  
The sample sizes were as follows: Control-Saline (n=10); Control-LPS (n=10); 2-
DG-Saline (n=9); 2-DG-LPS (n=10); Insulin-Saline (n=11); Insulin-LPS (n=13).  
 
 Sickness response measurements 
Following LPS injection, animals were monitored for signs of severe 
sickness, potentially indicating signs of sepsis, as outlined in our approved IACUC 
protocol. Animals that showed decreases in body temperature greater than 2°C 
below that of their group mean were removed from the study. These animals 
exhibited these temperature declines between 4 and 36 h post-injection. Due to a 
larger than expected number of animals showing these symptoms, we were able, 
post-hoc, to divide LPS-injected animals into two different groups: those that 
showed moderate sickness and remained in the study until the end (< 2°C decrease 
in colonic temperature) and those that showed severe sickness and were removed 
from the study (> 2°C decrease in colonic temperature).  
 
     Fever, anorexia, and body mass 
On the day of LPS or saline injection, colonic temperatures (Tc; to the nearest 0.1 
°C) were collected immediately before injection and 2, 4, 6, 8, 10, 12, 16, 20, and 
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24 h after injection using a MicroTherma 2T thermometer (ThermoWorks, Alpine, 
UT, USA) and a lubricated RET-3-ISO thermocouple probe (Physitemp 
Instruments, Inc., Clifton, NJ, USA) inserted ~12 mm into the rectum. To assess 
anorexia and body mass loss, daily body mass and food intake measurements 
continued until the end of the study. 
 
     Hedonic behavior  
To assess the effects of our treatments on hedonic behavior, we provided 
hamsters with a highly palatable sodium saccharin solution (Baillie and 
Prendergast, 2008). Beginning 5 days before LPS or saline injection, for the first 6 
h of the dark phase (1600 h to 2200 h) hamsters were provided with a fluid bottle 
containing a solution of 0.1% sodium saccharin (saccharin sodium salt hydrate, 
Sigma-Aldrich, St. Louis, MO, USA) dissolved in tap water (Baillie and 
Prendergast, 2008). The saccharin solution bottles were weighed (to the nearest 0.1 
g) before they were given and after they were collected from the hamsters each day. 
Presentation of saccharin solution continued daily through day 3 post-injection.  
 
     Nest building behavior 
To assess the effects of our treatments on thermoregulatory behavior, 
beginning five days before LPS or saline injection, each hamster was provided with 
a compressed cotton nestlet weighing ~2.5 g (Ancare, Bellmore, NY, USA) for the 
first 6 h of the dark phase (Baillie and Prendergast, 2008). The nestlet was weighed 
(to the nearest 0.1 g) before presentation, and the unshredded portion was weighed 
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after presentation. When provided a nestlet, hamsters quickly start shredding the 
cotton to build a nest. Nest building is an adaptive behavior to enhance energy 
conservation in low temperatures, however, hamsters readily build nests in room 
temperature (20-23 °C) (Puchalski et al., 1988). Presentation of nestlets continued 
daily through day 3 post-injection. 
 
Blood sampling and necropsies 
Blood samples were drawn from each animal 4 h after the onset of darkness 
(2000 h) at two time points (two days before injection and on the day of injection) 
to assess circulating blood glucose and serum cortisol concentrations. Briefly, 
animals were lightly anesthetized with isoflurane vapors, and blood samples were 
drawn from the retro-orbital sinus. Blood samples were allowed to clot at room 
temperature for 1 h, clots were removed, and samples were centrifuged at 4 °C for 
30 min at 2500 rpm. Serum aliquots were aspirated and stored in sealable 
polypropylene microcentrifuge tubes at -20 °C until assayed. All blood samples 
were collected within 3 min of initial handling. Animals were euthanized five days 
after LPS injection and necropsies were performed. Testes, inguinal white adipose 
tissue (IWAT), epidydimal WAT (EWAT), and retroperitoneal WAT (RWAT) 
were removed, cleaned of connective tissues, and weighed to the nearest 0.1 mg. A 
composite adipose tissue score was calculated by summing the individual WAT 
pad masses. 
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Blood glucose measurement 
Blood glucose was measured from both blood samples. Immediately upon 
sampling, ~5 µl of whole blood was transferred onto the test strips of a blood 
glucose monitoring system (ReliOn, Micro Blood Glucose Monitoring System, 
Arkray USA, Inc., Minneapolis, MN, USA), and the readout was recorded. The 
meter was previously calibrated using an internal standard provided by the 
manufacturer. 
 
Cortisol enzyme immunoassay (EIA) 
We assessed circulating cortisol levels to determine if our treatments 
influenced the magnitude of LPS-induced hypothalamic-pituitary-adrenal (HPA) 
axis activation. Glucocorticoids are released during sickness and are important for 
regulating its intensity (Sapolsky et al., 2000). Cortisol is the predominant 
glucocorticoid in Siberian hamsters, with concentrations ~100x that of 
corticosterone (Reburn and Wynne-Edwards, 2000). Serum cortisol concentrations 
were determined in multiple enzyme immunoassays (EIAs) from a commercially 
prepared kit (Cortisol EIA Kit; Enzo Life Sciences, Inc., Farmingdale, NY, USA). 
This assay was previously validated for use in Siberian hamsters (Demas et al., 
2004) and is highly specific for cortisol; cross-reactivity with corticosterone is 
27.7% and < 4.0% for other steroid hormones. The sensitivity of the assay is 56.72 
pg/ml. Samples were diluted 1:80 with assay buffer and run in duplicate. Intra-assay 
variabilities were 6.2%, 2.8%, and 3.1%. 
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Statistical analyses 
All statistical tests were performed using JMP 10 (SAS Institute Inc., Cary, 
NC, USA). Residuals were checked for normality and homogeneity of variance, 
and those data that were non-normally distributed were transformed. Two animals 
were excluded from the final analyses: one from the LPS-treated 2-DG group which 
obtained an injury unrelated to the experimental procedures and one from the 
saline-treated Insulin group which exhibited sickness symptoms despite not 
receiving any LPS. The final sample sizes were as follows: Control-Saline (n=10); 
Control-LPS (n=10); 2-DG-Saline (n=9); 2-DG-LPS (n=9); Insulin-Saline (n=10); 
Insulin-LPS (n=13). Non-normally distributed variables differed in their degrees of 
skewness, so each variable was transformed with the function that best fit the data 
to normality. Baseline saccharin solution intake and percent change in saccharin 
solution intake were square root transformed, while cortisol concentrations were 
log transformed. Baseline percent nesting material shredded could not be 
transformed to meet the assumptions of normality, so a Kruskal-Wallis test was 
performed to determine if there were differences among the groups for this 
measure. 
Pre-LPS baseline values were calculated for body mass, food intake, 
saccharin solution intake, and percent nesting material shredded by averaging the 
three daily measurements immediately prior to injections. To determine if there 
were effects of 2-DG or insulin treatment on pre-injection baseline body mass, 
baseline food intake, baseline saccharin solution intake, and pre-injection blood 
glucose levels, two-way (2-DG treatment (2) x insulin treatment (2)) analyses of 
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variance (ANOVA) were performed. Because expected values in some cells were 
less than five, Fisher’s Exact Test was performed to determine if treatment affected 
the frequencies of animals within each LPS-treated group that had to be removed 
from the study due to severe sickness. Comparisons between animals that exhibited 
moderate sickness and continued in the study and those that exhibited severe 
sickness and were removed from the study were performed with two-sided t-tests. 
Animals that showed severe sickness and were removed from the study were not 
included in subsequent between group comparisons of post-injection percent 
changes in body mass, food intake, saccharin solution intake, and nesting material 
shredded, post-injection blood glucose concentrations, cortisol concentrations, and 
tissue masses (Results section 3.3).  
Post-LPS changes in body mass, food intake, saccharin solution intake, and 
percent nesting material shredded were expressed as percentages of each animal’s 
baseline values. Repeated measures ANOVAs were performed on post-injection 
percent changes in body mass, food intake, saccharin solution intake, and nesting 
material shredded and colonic temperature, with 2-DG, insulin, and LPS as 
between-subjects factors and time as the within-subjects factor. The within-subjects 
comparisons for percent change in saccharin solution intake and colonic 
temperature violated the assumptions of sphericity and were Greenhouse-Geisser 
corrected. Differences in post-injection glucose levels, cortisol concentrations, and 
tissue masses were assessed with three-way (2-DG (2) x insulin (2) x LPS (2)) 
ANOVAs. Post-hoc comparisons were conducted using Tukey’s honestly 
significant difference (HSD) tests when ANOVAs were significant. 
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Results 
 Pre-LPS baseline measures 
Before receiving any 2-DG or insulin treatments, the groups did not differ 
in body mass (F2,58 = 0.88, P = 0.419) or food intake (F2,58 = 0.25, P = 0.783). After 
treatments, all three groups showed decreases in body mass (T > 4.54, P < 0.001 
for all comparisons), and the Insulin group showed increased food intake (T = 2.66, 
P = 0.014) while the Control and 2-DG groups showed no change in food intake 
pre- to post-treatment (T < 0.97, P > 0.347). After treatments and before LPS or 
saline injection, baseline body mass (F2,58 = 1.39, P = 0.256), baseline saccharin 
solution intake (F2,58 = 2.03, P = 0.140), baseline percent nesting material shredded 
(H = 4.07, P = 0.131), and pre-injection blood glucose levels (F2,58 = 1.82, P = 
0.171) did not differ among the Control, 2-DG and Insulin groups. Alternatively, 
pre-injection baseline food intake was affected by insulin treatment (F1,58 = 6.20, P 
= 0.016) (Table 1). Specifically, the Insulin group showed greater daily food intake 
than the Control group (P = 0.041). With the exception of baseline food intake in 
the 2-DG group (i.e., LPS-injected hamsters exhibited greater baseline food intake 
values than saline-injected hamsters; T = 2.49, P = 0.025), none of the baseline 
measures differed between LPS- and saline-injected hamsters within each group (P 
> 0.085 for all comparisons). 
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Table 1.  Mean (± SEM) baseline body mass, food intake, saccharin solution intake, 
percent nesting material shredded, and blood glucose levels prior to LPS or saline 
injection in control, 2-DG, and insulin-treated male Siberian hamsters. Baseline 
measurements were calculated by averaging the values collected for the 
measurements during the three days prior to LPS or saline injection. Groups with 
different letters indicate statistically significant differences between group means 
(P < 0.05); groups sharing the same letter (or no letters) are statistically equivalent. 
____________________________________________________________________________________________________________________________________   
Control  2-DG   Insulin 
____________________________________________________________________________________________________________________________________ 
 
Baseline Body  
Mass (g)  43.9 ± 1.4  45.7 ± 1.2  47.0 ± 1.3 
 
Baseline Food  
Intake (g/day)  4.7 ± 0.1a  4.9 ± 0.2a,b  5.2 ± 0.1b 
 
Baseline Saccharin  
Solution  
Intake (g / 6 h) 1.6 ± 0.2  1.8 ± 0.2  2.2 ± 0.2 
     
Baseline Percent  
Nesting Material  
Shredded    93.7 ± 2.7  91.6 ± 4.7  83.6 ± 4.3 
 
Pre-injection blood  
glucose concentration  
(mg/dl)  107 ± 4  98 ± 5   96 ± 4 
____________________________________________________________________________________________________________________________________ 
 
Animals displaying severe sickness 
After LPS-injection, six of the 13 animals in the Insulin group exhibited 
severe sickness and were removed from the study. No LPS-treated animals from 
the Control or 2-DG groups were removed from the study. The frequencies of 
animal removal among the three LPS-treated groups were significantly different 
(Fishers Exact Test, P = 0.005). Within the LPS-injected Insulin group, those 
animals that exhibited severe sickness showed lower baseline body masses (T = -
5.29, P < 0.001), higher pre-injection blood glucose levels (T = 2.41, P = 0.035), 
lower post-injection blood glucose levels (T = -2.83, P = 0.018), and higher post-
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injection cortisol concentrations (T = 2.92, P = 0.014) as compared to animals that 
exhibited moderate sickness (Table 2). There were no differences between the 
moderate and severe sickness animals in baseline food intake, baseline saccharin 
solution intake, baseline percent nesting material shredded, or colonic temperature 
immediately prior to injection (P > 0.063 for all comparisons). 
 
Table 2.  Mean (± SEM) baseline body mass, food intake, saccharin solution intake, 
percent nesting material shredded and colonic temperature and blood glucose levels 
prior to LPS injection and blood glucose and serum cortisol levels 4 h after LPS 
injection in insulin-treated male Siberian hamsters that exhibited moderate or 
severe sickness symptoms. Hamsters were classified as exhibiting moderate 
sickness and kept in the study if they showed a decrease in colonic temperature < 
2°C from the group mean after LPS injection and as severe sickness and removed 
from the study if they showed a decrease in colonic temperature > 2°C from the 
group mean after LPS injection. *P < 0.05 and **P < 0.001 for differences between 
the two groups. 
____________________________________________________________________________________________________________________________________ 
  
Measure   Moderate   Severe 
____________________________________________________________________________________________________________________________________ 
 
Baseline Body Mass (g)   52.5 ± 1.2   40.1 ± 2.0** 
 
Baseline Food Intake (g/day) 5.6 ± 0.1   4.8 ± 0.3 
    
Baseline Saccharin Solution  
Intake (g/6h)    2.9 ± 0.5   2.1 ± 0.5 
 
Baseline Percent Nesting 
Material Shredded   88.1 ± 5.8   70.7 ± 12.3 
 
Pre-injection Colonic  
Temperature (°C)   37.1 ± 0.2   36.7 ± 0.2 
 
Pre-injection Blood  
Glucose (mg/dl)   85 ± 8    112 ± 8.0* 
     
Post-injection Blood  
Glucose (mg/dl)   51 ± 5    31 ± 5* 
 
Post-injection Cortisol (ng/ml)  134.6 ±12.9   189.3 ± 13.6* 
____________________________________________________________________________________________________________________________________ 
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Sickness, physiological, and morphological measurements in animals showing 
moderate sickness responses 
     Colonic temperature 
Post-injection colonic temperature was affected by LPS injection (F1,49 = 
16.08, P < 0.001) but not by any of the other between subjects factors or between 
subjects interactions (P > 0.29 for all effects) (Figure 1). Temperature did change 
across time (within subjects, F5.4,265.9 = 50.78, P < 0.001, G-G corrected) and with 
the time x LPS (F5.4,265.9 = 8.48, P < 0.001, G-G corrected) and time x 2-DG 
(F5.4,265.9 = 3.13, P = 0.008, G-G corrected) interactions. Specifically, all LPS-
injected groups showed varying degrees of hypothermia post-injection. The LPS-
injected 2-DG group exhibited temperatures lower than their respective saline-
injected controls at the greatest number of timepoints post-injection (6, 10, 16, 20, 
and 24 h); whereas the LPS-treated Control and LPS-treated Insulin groups only 
showed lower temperatures than their saline-injected controls at two (6 and 16 h) 
and one (6 h) timepoints post-injection, respectively. 
 
133 
 
 Figure 1. Mean (± SEM) colonic temperature following LPS (black icons) or saline 
(white icons) injection delivered at the 0 h timepoint in control- ( ), 2-DG-               
( ), or insulin- ( ) treated male Siberian hamsters. Black and white bars at the 
top of the graph indicates the active, dark (black) and inactive, light (white) phases 
of the light-dark cycle. *P < 0.05 versus saline-injected group given the same 
treatment. 
 
     Anorexia 
Percent change in food intake was affected by LPS injection (F1,48 = 98.82, 
P < 0.001) but not by any of the other between subjects factors or between subjects 
interactions (P > 0.27 for all effects) (Figure 2A). In addition, percent changes in 
food intake changed across time (within subjects, F3,46 = 101.81, P < 0.001) and 
with the time x LPS (F3,46 = 11.61, P < 0.001) and time x insulin (F3,46 = 4.44, P = 
0.008) interactions. Specifically, all LPS-injected groups showed greater percent 
decreases in food intake in comparison to their respective saline-injected controls 
at days 1, 2, and 3 post-injection (P < 0.05 for all comparisons). By day 4 post-
injection, all LPS-injected groups no longer showed changes in food intake that 
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differed from their respective saline-injected controls (P > 0.09 for all 
comparisons).  
 
     Body mass loss 
Percent change in body mass loss was affected by LPS injection (F1,49 = 
102.47, P < 0.001), 2-DG treatment (F1,49 = 4.25, P = 0.045), insulin treatment (F1,49 
= 4.29, P = 0.044) and the insulin x LPS interaction (F1,49 = 6.78, P = 0.012) but 
not the 2-DG x LPS interaction (F1,49 = 0.25, P = 0.618) (Figure 2B). In addition, 
body mass loss changed with the time x LPS interaction (within subjects, F3,47 = 
14.15, P < 0.001) but not with any other of the within subjects factors or interactions 
(P > 0.08 for all tests). Specifically, LPS-injected Insulin animals showed 
attenuated body mass loss as compared to LPS-injected Control and 2-DG animals. 
Whereas the LPS-injected Control and 2-DG groups showed greater percent 
decreases in body mass loss in comparison to their respective saline-injected groups 
at all four timepoints post-injection (P < 0.001 for all comparisons), the LPS-
injected Insulin group only showed greater percent decreases in body mass loss in 
comparison to its saline-injected control group at days 2, 3, and 4 post-injection (P 
= 0.068 on day 1, P < 0.001 on other days). Furthermore, the LPS-injected Insulin 
group showed attenuated post-LPS body mass loss compared to the LPS-injected 
2-DG group at day 2 post-injection and both the LPS-injected 2-DG and Control 
groups at day 3 post-injection (P < 0.005 for these comparisons). 
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 Figure 2. Mean (± SEM) percent changes in (A) food intake and (B) body mass 
from baseline following LPS (black icons) or saline (white icons) injection 
delivered on day 0 in control- ( ), 2-DG- ( ), or insulin- ( ) treated male 
Siberian hamsters. Day +1 represents the time period from 0-24 h after LPS or 
saline injection, Day +2 represents the time period from 24-48 h after LPS or saline 
injection, and so forth. Within each panel: *P < 0.05 versus saline-injected group 
given the same treatment. #P < 0.05 versus LPS-injected Insulin group. ^P < 0.05 
versus other saline-injected groups. 
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     Saccharin solution intake 
Percent change in saccharin intake after injection was affected by LPS 
injection (F1,49 = 7.34, P < 0.009) but not by any of the other between subjects 
factors or between subjects interactions (P > 0.43 for all effects) (Figure 3A). 
Furthermore, saccharin solution intake changed with time (within subjects, F2.3,110.7 
= 11.69, P < 0.001, G-G corrected) and with the time x LPS interaction (F2.3,110.7 = 
2.23, P = 0.001, G-G corrected). Specifically, at the 0-6 h timepoint, animals in the 
LPS-injected 2-DG and Insulin groups showed greater percent decreases in 
saccharin solution intake as compared to their respective saline-injected controls (P 
< 0.044 for both comparisons), while there was no difference between the LPS-
injected Control group and its respective saline-injected control (P = 0.098).  
 
     Nesting material shredded 
Percent change in nesting material shredded after injection was affected by 
LPS injection (F1,49 = 188.82, P < 0.001) but not by any of the other between 
subjects factors or between subjects interactions (P > 0.09 for all effects) (Figure 
3B). Percent nesting material shredded did change over time (within subjects, F3,47 
= 41.18, P < 0.001) and with the time x LPS interaction (within subjects, F3,47 = 
56.30, P < 0.001). Specifically, animals from all LPS-injected groups showed 
greater percent decreases in nesting material shredded than their respective saline-
injected controls at the 0-6 h, 24-30 h, and 48-54 h timepoints (P < 0.040 for all 
comparisons); nest shredding returned to levels similar to saline-injected controls 
by the 72-78 h timepoint (P > 0.998 for all comparisons). In addition, animals in 
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the LPS-injected 2-DG group showed a greater percent decrease in nesting material 
shredded in comparison with the LPS-injected Control group at the 48-54 h 
timepoint (P = 0.016). 
 
 
 
Figure 3. Mean (± SEM) percent changes in (A) saccharin solution intake and (B) 
percent nesting material shredded from baseline following LPS (black icons) or 
saline (white icons) injection delivered at the 0 h timepoint in control- ( ), 2-DG- 
( ), or insulin- ( ) treated male Siberian hamsters. *P < 0.05 versus saline-
injected group given the same treatment. #P < 0.05 versus LPS-injected Control 
group. 
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Blood glucose 
Post-injection blood glucose concentrations were affected by LPS injection 
(F1,49 = 35.37, P < 0.001) and insulin treatment (F1,49 = 7.18, P = 0.010) but not by 
2-DG or the LPS x insulin and LPS x 2-DG interactions (P > 0.47 for all effects) 
(Figure 4A). Specifically, all LPS-injected groups had lower blood glucose 
concentrations than their respective saline-injected controls (P < 0.02 for all 
comparisons), and insulin-treated animals, as a whole, had lower post-injection 
glucose levels as compared to animals not treated with insulin (T = -2.77, P =0.008). 
 
Serum cortisol 
Post-injection serum cortisol concentrations were affected by LPS injection 
(F1,49 = 40.19, P < 0.001) but not by 2-DG or insulin treatment or their interactions 
with LPS (P > 0.37 for all effects) (Figure 4B). Specifically, all LPS-injected 
animals showed greater cortisol levels than their respective saline-injected controls 
(P < 0.004 for all comparisons). 
 
Tissue masses 
Paired testes mass was affected by 2-DG treatment (F1,49 = 6.62, P = 0.013) 
but not by LPS or insulin treatment or any interactions (P > 0.321 for all effects). 
Specifically, as a whole, animals treated with 2-DG had lesser paired testes masses 
as compared to animals not treated 2-DG (0.45 g ± 0.06 SE vs. 0.63 g ± 0.03 SE, 
respectively) (T = -2.57, P =0.013). Composite adipose tissue mass was not affected 
by any of the treatments or interactions (F5,49 = 0.842, P = 0.526). 
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Figure 4. Mean (± SEM) (A) blood glucose and (B) circulating serum cortisol 
concentrations taken 4 h following LPS or saline injection in control-, 2-DG-, or 
insulin-treated male Siberian hamsters. Within each panel, groups with different 
letters indicate statistically significant differences between group means (P < 0.05); 
groups sharing the same letter are statistically equivalent. 
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Discussion 
 The results of this study demonstrate that both direct manipulations of 
glucose availability, as well as signals of glucose availability, modulate the 
intensity of some of the energetically expensive symptoms of sickness. 
Specifically, reductions in glucose availability in the 2-DG group resulted in a 
greater hypothermic response as compared to the other two groups, potentially as 
an energy saving mechanism. Alternatively, contrary to our predictions, animals 
experiencing reduced glucose availability showed a more pronounced sickness-
induced decrease in nesting behavior as compared to control animals. Furthermore, 
among the animals that showed moderate sickness, there were no treatment effects 
on sickness-induced anorexia and contrary to our predictions, insulin-treated 
animals showed an attenuation of sickness-induced body mass loss as compared to 
the other two groups.  
 In addition to these effects on specific sickness symptoms, we also saw that 
a portion of the animals that were provided signals of increased glucose availability 
via insulin treatment displayed severe sickness after LPS injection. Although all 
insulin-treated animals showed hypoglycemia after LPS injection, the insulin-
treated animals that exhibited severe sickness showed lower glucose levels post-
injection than animals exhibiting moderate sickness. This relationship between 
post-LPS glucose levels and severe sickness is consistent with prior work in rats 
that showed that severe endotoxemia is associated with greater hypoglycemia 
(Lang et al., 1985). Although it seems that the drop in blood glucose may be 
predictive of which animals showed severe sickness, it is still not clear why the 
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animals that exhibited severe sickness were also the animals with the lowest body 
masses in the insulin-treated group. One possible explanation is that these smaller 
individuals had increased sensitivity to sickness-induced hypoglycemia due to 
differences in LPS dosing. Even though the insulin doses were corrected for body 
mass, all animals received a standard dose of LPS (25 µg). Therefore, smaller 
animals received a higher dose of LPS relative to their body masses. As all LPS-
injected groups were matched for body mass prior to injection, it is not likely that 
this severe sickness response was only due to dose differences among smaller and 
larger animals, as none of the smaller animals from the Control and 2-DG groups 
showed severe sickness. Therefore, it appears that insulin treatment may have 
increased the sensitivity of animals to LPS treatment.  
Interleukin (IL)-1, a pro-inflammatory cytokine released in response to LPS 
and infection, affects glucose homeostasis during infection and induces 
hypoglycemia, as it modulates glucose regulation via the brain and stimulates 
increases in glucose utilization by peripheral tissues (del Rey and Besedovsky, 
1989; del Rey et al., 2006; Vogel et al., 1991). While animals in the current study 
exhibited hypoglycemic responses to LPS treatment, it is also common for human 
and non-human animals to exhibit hyperglycemic responses to infection 
(McGuinness, 2005). In cases of sickness-induced hyperglycemia, insulin 
treatment improves survival in the critically ill, and this is likely mediated through 
a normalization of glucose levels via decreases in pro- and increases in anti-
inflammatory cytokine release (Jeschke et al., 2004; van den Berghe et al., 2001). 
In the current study, all LPS-treated animals showed hypoglycemia, so 
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administering insulin during experimental infection likely was the cause of the 
potentiated hypoglycemic response in the insulin-treated animals as compared to 
the other two groups. Thus, the potential enhanced hypoglycemic effects of the 
greater LPS dose in these smaller animals coupled with the hypoglycemic effects 
of insulin treatment may explain why the smaller animals in the insulin-treated 
group showed the most severe sickness responses of all groups. 
 Whereas insulin treatment facilitated an enhanced sickness response in the 
smaller individuals in that group, the larger individuals that exhibited moderate 
sickness and continued in the study actually showed attenuation of an energetically 
expensive sickness symptom. The insulin-treated animals that remained in the 
study showed lesser percent decreases in body mass after LPS injection as 
compared to the Control and 2-DG groups. This attenuation of body mass loss in 
the insulin-treated group is not a product of differences in sickness-induced 
anorexia, as all three LPS-treated groups showed similar patterns and intensities of 
anorexia post-LPS. Furthermore, this attenuation is surprising because the animals 
that displayed moderate sickness in the LPS-treated Insulin group had an average 
body mass that was 6-8 grams greater than animals in the LPS-treated Control and 
2-DG groups. In Siberian hamsters and white-crowned sparrows (Zonotrichia 
leucophrys), pre-sickness body mass is negatively correlated with percent decrease 
in body mass loss after LPS-injection, such that larger individuals show greater 
percent decreases in body mass after injection, even when all animals are given the 
same quantity of LPS (Carlton and Demas, in review; Owen-Ashley et al., 2008; 
Owen-Ashley et al., 2006). Based upon these previous results, it was expected that 
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the LPS-injected Insulin group would show even greater percent decreases in body 
mass loss than we initially predicted (i.e., when we expected that all LPS-treated 
groups would share similar average body masses). Although we did not see insulin 
attenuate sickness responses in the smaller individuals in the group, these heavier 
animals that continued until the end of the study could have experienced some of 
the anti-inflammatory properties of insulin (Jeschke et al., 2004). The LPS-injected 
Insulin group showed attenuated body mass loss compared to the other groups at 
days 2 and 3 post-LPS. At this point in the study, if animals were no longer 
hypoglycemic, insulin-treatment could have induced anti-inflammatory 
mechanisms rather than exacerbating hypoglycemia as it did in the few hours after 
LPS injection. 
 Animals experiencing glucose deprivation showed the most pronounced 
hypothermic responses of the three LPS-treated groups. Hypothermic responses to 
LPS treatment or infection, rather than febrile responses, are hypothesized to be 
advantageous for pathogen clearance when energy availability is low or in cases 
where animals are experiencing more severe inflammatory responses (Deen and 
Hutchison, 2001; Romanovsky and Szekely, 1998). In the context of this study, the 
hypothermic response exhibited by all LPS-treated groups is more likely a response 
to greater inflammation rather than energy availability, as animals in the Control 
and Insulin groups were experiencing no sources of energy limitation. 
Alternatively, the 2-DG group was experiencing energy limitation, and the 
increased hypothermic response shown by this group could have been a mechanism 
of energy conservation. In a previous study, we showed that hamsters that were 
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experimentally provided with a hormonal signal of increased energy stores (i.e., 
leptin) showed lesser LPS-induced hypothermic responses as compared to animals 
receiving a vehicle control (Carlton and Demas, 2014). The results of the current 
study further support the conclusion that the magnitude of LPS-induced 
hypothermia can be modulated by energetic state and signals of energetic state, as 
hypothermia was enhanced when animals were experimentally deprived of glucose. 
 While 2-DG disrupts glycolysis and induces glucoprivation, it is often used 
in experimental contexts as a “metabolic stressor,” as its effects on glucose use are 
often accompanied by activation of the HPA axis and increased circulating 
glucocorticoid levels (Demas et al., 1997b; Weidenfeld et al., 1994). In the current 
study, there were no effects of 2-DG on cortisol levels in both the saline- and LPS-
injected animals. This lack of increased cortisol in response to 2-DG has been 
observed in two other studies in this species, so it was not necessarily unexpected 
(Carlton et al., 2014; Zysling and Demas, 2007). Glucocorticoids are critical for the 
regulation of inflammatory responses and sickness symptoms (Sapolsky et al., 
2000). Specifically, lack of glucocorticoid regulation of the inflammatory response 
during infection can augment the amplitude and duration of fever, enhance 
behavioral depression, and in some cases, increase susceptibility to death; however, 
glucocorticoid replacement can ameliorate these effects (Coelho et al., 1992; 
Goujon et al., 1995a; Morrow et al., 1993; Ruzek et al., 1999). Glucocorticoids are 
also involved in the regulation of sickness-induced hypothermia (Goujon et al., 
1995b); however, since there were no treatment effects on either saline- or LPS-
injected cortisol levels, this suggests that the increased hypothermic response in the 
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LPS-injected 2-DG group was mediated by changes in energy availability rather 
than glucocorticoids produced as a product of metabolic stress. 
 One reason why we may not have seen attenuation of sickness-induced 
anorexia, body mass loss, or percent decreases in nesting material shredded in the 
LPS-injected 2-DG group was that animals in this group were shifting energy away 
from other physiological systems in order to allocate energy to the immune system. 
2-DG-treated animals had lower paired testes masses than the animals in the 
Control and Insulin groups, which suggests that animals in this group were shifting 
energy away from reproductive maintenance. Previous work has found that when 
experiencing glucose deprivation while mounting a delayed-type hypersensitivity 
(DTH) immune response, male Siberian hamsters show reduced testes mass but no 
reductions in the magnitude of their DTH response as compared to animals not 
experiencing glucose deprivation (Martin et al., 2008a). In females, the reverse is 
found, as glucose-deprived animals show no reductions in reproductive tissue 
masses but show decreases in DTH response as compared to controls (Martin et al., 
2008a). Thus, in the current study, if energy had not been shifted away from 
reproductive maintenance in 2-DG-treated animals, then we may have seen 
attenuation of these additional energetically-expensive sickness symptoms in this 
group. 
 In conclusion, our data show that sickness symptoms in Siberian hamsters 
can be modulated by glucose deprivation and by signals of increased glucose 
availability. Insulin treatment appears to have both enhancing and suppressive 
effects on sickness in this species, as it facilitated severe sickness responses in 
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smaller individuals but attenuated sickness-induced body mass loss in the larger 
individuals that displayed moderate sickness. Glucose deprivation resulted in 
increased sickness-induced hypothermia, but its lack of effect on the other 
energetically expensive sickness symptoms suggests that energy may have been 
reallocated from another physiological system (i.e., the reproductive system) to 
maintain the full expression of sickness symptoms in this group. Collectively, these 
results suggest that glucose availability can modulate sickness symptoms but that 
its effects depend on factors such as infection severity and energetic trade-offs 
among multiple physiological systems.  
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CONCLUSIONS 
Allocation of finite energy resources to competing physiological and 
behavioral processes is essential for ensuring survival and reproductive success in 
both predictable and unpredictable environmental conditions. Seasonally-breeding 
animals experience predictable changes in environmental energy availability as the 
seasons change between the more resource-abundant spring and summer months to 
the less energetically-plentiful fall and winter months. Alternatively, within 
seasons, unexpected variation in abiotic or biotic factors can result in periods of 
resource abundance or scarcity. Internally, animals have a suite of endocrine and 
neuroendocrine factors that respond to changes in food consumption and existing 
energy reserves and act to regulate energy allocation among different processes. 
The broad goal of this dissertation was to elucidate the function of different 
forms of energy and their signals on the regulation of energy allocation to 
immune function and sickness responses within and across seasons in Siberian 
hamsters (Figure 1). To accomplish this goal, I assessed the roles of two main 
forms of chemical energy used by animals (i.e., glucose and fat) and their signals 
(i.e., insulin and leptin) in energy allocation. I experimentally manipulated glucose 
availability via pharmacological induction of glucoprivation with the non-
metabolizable glucose analog 2-deoxy-D-glucose (2-DG) and modulated signals of 
glucose availability with treatment with the pancreatic peptide hormone insulin. I 
manipulated fat reserves through long-term food restriction and altered signals of 
fat reserves with treatment with the adipose peptide hormone leptin. Use of these 
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manipulations, individually or simultaneously, allowed me to tease apart the 
mechanisms of energy allocation toward and away from immune responses.  
 
Figure 1. A simplified model illustrating the measured and unmeasured 
environmental, physiological, and immunological variables assessed in this 
dissertation. Briefly, environmental variables affect energy intake (i.e., glucose) 
and reserves (i.e., fat) of an organism. These environmental variables can all change 
predictably and simultaneously with the seasons. Alterations in glucose intake and 
fat reserves result in changes in circulating levels of the hormones insulin and 
leptin, respectively. These hormones increase with increased glucose 
concentrations or fat masses and decrease with lower quantities of these energy 
sources. Insulin and leptin can act on multiple tissues and systems, including the 
reproductive, immune, and nervous systems (and energy prioritized to one of these 
systems can result in lesser energy allocation to another system). Immune responses 
are generated by activated immune cells and sickness responses are generated via 
a coordination between immune cells and the brain. Finally, the immune and 
sickness responses generated by the organism result in clearance of the pathogen. 
Black boxes around text highlight variables that were measured and/or manipulated 
in this dissertation. Solid black lines indicate direct pathways between variables 
that were manipulated and quantified in this dissertation. Dotted black lines indicate 
indirect pathways between variables that were manipulated and quantified in this 
dissertation (i.e., some intermediaries in the direct pathway were not investigated 
or quanitified). Grey lines show pathways that exist between variables but were not 
assessed in these studies. The numbers found along the solid or dotted black lines 
refer to the dissertation chapter in which the link was measured or manipulated. 
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Summary 
The purpose of Chapter 1 was to determine how different severities of 
glucose deprivation affect energy allocation between the immune and 
reproductive systems and if the effects of glucose limitation on these trade-offs 
can be alleviated with a neuroendocrine signal of increased fat stores. I 
demonstrated that energy allocation in reproductively-active female Siberian 
hamsters depends on the severity of glucose deprivation, as animals experiencing 
lower levels of glucose deprivation allocated energy away from reproductive 
cycling, however, animals experiencing more severe glucose deprivation 
maintained reproductive cycling. Providing a signal of increased fat stores via 
leptin administration alleviated the reproductive inhibition in animals experiencing 
lower levels of glucose deprivation, suggesting that under mild energetic stress, 
tapping into a different energetic system (i.e., lipid stores) can alleviate the 
suppressive effects of this stress. Alternatively, experiencing high levels of 
glucoprivation while receiving a signal of increased fat stores resulted in lower 
antibody production, possibly indicating that resources were shifted toward another 
unmeasured physiological system or process in this case. 
The purpose of Chapter 2 was to examine if seasonal variation in 
sickness intensity is mediated by seasonal changes in circulating leptin levels. 
Since I discovered in Chapter 1 that leptin altered energy allocation toward humoral 
immunity, I wanted to determine its role as an energetic signal that could modulate 
seasonal sickness intensity. I found that providing short-day housed male Siberian 
hamsters with exogenous leptin to simulate long-day leptin levels modulated 
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sickness-induced hypothermia, such that it was attenuated in this group as 
compared to vehicle-treated short-day hamsters. This result suggests that seasonal 
variation in leptin levels may mediate the magnitude of sickness-induced body 
temperature changes. Contrary to predictions, sickness-induced anorexia was 
attenuated, rather than enhanced, in short-day leptin-treated animals, indicating that 
seasonal changes in leptin levels do not modulate seasonal sickness intensity as a 
whole. Rather, different sickness symptoms may be coordinated by other energetic 
(or non-energetic) signals.  
The purpose of this Chapter 3 was to determine if seasonal variation in 
sickness intensity was modulated by seasonal changes in body mass. The lack 
of leptin-induced modulation of the full suite of sickness symptoms in Chapter 2 
led us to investigate if seasonal decreases in actual energy stores would facilitate 
attenuation of the sickness response as a whole. I used experimental food restriction 
to induce a short-day-like pattern of body mass loss in long-day housed hamsters. 
I predicted that if seasonal changes in body mass modulate seasonal variation in 
sickness responses, then long-day food-restricted animals would show short-day-
like sickness responses. I discovered that long-day food restricted animals showed 
more short-day-like body mass loss, anorexia, and hypothermia in response to 
sickness, suggesting that seasonal changes in body mass may mediate some of the 
variation in sickness intensity across the seasons. However, the anorexic and 
hypothermic responses of the long-day food-restricted group fell intermediate 
between those of the short-day and long-day ad libitum groups, even though there 
were no differences in body mass between the long-day food-restricted and short-
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day ad libitum groups. These results suggest the possibility that seasonal changes 
in circulating cortisol levels may be involved in the attenuation of sickness 
symptoms in short-day animals, providing a new avenue for future research in the 
mechanisms coordinating seasonal variation in sickness intensity. 
The purpose of Chapter 4 was to determine how sickness intensity in 
long-day conditions is modulated by glucose availability and a signal of glucose 
availability. In Chapters 2 and 3, I manipulated energy stores and a signal of energy 
stores, simulating predictable seasonal energetic changes for the organism. In 
Chapter 4, I wanted to investigate how sickness intensity is modulated in response 
to more short-term and unpredictable changes in glucose availability. I found that 
glucose deprivation resulted in increased sickness-induced hypothermia, yet had no 
effects on sickness-induced anorexia and body mass. This result suggests that 
glucose availability does limit the magnitude of at least one energetically-expensive 
sickness symptom in long-day animals but not all symptoms. Insulin treatment had 
opposing effects on sickness intensity depending on the pre-sickness body mass of 
the individual. Smaller animals showed severe responses to LPS treatment, 
requiring their removals from the study, whereas larger animals actually showed 
attenuated LPS-induced body mass loss. The presence of lower blood glucose 
levels after LPS injection in the smaller animals that displayed severe sickness as 
compared to the larger animals that displayed moderate sickness suggests that 
insulin may have severe potentiating effects on sickness-induced hypoglycemia in 
smaller animals. 
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Implications and future directions 
These present research findings highlight the complexity of determining the 
effects of different energetic signals and stressors on physiological and behavioral 
responses. In this dissertation, I focused my efforts on understanding how two 
energy sources and two neuroendocrine signals of energy availability influence 
reproductive-immune trade-offs and sickness intensity. One of the recurring themes 
throughout this dissertation is that these energy sources and their signals cannot be 
modulated in a simple input-output system, but instead, changes in these individual 
sources and signals result in feedback and responses that lead to unexpected 
energetic trade-offs. This result is not necessarily surprising as, highlighted in 
Figure 1, leptin and insulin do not only act on the immune system but also have 
effects on the nervous and reproductive systems, in addition to other physiological 
systems not included in this simplified model. Thus, even though I only measured 
two main physiological systems in this dissertation, it is unlikely that these are the 
only two systems that are responding to my manipulations of energy source and 
signal. Furthermore, the endocrine and neuroendocrine signals involved in energy 
regulation are numerous and responsive to each other (Badman and Flier, 2005; 
Spiegelman and Flier, 2001). Therefore, when we manipulate one signal, we are 
likely manipulating a suite of other factors involved in energy regulation. 
Throughout this dissertation, I found examples of these complex 
interactions between energy sources and signals. These examples were often 
manifested as unpredicted occurrences of or lacks of energetic trade-offs. Trade-
offs were observed throughout all four chapters and at all different levels of 
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investigation—between fuel sources, within immune responses, and across 
different physiological systems. Examples of trade-offs between fuel sources were 
observed in Chapters 1 and 3. For instance, in Chapter 1, contrary to my predictions, 
I saw no suppression of the reproductive or immune measures in the group 
experiencing high glucose deprivation, yet I did see suppression of reproduction in 
the group experiencing moderate glucose deprivation. These results were puzzling 
at first, as I expected that under high levels of glucose deprivation I would see 
suppression of both reproduction and immunity; however, upon assessment of 
serum triglyceride levels, I discovered that high levels of glucose deprivation likely 
resulted in a shift in energy utilization from glucose to free fatty acids. This 
discovery highlights that the expression of trade-offs is not only dependent on the 
amount of energy going into the system (i.e., glucose) but is also a product of how 
and when an animal taps into its energy reserves. In Chapter 3, trade-offs between 
energetic fuel sources may explain why I observed incomplete attenuation of 
sickness symptoms in the long-day food-restricted relative to the short-day ad 
libitum group. For instance, even though the short-day ad libitum and long-day 
restricted groups showed similar body masses at the time of LPS treatment, they 
differed in their body fat levels and circulating leptin concentrations. Consequently, 
even though these animals shared similar body weights, they showed variation in 
both their energy sources and signals. The differences in internal energetic 
environment between these two groups could explain why long-day restricted 
animals exhibited greater sickness-induced anorexic responses than short-day ad 
libitum animals. Since long-day restricted animals had greater body fat stores than 
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short-day ad libitum animals, then they may have received neuroendocrine signals 
indicating that energy was not as limited as it was in the short-day animals, even 
though body mass measurements would suggest otherwise. Thus, when energy 
reserves are limited, it is possible that trade-offs among different types of energy 
may influence sickness response intensity. 
I identified the presence of a trade-off within the sickness response in 
Chapter 2, as attenuated LPS-induced hypothermia in the leptin-treated short-day 
group was coupled with an unpredicted attenuation of LPS-induced anorexia. I had 
initially predicted that leptin treatment would result in enhanced LPS-induced 
anorexia in short-day animals if seasonal variation in sickness intensity as a whole 
was mediated by seasonal changes in leptin levels; however, this attenuation of 
anorexia suggests that the energetically-costly sickness symptoms may be regulated 
by different energetic signals. It is possible that attenuating hypothermia resulted 
in increased energy expenditure and alterations in (unmeasured) energetic signals 
that facilitated decreased anorexia. Alternatively, in Chapter 4, I observed a 
potential trade-off across systems as I saw a trade-off between the sickness response 
and the reproductive system. I predicted that glucose depriving long-day hamsters 
would result in attenuation of all energetically-expensive sickness symptoms. 
Instead, I found that glucose deprivation enhanced sickness-induced hypothermia 
but did not suppress sickness-induced anorexia or body mass loss. Yet, I also found 
that glucose-deprived hamsters had smaller testes masses, suggesting that energy 
may have been shunted away from reproductive maintenance to facilitate normal 
expression of sickness-induced anorexia and body mass loss. From the results of 
155 
 
these four dissertation studies, it is apparent that the processes of energy allocation 
within and between physiological systems involves precise coordination among 
systems, fuels, and signals. Shifting our models of energetic trade-offs from simple 
input-output systems to those that consider additional signaling molecules, 
physiological processes, and feedback loops will no doubt allow us to gain better 
understanding of the true mechanisms facilitating energetic allocation among 
competing systems.  
It cannot be ignored that one of the greatest gaps in this body of work is the 
lack of investigation into the role of the central nervous system in these studies. The 
unexpected energetic trade-offs I observed in this dissertation likely were facilitated 
in part by actions to and from the energy-regulating components of the brain. 
Furthermore, the sickness response is a coordinated set of physiological and 
behavioral responses to infection, and as such, these behaviors are regulated and 
coordinated by the brain. Thus, the plethora of grey lines pointed toward the brain 
in Figure 1 are important missing links (and future targets of research) in this body 
of work. It is likely that the behavioral differences that I observed among LPS-
treated groups in each of these final three studies were not mediated directly by 
changes in energetic signals but rather by changes in the release of and sensitivity 
to pro-inflammatory and anti-inflammatory cytokines and glucocorticoids. 
Previous work has shown that Siberian hamsters show seasonal differences in 
sickness upon treatment with the pro-inflammatory cytokine interleukin (IL)-1β, 
such that short-day housed hamsters show attenuated sickness in response this 
treatment as compared to long-day housed hamsters even though they receive 
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similar quantities of IL-1β (Wen and Prendergast, 2007). Additionally, upon LPS 
treatment, short-day housed hamsters show lower circulating serum concentrations 
of IL-6 and lower levels of IL-1β and tumor necrosis factor (TNF)-α from cultured 
lymphocytes and macrophages, respectively (Bilbo et al., 2002; Prendergast et al., 
2003). Much like leptin and insulin do not only affect processes directly related to 
energy balance, cytokine actions are not limited to immune function, but rather, 
they can also communicate with and modulate energetic systems and processes 
(Matarese and La Cava, 2004). Based upon the results of previous explorations of 
cytokines in Siberian hamsters and the connections between cytokines and 
metabolism, it seems likely that the energetic treatments I provided the hamsters in 
this dissertation may have modulated cytokine release and/or sensitivity. 
Unfortunately, antibodies that recognize and bind to pro-inflammatory cytokines in 
Siberian hamsters are no longer commercially available, so I was not able to explore 
these potential connections in this dissertation. However, we hope that in the future, 
if these antibodies become available, the missing links in Figure 1 will start to 
appear. 
Collectively, the results of this dissertation shed light into the complex 
relationships among energy sources and signals in the regulation of energetic trade-
offs and seasonal sickness response variation. Appropriate coordination of energy 
use is critical to produce immune responses that will result in effective pathogen 
clearance. As we move forward in our understanding of the mechanisms that 
facilitate energy allocation to immunity and other physiological and behavioral 
processes in variable ecological contexts, future work targeted at cytokines and 
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neural regulation of these mechanisms will allow us to start to build a complete 
model of the environmental, hormonal, and neural pathways that allow animals to 
express optimal immune responses. 
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